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Abstract
The relationship between ground-state structure and fluorescence lifetime of 
tomaymycin was studied using steady-state and time-resolved fluorescence, absorption, 
NMR, and photochemical techniques. Excited-state proton transfer and intersystem 
crossing were identified as the major nonradiative processes. Solvent isotope effect was 
found in aqueous solution, which did not involved C80H . Photochemical H-D exchange 
on aromatic C6H and C9H were observed with similar rate. At 77 K, the total 
luminescence quantum yield was determined as 0.99. The quantum yield ratio of 
phosphorescence to fluorescence was 1.2. The limiting anisotropy was -0 .34  for 
fluorescence and -0.1 for phosphorescence.
The number and type of tomaymycin-DNA adducts present on natural DNA were 
identified using time-resolved fluorescence spectroscopy. At low bonding density, only 
two species were observed with lifetimes of 4.3 and 7.1 ns and amplitude ratio of 
0.4:0.6, presumably representing R5' and S3' binding modes at preferred bonding site 
5'AGA. These species were present over a range of solution conditions. The two 
species have the same emission spectra, but slightly shifted absorption spectra. The 
fluorescence lifetimes were weakly temperature dependent with Ea = 21 kJ*moH. The 
kinetics of adduct formation was also studied. At saturating bonding density, the 
fluorescence decay showed a bimodal lifetime distribution whether analyzed by least 
squares assuming a Gaussian distribution model or by the maximum entropy method.
The bimodal distributions were centered around 2-3 and 6-6.6 ns, reflecting multiple 
species on different bonding sequences.
Flexibility of calf thymus DNA and poly(dAdG)*poly(dCdT) (1000+50 bp) were 
measured in <41 ns range using time-resolved fluorescence emission anisotropy. A 
global data analysis program was developed from the predicted non-exponential
anisotropy decay model for twisting and bending motions of a semi-flexible rod. The 
program provides options of linking or fixing decay parameters and associating lifetimes 
with anisotropies. Initial anisotropy of -0.36 and orientation of the emission transition 
dipole of the drug toward the DNA helix axis of -35° were obtained for both DNA 
samples. The torsional rigidities were 2.4 and 2.2 x 10-19 erg«cm~1, and the persistence 
lengths were 470 and 140 A, respectively.
x
Chapter 1. Introduction
1.1 Biological Activity and Structure of Pyrrolo[ 1,4]benzodiazepines
Anthramycin, tomaymycin, and sibiromycin (Figure 1.1) are the best-known 
members of the structurally related pyrrolo[l,4]benzodiazepine antitumor antibiotics 
produced by various Actinomycetes. The drugs were isolated from Streptomyces 
refuineus var. thermotolerans , Streptomyces achromogenes var. tomaymyceticus, and 
Streptosporangium sibiricum, respectively (Arima et al., 1972; Brazhnikova et al., 
1972). Other known members are neothramycins A and B, and dextrochrysin. 
Extensive reviews on biological activities, structure elucidation, chemical synthesis, 
biosynthesis, interaction with DNA, and DNA adduct structure have appeared over the 
years (Kohn, 1975; Hurley, 1977; Hurley, 1980; Thurston & Hurley 1983; Hurley & 
Thurston, 1984; Hurley & Needham-VanDevanter, 1986; Remers, 1988; Mountzouris 
& Hurley, 1992; Remers et al., 1992). This introduction will give a brief summary with 
emphasis on tomaymycin and its interaction with DNA.
Pyrrolo[l,4]benzodiazepines have shown highly potent cytotoxic activities as 
antitumor agents in animal model studies (Horwitz & Grollman, 1968) and in the trial 
o f human cancer treatment (Hurley, 1977; Korman & Tendler, 1965), which was 
attributed to their ability to alkylate DNA to inhibit DNA synthesis in cells (Hurley & 
Needham-VanDevanter, 1986). The cytotoxic potency in vivo showed an excellent 
correlation with the ability to form covalent adduct, i.e., sibiromycin > anthramycin > 
tomaymycin > neothramycins (Thurston & Hurley, 1983; Hurley & Needham- 
VanDevanter, 1986; Hurley et al., 1988). These drugs have little effect on the synthesis 
of protein and RNA (Nishioka et al., 1972). They are nonmutagenic, but highly
1
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Figure 1.1. Structures of (lli?,llaS)-anthram ycin (I), (ll/? ,llaS)-tom aym ycin  (II), 
and sibiromycin (III).
3recombinogenic in bacteria (Hannan et al., 1978). Unfortunately, their clinical 
application has been limited by various dose-limiting toxicities. For example, 
anthramycin and sibiromycin can cause cardiotoxicity and tissue necrosis at the site of 
injection, while tomaymycin and neothramycins do not. The cardiotoxicity is 
presumably due to 9-phenolic and N10-H groups, which the latter two drugs lack and 
which can be oxidized into quinone imine (Petrusek et al., 1981). Aided by molecular 
modeling studies, nevertheless, it is very promising to use these naturally occurring 
drugs as templates for the design of new antitumor agents that have reduced side effects 
while maintaining the potent antitumor activity of the parent compounds. Combining 
multidimensional NMR, fluorescence, and molecular modeling techniques, 
investigations of the drug-DNA interaction and the structures of adducts has developed 
a firm basis for subsequent design and synthesis aiming at this purpose. A recent 
example is DSB-120, a DNA-DNA cross-linker, designed based on tomaymycin (Bose 
et al., 1992; Wang, et al., 1992).
These drugs share the same tricyclic nucleus but differ in the ring substituents 
and the saturation degree of the pyrrolo ring. The chemical structure of tomaymycin 
was originally proposed by Kariyone et al. (1971) using chemical degradation methods. 
The hydroxy group at C l 1 will be replaced by methoxy group in methanol, from which 
the crystal was prepared. The X-ray structure was solved by Arora in 1981. The seven 
membered ring appears to adopt a boat conformation with prow at C l 1. C l 1 has R 
configuration, while C l la  has S configuration. The chiral C l la  atom causes a 9° right- 
handed twist conformation along the length of the nucleus, compared to 45° in 
anthramycin crystal (Mostad et al., 1978). Although the exclusive R configuration at 
C l 1 was found in the crystal, a mixture of C l \-R  and C l 1-5 diastereomers were 
observed in methanol solution from a combined *H and l3C NMR, fluorescence, and 
absorption study (Barkley et al., 1986). This facile epimerization reaches equilibrium in 
two hours, presumably by a nucleophilic substitution mechanism through an N10-C11
4imino intermediate (Figure 1.2). The ,H NMR conformational analysis and absorption 
spectra also indicate that the C5 carbonyl lies closer to the aromatic ring plane in the 
(1 IR,1 laS)-diastereomer. The *H and 13C NMR results from another study showed 
that the natural tomaymycin in solution had exclusive trans structure at the tail as found 
in the crystal, although the cis isomer possessed the similar antitumor antibiotic activity 
(Tozuka & Takaya, 1983). In non protic solvent such as chloroform, tomaymycin is 
rapidly converted to 10,11-anhydrotomaymycin, a nonfluorescent species.
The total syntheses of tomaymycin (Tozuka et al., 1983) as well as anthramycin 
(Leimgruber et al., 1968) and neothramycins (Aoki et al., 1969) have been reported.
The biosynthetic studies using radioisotope ( 14C and 3H) labeling and ,3C enriched 
methods indicate that tryptophan, tyrosine, methionine, and dihydroxyphenylalanine all 
serve as precursors for anthramycin, tomaymycin, and sibiromycin (Hurley, 1977).
1.2 Interaction with DNA
Pyrrolo[l,4]benzodiazepine drugs specifically react with B DNA in the minor 
groove through a covalent bond between the C l 1 o f the drugs and guanine N2 of DNA. 
Although the covalent linkage site was proposed as early as 1970 (Kohn & Spears,
1970), direct evidence was not provided until 1984 in anthramycin-d(ATGCAT )2  
adduct (Graves et al., 1984) and 1990 in tomaymycin-d(CICGAATTCICG ) 2  adduct 
(Boyd et al., 1990b) from two-dimensional 'H  and ,3C NMR experiments. Shown in 
Figure 1.2 is the proposed reaction mechanism, which has the same intermediate as in 
the epimerization of tomaymycin. The reaction is quite slow compared to other DNA- 
binding drugs such as mitomycins, adriamycin, or actinomycin. The DNA adducts are 
stable over a range of pH 5-10. The adducts saturated with drug have P/D ratio of 18.2 
for tomaymycin, 12.9 for anthramycin, and 8.8 for sibiromycin as determined from
Figure 1.2. Proposed mechanism for the reaction of pyrrolo[l,4]benzodiazepines with DNA.
6radioisotope labeling method (Hurley et al., 1977). The binding kinetics as well as 
stability of adducts exactly mirrors the order of the P/D ratio at saturation (Hurley,
1977; Hurley & Needham-VanDevanter, 1986).
Pyrrolo[l,4]benzodiazepines are buried inside the minor groove of B DNA helix 
as indicated by NMR, fluorescence quenching, and molecular modeling studies 
(Petrusek et al., 1981; Barkley et al., 1991; Remers et al., 1992). Unlike many other 
minor groove DNA-binding drugs, pyrrolo[l,4]benzodiazepines are basically non- 
distortive to the DNA helix. For example, viscosity and sedimentation data indicate 
that anthramycin causes only stiffening without lengthening of the DNA helix 
(Glaubiger et al., 1974). Some other experimental results including the digestion of 
drug-bound DNA by SI nuclease (Hurley & Petrusek, 1979) and the tomaymycin-DNA 
adduct structures resolved from NMR spectra (Boyd et al., 1990b; Wang et al., 1992) 
do not show helix distortion or unwinding either. The DNA helix is stabilized by drug 
binding as indicated by about 15 °C increase of the melting point of E. coli DNA in the 
presence of excess of drug (Nishioka et al., 1972). Footprinting data shows that each 
drug molecule covers about 3-4 base pairs (Hertzberg et al., 1986; Hurley et al., 1988). 
Several molecular modeling studies suggest that this class of drugs fits very well into 
the minor groove of B DNA because of the right-handed twist conformation of these 
drugs caused by 1 la  chiral carbon (Petrusek et al., 1981; Remers, 1986; Barkley et al., 
1991; Hurley et al., 1988; Wang et al., 1992). In tomaymycin-d(ATGCAT)2  adduct, for 
example, it is suggested that there are three to five water molecules displaced from the 
minor groove with little distortion of B DNA helix, depending on binding mode 
(Barkley et al., 1991). The modeling studies also explain why these drugs do not 
directly bind to Z DNA (Hurley et al., 1988), although the bound tomaymycin may not 
be dissociated when B DNA is converted to Z DNA (our unpublished data). Another 
molecular modeling study on d(GCGCGCGCGC ) 2  and
d(GCGCGTGCGC)*d(GCGCACGCGC) adducts predicted that anthramycin could bind
to Z DNA, but with a few key structural differences from B DNA adduct. The 5' 
orientation is preferred and the drug has a left-handed twist. The Z DNA in the adducts 
was "bent due to a wedge created in the vicinity o f the guanine covalently bound to the 
drug" although the overall DNA distortion energies were less than those in the B DNA 
(Rao, 1990).
According to the reaction mechanism (Figure 1.2), the original stereochemistry 
of C l 1 of the drug in solution is not necessarily maintained after binding. In addition, 
the aromatic ring of the drug may point toward either 3' or 5' end of the modified DNA 
strand. Therefore, there are four possible binding modes: 53', 55', R3', and R5'. In spite 
of the specific binding site at N2 of guanine, experimental data indicate that the 
occupancy of a site as well as the binding mode varies with drug structure and flanking 
base sequence (Remers et al., 1992). There are 16 flanking base sequences with G in 
the middle. 5'PuGPu groups were reported to be preferred binding sequences 
(Hertzberg et al., 1986; Hurley et al., 1988). Recent results indicate that 5'AGA is most 
preferred (Pierce et al., 1993).
Both NMR and molecular modeling techniques can give detailed structural 
information but are limited to oligonucleotide adducts. The definite elucidation of 
fluorescence results from oligonucleotide can be helped by NMR results and then 
extended to high molecular weight DNA. Therefore, a combined multidimensional 
NMR (*H, 13C, and 3lp), fluorescence, and molecular modeling approach is very 
powerful in investigating the structure of drug-DNA complex containing multiple 
binding sites (Remers, 1992). NMR data have shown that anthramycin-d(ATGCAT ) 2  
adduct contains only a single adduct 53' (Graves et al., 1985; Boyd et al., 1990). In 
contrast, a combined fluorescence, NMR, and molecular modeling study showed there 
are two diastereomeric species (11R and 115) on tomaymycin-d(ATGCAT ) 2  adduct. 
The relative populations of the two species are roughly equal. The identity of the two
species were inferred as S3’ and R5' (Cheatham et al., 1988). On the other hand,
NMR of tomaymycin-d(TTCGAA ) 2  and -d(AAGCTT ) 2  adducts showed predominantly 
one species (Cheatham and Boyd, unpublished results, from Boyd et al., 1990b). Only 
one species was found in the bis(tomaymycin)-d(CICGAATTCICG )2  adduct from *H 
and ,3C NMR experiments, while fluorescence studies revealed the presence o f two 
species with more than 90% of the major one. 2D COSY spectra unequivocally showed 
that C l 1 o f tomaymycin covalently bonds through N2 of guanine with an 1 IS" 
stereochemistry in the sequence 5’CGA. 2D NOESY spectra indicated 3' orientation. 
These results suggested that only one or a predominating species was present in 5'AGC 
or 5'CGA, while two species in 5’TGC. In general, these observations agree with the 
predictions made by the molecular modeling studies in the error margin o f about 7 
kcal/mol (Remers et al., 1986; Wang et al., 1992).
1.3 Fluorescence Spectroscopy
Many processes occur in the time scale of 10"8- lO 10 s, including protonation or 
deprotonation, solvent-cage relaxation, translational and rotational diffusion of small 
and moderate size molecules, local conformational changes and internal motions of 
macromolecules. Therefore, fluorescence, which takes place in the same time scale, can 
be a powerful tool to monitor these processes. It is also very sensitive to fluorophore 
environment and can be used in structural studies. For example, a molecule that is 
nonfluorescent in aqueous solution may become strongly fluorescent in a nonpolar or 
rigid environment. Solute quenching studies may tell the accessibility of the binding 
site to quencher and solvent molecules. Energy transfer between chromophores can be 
used to determined the dynamic as well as static distance between the donor and the 
acceptor up to 50 A.
Fluorescence theory and techniques have been well established (Cantor & 
Schimmel, 1980; Lakowicz, 1983; O'Connor & Phillips, 1984). Briefly, fluorescence 
refers to the radiative process in which a molecule in the singlet excited state (Si) 
returns to the singlet ground state (S0) by emitting a photon (hv). At room temperature, 
as illustrated in Figure 1.3, most molecules are in the lowest vibrational level of the 
ground state. A molecule can be excited to the singlet excited state by absorbing a 
photon. The excited molecule will quickly decay to the lowest vibrational level of S \ 
through vibrational relaxation, which happens in a very short time scale of 10-12 s. 
Afterwards, many non-radiative processes may occur to compete with fluorescence. 
Therefore, the observed fluorescence lifetime, which is a measure of the period a 
fluorophore molecule remains in the singlet excited state, is defined as
X = (&r +  ^nr)~* (1-1)
where kT is the rate constant of the radiative process and Icm the sum of the rate 
constants of all non-radiative processes including intersystem crossing (k isc), internal 
conversion (kic), solute quenching (&q[QJ), proton transfer (&pt), and various other 
excited state reactions. The radiative rate is typically around 108 s '1. The lifetime value 
varies from a few picoseconds to hundreds of nanoseconds depending on kr and what 
can take place rapidly enough to compete with emission. The fluorescence lifetime can 
be experimentally determined from fluorescence intensity decay data, 7(t), which is 
usually a sum of exponentials:
n
/( t) = X  Oj exp(-t / Xj)
i = i ( 1 . 2 )
where n is the number of distinct lifetime species, a ;  the relative amplitude, and Xj the 
lifetime value. The fluorescence quantum yield is defined by
<j)f = kr / (kr + km) = kr x (1.3)
and is usually experimentally determined by comparison to a standard.
10
S,
cr
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Figure 1.3. Modified Jablonski diagram. S0, S,, and T, indicate the ground state, 
the first singlet excited state, and the lowest triplet state. The first order rate constants 
k{, kic, kpt, and kisc refer to radiative process, internal conversion, proton transfer, 
and intersystem crossing. Solid arrow indicates radiative process, and dashed arrow 
represents non-radiative process.
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Molecules in the singlet excited state can also undergo conversion to the first 
triplet excited state (T i), which is called intersystem crossing. Phosphorescence refers 
to the radiative transition from T \ to S0, which is quantum mechanically forbidden. It 
thus has a very slow radiative rate and very long lifetime which is in the range of 
milliseconds to seconds. The observed phosphorescence quantum yield depends on 
both intersystem crossing yield and decay of the triplet excited state. The intersystem 
crossing yield (<f>isc) and phosphorescence yield (<j)p) are defined as
where kp is the phosphorescence radiative rate and k' the sum of all other nonradiative 
processes that occur in the triplet excited state. At room temperature, kp is usually so 
slow compared to k' that phosphorescence cannot be detected.
Fluorescence anisotropy (r) exists due to photoselection. The incident light 
selectively excites those fluorophore molecules whose absorption transition dipole is 
parallel to the electric vector of the light. It is defined by
where I\\ and I± are the vertically and horizontally polarized fluorescence intensities 
when molecules are excited with vertically polarized light, respectively. For molecules 
whose absorption transition dipole is randomly distributed in three dimensions, the 
limiting anisotropy (rc) is determined by
^isc — ^isc ! (kr + knT) (1.4a)
^p — ^isc I (&p +  k ) (1.4b)
r
(1.5)
r,o
2 (3 cos20 - 1) 
5* 2 ( 1.6 )
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where 0 refers to the relative orientation o f the absorption and emission transition 
dipoles. The value o f r0 will be 0.4 for parallel transition dipoles and -0.2 for 
perpendicular. Any factors that can displace the emission dipole during the lifetime of 
the excited state will decrease the observed value of r. For example, the observed 
average value of anisotropy for a rigid molecule in solution is determined by 
= ro
1 +(T /< t>)  ( 1 . 7 )
where the rotational diffusion correlation time <j) for a sphere is given by
<|> = r)Vh/KBT  (1.8)
where r\ is the solvent viscosity, KB the Boltzmann constant, T the absolute 
temperature, and ty, the hydrodynamic volume of the molecule. Therefore, 
fluorescence anisotropy is a very useful and powerful tool to study the hydrodynamic 
properties and conformational changes of molecules.
1.4 Dynamics of the DNA Helix: Twisting and Bending Motions
Like fluorescent intercalating drugs, tomaymycin may also serve as an effective 
fluorescence probe for monitoring the dynamics of the DNA helix. The dynamics of 
the DNA helix is involved in DNA-protein recognition and attributed to the stability 
and biological activity o f the resultant complex. Although the DNA helix alone is 
rather rigid in principle due to basepair stacking interactions, Watson-Crick hydrogen 
bonding, electrostatic repulsion of negatively charged phosphate groups on the 
backbone, and solvation, it is often bent in DNA-protein complexes. A typical example 
is histone in which the DNA helix is wrapped in a very tight circle of about 140 A 
diameter (McGee & Felsenfeld, 1980), compared with the persistence length of about
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500 A (Schurr & Schmitz, 1986; Hagerman, 1988). The energetics of deforming the 
helix is governed by its elastic properties, which include torsional (or twisting) and 
bending rigidity. The twisting is due to the shearing of adjacent basepairs over each 
other. The bending of duplex DNA is caused by opening up the distance between 
adjacent basepairs. These internal motions o f the DNA helix occur on the time scale of 
subnanosecond to microseconds (Barkley & Zimm, 1979).
The bending and twisting motions in B DNA have been studied by fluorescence 
anisotropy decay (Wu et al., 1988), triplet anisotropy decay (Hogan et al., 1983), 
dynamic light scattering (Sorlie & Pecora, 1988), transient electric birefringence and 
dichroism (Hagerman, 1985), electron microscopy (Revet et al., 1984), *H NMR (Mirau 
et al., 1985), and ligase-catalyzed cyclization rate of DNA (Shore et al., 1981). Except 
for electron microscopy which can actually detect differences in various regions of 
DNA molecules, statistical evaluations of motions are obtained. Analytic theories for 
an elastic DNA model (Allison & Schurr, 1979; Barkley & Zimm, 1979; Schurr, 1984) 
as well as Monte Carlo (Hagerman & Ramadevi, 1990) and Brownian dynamics 
simulations (Lewis et al., 1988) have been used to extract dynamic parameters from 
experimental data. The values of 1.3-3 x 10 '19 erg-cm for torsional rigidity (C) and 
400-850 A for persistence length (P) were generally obtained in most laboratories 
depending on the measuring conditions, methods, and the theories used. The torsional 
rigidity is related to the equilibrium root-mean-square fluctuation in the torsion angle 
(Ay)rms between one base pair and the next as C<Ay2> = 3.4 x 10-8 lifeT where ATb is 
the Boltzmann constant and T the absolute temperature. The bending rigidity, El =
P/^bT.
Besides the B double helix, which cellular DNA mainly adopts, many other 
unusual DNA structures have been identified and characterized. Some examples are A 
and Z double helices, triple and quadruple helices, bent DNA, bulges, junctions, and
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loops. The biological significance of non-B structures has yet to be established.
However, a lot of circumstantial evidence has strongly suggested an important role for 
these non-B structures in gene expression. Non-B DNA structures should have 
different dynamics, possibly even perturbing the flexibility of contiguous B DNA 
regions. However, little is known about structural consequences for flexibility, except a 
few studies of Z DNA flexibility which drew contradictory conclusions (Thomas & 
Bloomfield, 1983; A shikaw aet al., 1984; Mirau et al., 1985).
The fluorescence anisotropy decay of a probe that binds tightly to the DNA 
helix depends only on the rates of rotational diffusion and internal motions of the helix 
and thus reports the dynamics o f the DNA helix. To observe only the internal motions, 
the length of the DNA helix has to be much longer than its persistence length or 150 
base pairs. Ethidium bromide is the most commonly used probe in previous studies 
(Ashikawa et al., 1987; Wu et al., 1987; Millar, 1990; Winzeler & Small, 1991). Its 
fluorescence lifetime is only 2 ns in water but as high as 23 ns in DNA complex 
(Olmsted & Kearns, 1977). The fluorescence anisotropy decay r(t) of a probe that binds 
tightly to the DNA helix and reports only the internal motions of the DNA helix will 
obey the following equation:
2
r(0 = ro X l n ( t ) F n( t ) G n(t)
n=0 ( 1 . 9 )
where In(t) is the internal correlation function that depends only on the angle £ between 
the emission transition dipole and the helix axis when the probe is rigidly attached.
F n(t) and Gn(t) are the twisting and bending correlation functions. However, the 
bending motion has been ignored or assumed to be a fixed value in previous studies. 
Therefore, the torsional rigidity may have been either underestimated or ill-interpreted 
due to the uncertainty of the bending rigidity (Fujimoto & Schurr, 1990).
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1.5 Objectives of This Research Project
Tomaymycin is an important member of pyrrolo-[l,4]-benzodiazepine antitumor 
antibiotics. It lacks cardiotoxicity but has weak potency. Attempts to design new drugs 
based on it have been made. Its success will highly depend on the knowledge of the 
interaction between tomaymycin and DNA and the structure of the resultant complex. 
This dissertation involves the use of steady-state and time-resolved fluorescence 
spectroscopy to study the structure of tomaymycin-DNA adducts, in conjunction with 
NMR and molecular modeling studies. The first part of the dissertation deals with the 
relationship between the fluorescence and molecular structure of tomaymycin. Solvent 
effects, solvent isotope effect, photochemical H-D exchange, and luminescence at 
cryogenic temperature are studied. The second part investigates the structure of 
tomaymycin-DNA adduct by time-resolved fluorescence spectroscopy. Global non­
linear least squares fitting and maximum entropy methods in conjunction with 
simulation are used to established the fluorescence lifetime model for the adducts. The 
structures of binding species in the adduct are determined by comparison with 
fluorescence results for synthetic DNAs of defined sequence.
Tomaymycin is also a fluorescent probe to study the dynamics of the DNA helix 
which is very important to DNA-protein recognition. The third part of the dissertation, 
therefore, involves studies on the flexibility of the DNA helix using time-resolved 
fluorescence emission anisotropy. A global non-linear least squares data fitting 
program is developed based on the existing theory of the torsional and bending motions 
of the DNA helix. The torsional rigidity and persistence length of calf thymus DNA 
and poly(dA-dG)*poly(dC-dT) are measured in different time ranges.
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Chapter 2. Fluorescence Properties of Free Tomaymycin
2.1 Introduction
As a potent antitumor antibiotic, tomaymycin binds specifically to the N2 of 
guanine in the minor groove o f B DNA (Figure 1.2) to inhibit DNA synthesis both in 
vivo and in vitro. It can also serve as a fluorescent probe of the rapid internal bending 
motions in the DNA helix using time-resolved fluorescence emission anisotropy 
(Barkley & Zimm, 1979). Therefore, it is very important to understand the fluorescence 
quenching mechanism of tomaymycin in order to further investigate the interaction with 
DNA, the structure o f the DNA adduct, and the dynamics of the DNA helix by means 
of fluorescence spectroscopy.
The fluorescence quantum yield and lifetime o f tomaymycin in aqueous buffer 
are much smaller than in organic solvent and in DNA adduct (Barkley et al., 1986, 
Remers et al., 1992). Different diastereomers (i.e., 1 I R , \ la5  and 115,1 la5) and DNA 
adducts of different binding mode (i.e., 53', 55', R3', and R5') also possess different 
lifetimes and quantum yields. For example, (11/?,1 Ia5)-TME in methanol has a 
lifetime o f 4.9 ns compared to 3.3 ns for (115,1 Ia5)-TME (Barkley et al., 1986). The 
lifetime of 53' species in tomaymycin-d(ATGCAT)2  adduct is 5.9 ns, while R5' is 3.3 ns 
(Cheatham et al., 1988). Several possibilities, such as different substituents on C l 1, 
polar or non-polar solvation effects, H-bonding, and excited-state proton transfer 
(Schulman, 1976), could contribute to the fluorescence differences (Lakowicz, 1983).
In this work, excited-state proton transfer has been shown to be a major 
quenching process affecting the fluorescence of tomaymycin. The solvent isotope 
effect on the fluorescence of tomaymycin has been investigated using both steady-state
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and time-resolved techniques. Photochemical H-D exchange at aromatic carbons of 
tomaymycin in methanol-d4 will also be reported. To the best of our knowledge, this is 
the first report of H-D exchange occurring on aromatic carbon under neutral conditions.
In addition, several important molecular parameters including the limiting anisotropy 
value, the total luminescence quantum yield, and the intersystem crossing rate were 
directly measured at 77 K in ethanol glass. Based on these results, a mechanism for 
fluorescence quenching and excited state H-D exchange reaction is proposed.
2.2 Materials and Methods
Chemicals. (11/?, 11 aS)-tomaymycin methyl ether (TME) was a generous gift 
from Dr. M. Kohsaka, Fujisawa Pharmaceutical Co. (Japan). 8 -methyl tomaymycin 
methyl ether (MTME) was synthesized at University of Texas at Austin as described in 
Barkley et al., 1986. Other chemicals were obtained from commercial sources. They 
were spectroscopic or HPLC grade and used without further purification. Oxygen gas 
was removed from organic solvent simply by flushing with argon for 15 min. Double­
distilled and microfiltered H2 O was used at all stages. The percentages o f deuterium 
atoms in deuterated solvent was 99.99 % in D2 O, 99.8 % in CD3 OD, 99+ % in DC1, 
and 99+ % in NaOD. The aqueous buffer is 0.01 M cacodylic acid, 0.1 M NaCl, and 
0.1 mM EDTA, adjusted to pH (or pD) 5.1, unless indicated otherwise. The pD value 
was estimated from the reading of pH meter plus 0.4 (Lumry et al., 1951).
Fluorescence Studies. Drug solutions were prepared from a methanol stock 
solution stored at -20 °C. The concentration of the stock solution was determined from 
the absorbance at 319 nm (extinction coefficient e = 3600 M 'lcm_1) for TME (Arima et 
al., 1972) and 320 nm (e = 3700 M‘,c n r 1) for MTME (Barkley et al., 1986) on an 
AVIV 118DS UV-VIS spectrophotometer. An aliquot of the stock solution was placed
22
in a vial, and the methanol was evaporated under vacuum. Solvent was added to give 
the desired concentration. Solution was equilibrated overnight at room temperature 
prior to use.
The fluorescence quantum yield or relative intensity was measured in 10x10 
mm 2 stoppered cuvette on an SLM 8000 fluorometer. The band-pass was 4 nm for 
excitation and 8  nm for emission. The polarizer was set at 54.7° to the vertical for 
excitation and at 90° for emission. The spectra were corrected for both solvent blank 
and wavelength-dependent instrumental factors. Quinine sulfate (Eastman Kodak) in
1.0 N sulfuric acid (double distilled, GFS Chemicals) solution was used as the standard 
with a quantum yield of 0.546 at 25.0 °C (Melhuish, 1961). All measurements were 
carried out at 25.0 °C unless indicated otherwise. The refractive index correction was 
not applied because of the similar refractive indices of methanol, water, and acetonitrile. 
Solution concentration was controlled with the absorbance at the longest maximum 
absorption wavelength less than 0.1. Time-resolved fluorescence techniques will be 
described in Chapter 3.
Photochemical H-D Exchange Reaction. Photochemistry was carried out in a 
quartz cuvette for wavelengths shorter than 300 nm or in a thin wall Pyrex NMR tube 
for longer wavelengths. TME or guaiacol (i.e., 2-methoxyphenol) was dissolved in 
99.8% CD 3 OD. Guaiacol was selected as a simple model compound of tomaymycin 
only for the purpose of investigating the effect of hydroxy and methoxy groups on the 
photochemical aromatic H-D exchange (Ericsson et al., 1964; Wan & Wu, 1990;
Pollard et al., 1993). Solutions were irradiated with a 200 W Hg-Xe lamp filtered by a 
Corning 0-53 UV light cut-off filter for > 300 nm or without any filter for shorter 
wavelengths. TME solution was irradiated only at > 300 nm and guaiacol solution at 
both wavelength ranges. The photochemical H-D exchange was monitored as a 
function of time from *H NMR spectra measured on a Bruker AC-400 MHz FT-NMR
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spectrometer. The extent of H-D exchange (D%) of tomaymycin was determined from 
the integrals o f the aromatic proton resonances (C6 -H and C9-H) relative to the methyl 
proton resonances (C I2 -CH3 ) o f the pyrrolo ring substituent (Figure 2.1). The apparent 
pseudo-first-order rate constant (k) was obtained from the slope of the linear portion of 
a plot of In (D%) vs time where D%  < 18 %. The H-D exchange reaction of guaiacol 
was monitored by mass spectrometry as well as *H NMR spectroscopy. The relaxation 
delay time in 'H  NMR measurements was 5 s, and the same instrumental set-up was 
used for all experiments including the unirradiated control samples.
Solute Quenching. The fluorescence intensity and H-D exchange reaction rate 
were monitored as a function o f quencher concentration. Concentrations of stock 
solutions of TME, acrylamide, and KI in methanol-d4 are 0.026, 1.04, and 0.64 M, 
respectively. Aliquots of stock solutions are added to methanol-d4 to give desired 
concentrations. The concentration of TME was 0.011M in NMR measurements. 
Fluorescence intensities were measured at 320-nm excitation wavelength and 400-nm 
emission wavelength for 5 5-s intervals, and the average values were used. The H-D 
exchange rates were determined from 'H  NMR as described above. For acrylamide, 
only the (1 l/?)-C9H was clearly distinguished from the resonance signal of acrylamide 
and used to calculate the H-D exchange rate. Quenching data were fit to the Stern- 
Volmer equation
X0 / X  = (l+*sv[Q]) (2-1)
where Xo and X  are the fluorescence intensities or the H-D exchange rates in the 
absence and presence of quencher Q, and A"sy is the Stern-Volmer constant (Lakowicz, 
1983). For fluorescence, Afsv = ^ 0 * where kq is the bimolecular quenching rate 
constant and tq  the fluorescence lifetime in the absence of quencher.
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CH .O
Tomaymycin (TOM) R 1 = H, r 2 =
8 -Methoxytomaymycin (mTOM) R 1 A
O11 R2
Tomaymycin methyl ether (TME) R 1 = H, R2
8 -methoxytomaymycin methyl ether (mTME) R 1 = c h 3, R2
DNA adduct R 1 = H, R2
= OH 
= OH 
= OCH3 
= OCH3 
= NH-base
Figure 2.1. Structures of (1 li?,l laS')-tomaymycin and derivatives.
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Total Luminescence Studies. Measurements of the total luminescence were also 
carried out on the SLM 8000 fluorometer using a quartz ESR tube (5 mm diameter) as a 
sample cell and ethanol as cryogenic solvent at 77 K. Sample solution in the tube was 
degassed by several cycles of freeze-pump-thaw to prevent cracks in the frozen ethanol 
glass. The tube was sitting in a quartz Dewar flask containing liquid nitrogen, which 
replaced the regular sample holder. The slit width at excitation was set to 0.5-nm 
bandpass for better placement of the incident light on the sample surface and less 
reflection. The position of the tube in the flask was carefully adjusted to give minimum 
intensity at 325 nm (7iex = 320 nm) but maximum intensity at 376 or 444 nm in order to 
minimize scattered light. A flow of nitrogen gas was used to remove moisture in the 
sample chamber. The fluorescence spectra from the same ethanol solution and quinine 
sulfate in 1 .0 N sulfuric acid were also taken in the same set-up but at room temperature 
and used as the standards. In this case, liquid nitrogen was replaced by water. The 
temperature correction factor is -0.25% (°C) _1 for quinine sulfate (Miller, 1981). The 
observed intensity (70) is approximately corrected for the refractive index (n) effect as 
n2I0 (Miller, 1981). The whole spectra and the total quantum yield were obtained. The 
total quantum yield of tyrosine in 6.0 N HC1 solution at 77 K is 1.0 (Bishai et al., 1967; 
Kuntz et al., 1966) and was measured to check the set-up.
In another measurement, the phosphorescence spectra were recorded using the 
above set-up with the Dewar flask sitting in a rotating can phosphoroscope to prevent 
fluorescence from reaching the photomultiplier. The phosphoroscope is a mechanical 
device that periodically modulates the excitation events out of phase of the observation 
events. Only the photon whose lifetime is in the range of milliseconds or longer is 
observable, which is the time scale of phosphorescence. The detected light intensity 
depends on the time that the sample is exposed to the excitation light and to the 
photodetector and the time that each rotating circle takes (tc), as well as the excited
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state lifetime (x). When x » tc, the detected light intensity becomes independent of the 
rotating speed (McCarthy & Winefordner, 1967).
After corrections for solvent blank and wavelength-dependent instrumental 
factors, both the phosphorescence and total luminescence spectra were normalized at 
525 nm where the fluorescence was assumed to be negligible while phosphorescence 
was still much stronger than background noise. The normalized fluorescence spectra 
were obtained by subtracting the normalized phosphorescence spectra from the 
normalized total luminescence spectra. The ratio of the areas under the 
phosphorescence and fluorescence spectra is equal to the quantum yield ratio of 
phosphorescence verse fluorescence (P/F). From the P/F ratio and the total quantum 
yield, the individual quantum yield of phosphorescence and fluorescence was 
determined. More than twelve measurements were repeated and the average value was 
used. The limiting values of anisotropy through the wavelength range of the total 
spectra were also recorded in the same set-up and corrected for the polarization- 
dependent G factor of the detection train:
7VV - G /vh
r = ---------------------
7VV + 2G/vh (2.2)
where G = 7hv  / 7hh> FI = horizontal, V = vertical, and the first letter in the subscript 
refers to the orientation of the excitation polarizer, while the second to the emission 
polarizer.
The temperature dependence of the absorption spectrum of tomaymycin ethyl 
ether in ethanol was determined separately in a 1 0  x 1 0  mm2  stoppered quartz cuvette 
on an AVIV 14DS UV-VIS spectrophotometer equipped with an Oxford DN1704 
nitrogen cryostat controlled by an Oxford ITC4 digital temperature controller. The 
absorption spectra was found independent of temperature over the range of 300 K to
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160 K, which is close to the melting point of ethanol. No attempt below 160 K was 
made due to the high risk of breaking the quartz windows of the cryostat when ethanol 
glass cracks. The relative absorbance change was exactly the same as the relative 
volume change o f ethanol. The absorbance at 77 K was then estimated from the 
absorbance at 25 °C after correction for solvent contraction at low temperature, which 
was easily determined as 20 ±  3 % from the height change of the sample in the tube.
2.3 Results
Radiative Rate Constants. The substituent as well as the stereochemistry on 
C l 1 of tomaymycin depends on solvent (Figure 2.1). For example, the substituent on 
tomaymycin is -OF! and has S  configuration in aqueous solution, -OR and a mixture of 
S and R configurations in alcoholic solvent (ROH). C l 1 links to the guanine-NH of 
DNA and is a mixture of S  and R  configurations in DNA adducts (Remers et al., 1992). 
However, the fluorescence radiative rate constants (kr) of these different species 
determined from quantum yield (<()) and lifetime (x) data with kr = <|) / x are very similar 
(Table 2.1). The average kf  is about 6 . 8  x 107 s-1. The fluorescence differences among 
these compounds must be due to differences in the nonradiative rates.
Solvent Effects. When TOM in water was diluted into methanol, the 
fluorescence increased instantaneously to the same intensity as TME in methanol. 
Likewise, when TME in methanol was diluted into water, the fluorescence decreased 
instantaneously to the same intensity as TOM in water (Figure 2.2). In comparison, 
methylation of TOM and hydrolysis of TME were slow processes as monitored by 
absorption spectra (Figure 2.3). The maximum absorption wavelength of tomaymycin 
is -320  nm in methanol and -313 nm in water. Epimerization of the R and S 
diastereomers at C l 1 as monitored by fluorescence, absorbance, and ’H NMR was also
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Table 2.1 Radiative Rates of Different Compounds
compound solvent <t> ^ (ns)a kr x  1 0 -7 s' 1
TOM H2 O buffer 0.067 1.04 6.4
D 2 O buffer 0 . 1 0 1 1.59 6.4
TME MeOH 0.34 4.4 7.5
MeCN^ 0.13 1 .8 7.2
TOM DNA adduct 0.31 4.65 6.7
mTOM H 2 O buffer 0.098 1.4 7.0
D 2 O buffer 0.141 2 . 0 7.1
mTME MeOH^ 0.37 5.2 7.1
MeCN^ 0.18 2.3 7.8
mTOM DNA adduct^ 0.40 5.88 6 . 8
a x =  (XajTj) / (Ea;). b Data adopted from Barkley et al., 1986.
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TOM in 9:1 methanol/water
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0 .4 -
TME in 1:9 methanol/water
0.0
64 5 71 2 30
Hours after Changing Solvent
Figure 2.2. Solvent effects on the fluorescence of tomaymycin. The time axis for 
TME is shifted 0.1 hr for better separation at 0 hr.
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Figure 2.3. Solvent effects on the absorption spectra of tomaymycin.
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slow (Barkley et al., 1986). Therefore, the instantaneous changes in fluorescence 
intensities were exclusively due to the solvent changes rather than the different 
substituent or stereochemistry on C l 1.
After the dramatic change immediately after mixing, the fluorescence intensity 
o f TOM in 9:1 methanol/water mixture was slightly increased by about 10-15% in 2-3 
hours and leveled off gradually afterwards. TOM in aqueous solution is predominately 
(115,1 laS)-diastereomer, while TME in methanol is the mixture of (11/?,1 la5)- and 
(11S, 11 a5 )-diastereomers. (11R, 11 aS)-TME has a longer lifetime than (11S, 11 a5)-TME 
(Barkley et al., 1986). After mixing TOM aqueous solution with methanol, both 
methylation and epimerization on C l 1 occurred by the same nucleophilic substitution 
mechanism through the imino intermediate (Figure 1.2). These reactions were complete 
in the period of 2-3 hours as monitored by absorption spectra (Figure 2.3) and 1H and 
13C NMR spectra (Barkley et al., 1986). This suggested that the 15% after-mixing 
change in fluorescence intensity was due to the different diastereomers at C l 1. This 
intensity change is rather small compared to the about 300% change due to solvent 
change.
A similar solvent dependence of fluorescence of TOM in the mixture solvent of 
water and acetonitrile was observed (Figure 2.4) although it is complicated probably by 
the dehydration of tomaymycin into an imino form in the excited state in acetonitrile. 
The imino form of tomaymycin is completely nonfluorescent (Barkley et al., 1986).
The quantum yield increased from 0.067 to more than 0.2 when acetonitrile 
concentration was increased from 0% to 30% and leveled off. But the quantum yield 
quickly dropped from 0.27 to 0.13 when the concentration of acetonitrile increased from 
90% to 100%, indicating that the effect of dehydration seemed to become significant at 
high acetonitrile concentration.
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Figure 2.4. The quantum yields of tomaymycin in water/acetonitrile mixture.
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Solvent Isotope Effect. Tomaymycin and 8-methoxytomaymycin had greater 
quantum yields and lifetimes in D2O than in H2 O (Table 2.1). The isotope effect was 
constant and the same in both compounds from pH 3-7. The quantum yield was also 
constant over this pH range (Figure 2.5). The isotope effect suggested that excited-state 
proton transfer was an important nonradiative process. The fluorescence quenching at 
high pH represented ground-state reaction. The 8-phenolic proton of TOM dissociates 
with pKa = 8 and the phenolate is non-fluorescent (Barkley et al., 1991). At pH < 2.5, 
fluorescence was probably quenched through protonation. The fluorescence quantum 
yield was also measured in H2 O/D2 O mixtures (Table 2.2). Assuming that excited-state 
proton transfer and intersystem crossing (&isc) were the major nonradiative channels, 
the proton transfer rates (&pt) in the mixtures were estimated using &r = 6.8 x 107 s~* 
and &isc = 8.5 x 107 s_I (see the results at 77 K later in this section for details). The 
proton inventory technique gave a linear plot of k p j  vs D % (Figure 2.6), indicating that 
proton transfer involved a single exchangeable hydrogen (Isaacs, 1987). The proton 
transfer rates in H7O and D2 O were 8.6 x 108 and 5.2 x 108 s_l, respectively. On the 
other hand, the estimated proton transfer rate of TME in methanol was only 4 x 10"7 s_1, 
which yielded a negligible isotope effect on the quantum yield in methanol.
Photochemical H-D Exchange. About 50 % H-D exchange at both C6 and C9 
positions of the aromatic ring of TME in methanol-d4 was observed by *H NMR after 2 
hr irradiation with > 300 nm light (Figure 2.7). Both positions had similar amounts of 
H-D exchange (Figure 2.8). No H-D exchange was detected without light irradiation. 
Guaiacol in methanol-d4 did not show any H-D exchange after 5 hr irradiation even 
without the UV cut-off filter. Guaiacol and its hydroxy and/or methoxy substituted 
derivatives can undergo the photochemical H-D exchange reaction in the presence of 
strong acid, strong base or metal complex catalyst (Ericsson et al., 1964; Wan & Wu, 
1990; Pollard et al., 1993). This suggested that the hydroxy and methoxy substituents
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Figure 2.5. The solvent isotope effect on fluorescence intensity of tomaymycin: ( • )  H20  and (A) D20 .
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Table 2.2 Quantum Yield ((|>) of Tomaymycin in D2O/H2 O Mixtures
0 0.067
25 0.074
50 0.082
75 0.094
100 0.101
36
8 -
o
6 -
0.60.2 0.4 0.8
Fraction of D-Atom in Water
Figure 2.6. Proton invenory plot. Proton transfer rate kpj was estimated from the
7 1quantum yield in D20 /H 20  mixture using k = k{ + k]sc + fcpp, where kr = 6 . 8  x 10 s' 
and fcisc = 8.5 x 107 s '1.
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7.0 6.0 2.0
Figure 2.7. Partial *H NMR spectra o f TME in methanol-d4: (top) no irradiation, 
(middle) 2 hr irradiation, and (bottom) 2 hr irradiation with 0.45 M KI.
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Figure 2.8. The positions and amount of photochemical H-D exchange on 
tomaymycin methyl ether in methanol-d4 as monitored by 'H  NMR.
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alone did not lead to the excited-state H-D exchange in neutral solution. The H-D 
exchange was quenched by acrylamide and KI (Figure 2.7 & 9). The Stern-Volmer 
quenching constant (Ksv) of acrylamide for H-D exchange was comparable to K$v  for 
fluorescence of TME, while the ATsv ° f  KI for H-D exchange was about twice the value 
of K$y  for the fluorescence (Table 2.3).
Cryogenic Measurements and Phosphorescence. The absorption spectrum of 
tomaymycin ethyl ether in ethanol did not change with temperature. The maximum 
absorption wavelength remained at 319-320 nm (Figure 2.10). However, two peaks 
(376 nm and 444 nm) appeared in the emission spectrum at 77 K (Figure 2.11). Only 
the 444 nm peak remained when the rotating can phosphoroscope was used, indicating 
that it was phosphorescence (McCarthy & Winefordner, 1967). The intensity did not 
depend on the rotating speed o f the phosphoroscope, suggesting that the triplet excited- 
state lifetime was in the millisecond or longer time scale.
The average value of total quantum yield was 0.99 ±  0.10 with P/F ratio of 1.2 + 
0.2. The estimated quantum yield was 0.55 ±  0.10 for phosphorescence with maximum 
emission at 456 ± 1 nm and 0.44 ± 0.04 for fluorescence with maximum emission at 
376 ± 1 nm. The Stokes' shift is still quite large although it decreases from 100 nm at 
298 K to 56 nm at 77 K. In solvent glass and at very low temperature, molecules are 
presumably immobile and all temperature-dependent nonradiative processes are 
negligible compared to the radiative process which is usually temperature-independent. 
The remaining competitive nonradiative process is usually only intersystem crossing. 
Thus the intersystem crossing rate (&js c ) can be estimated. From (1 - <|)f)/<|>f =  ^isc^r* 
the intersystem crossing rate was calculated to be (8.5 ± 1.0) x 107 s_1. In addition, 
molecules will stay at exactly the same orientation during the period between 
absorption and emission. Therefore, the limiting value of the fluorescence anisotropy 
can be directly measured. It is a crucial parameter in the data analysis of time-resolved
40
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Figure 2.9. The Stern-Volmer plot of photochemical H-D exchange ( • )  and 
Fluorescence (■ ) of tomaymycin methyl ether in methanol-d4 quenched by 
acrylamide (a) and KI (b). k  refers to the first-order rate constant o f the H-D 
exchange reaction, I  the fluorescence intensity.
Table 2.3 The Quenching Parameters
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quencher fluorescence H-D exchange
_________  M M - U - l)  KSy  (M -1) g Sv(M -»)
acrylamide 2.5 x 109 10.2 ± 0 .3  12 ± 1
KI 2.7 x lO 8 1.22 + 0.02 2.8 ± 1 .5
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Figure 2.10. The absorption spectra of tomaymycin ethyl ether in ethanol 
at different temperatures.
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Figure 2.11. The total luminescence (thick line), fluorescence (solid line), and phosphorescence (dotted line) 
spectra of tomaymycin ethyl ether in ethanol glass at 77 K. Excitation wavelength 320 nm. The dots 
represent the anisotropy values.
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and steady-state fluorescence emission anisotropy measurements. The measured 
limiting anisotropy value was about 0.34 for fluorescence and about -0.1 for 
phosphorescence (Figure 2.11).
2.4 Discussions
Excited state proton transfer appeared to be another major nonradiative process 
besides intersystem crossing due to the following reasons: i) fluorescence intensity 
depends on the nature of solvent rather than the molecular structure change occurring in 
different solvents; ii) the solvent isotope effect is present; iii) the H-D photochemical H- 
D exchange occurs; and iv) the H-D exchange reaction can be quenched by 
fluorescence quencher, implicating it occurs at the singlet excited-state. The same 
isotope effect for both TOM and MTOM indicates that the 8 -phenolic group does not 
contribute to it. The photochemical H-D exchange reaction happens at the singlet 
excited-state because the Stern-Volmer quenching constants (ATsv) of acrylamide is the 
same as the A sv f° r fluorescence. On the other hand, the A'sv of KI for the H-D 
exchange is larger than that for fluorescence, suggesting the involvement of more than 
one excited-state. Heavy atoms such as iodide usually quench fluorescence through the 
enhancement of the intersystem crossing rate (Lakowicz 1983; Miller et al., 1977). The 
ineffective quenching of KI to the fluorescence of tomaymycin is probably because the 
intersystem crossing rate in tomaymycin is already very large. The H-D exchange 
reaction may also occur at the triplet excited-state as well as the singlet excited-state. It 
would be quenched by KI in both cases, which yields a larger A'sv for the H-D 
exchange than that for fluorescence. Acrylamide, however, can effectively quench the 
singlet excited-state. The H-D exchange reaction will occur at the singlet excited-state 
as suggested by the same A sv f°r both the H-D exchange reaction and fluorescence.
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Based on these observations, an excited-state proton transfer quenching 
mechanism is proposed. Shown in Figure 2.12 is the intermediate structure for both 
fluorescence quenching and the H-D exchange reaction. Deuterium will be replaced by 
hydrogen in a protium solvent. At the singlet excited state, N10-H donates a proton to 
solvent, leaving the aromatic ring susceptible to protonation from protic solvent. The 
fluorescence is quenched during proton transfer. When the aromatic ring is protonated 
at C6  or C9, hydrogen may leave and result in a deuterated aromatic ring.
According to this mechanism, the H-bonding pattern of N10-H will be the major 
factor affecting the fluorescence. Stronger H-bonding will increase the proton transfer 
rate and thus quench the fluorescence. This is the major reason that the quantum yield 
and lifetime in aqueous buffer are less than those in organic solvent and adduct. In 
DNA adducts, different binding modes have different H-bonding patterns (Table 2.4). 
Molecular modeling calculations show that the longer lifetime species S3' has a weaker 
H-bonding on N10-H than the shorter lifetime species R5' (Barkley et al., 1991;
Cheatham et al., 1988). In addition, the dipole-dipole interaction between N10-H and 
C l I-OCH 3  will also increase the proton transfer rate. The more parallel orientation and 
shorter distance between N10-H and C l I-OCH3 in (I IS, 1 Ia5)-TME lead to its shorter 
lifetime compared to (11/?,1 la ^ -T M E  (Table 2.5).
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DO-
CH
Figure 2.12. The proposed mechanism of the excited-state proton transfer process and 
photochemical H-D exchange reaction of tomaymycin. ROD can be any protic solvent 
or proton acceptor and donor.
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Table 2.4 H-Bonding Parameters of Solvated Tomaymycin-d(ATGCAT )2  Adductsa
adduct acceptor to 
N10-H b
distance
o
A
angle donor to 
C 5=0
distance
o
A
angle
S3' 0 2  (CIO) 2.30 147.8° OH(water) 1 .8 8 149.5°
S5' N3 (A il) 1.97 155.6° OH(water) 1.91 164.7°
R3' 0 2  (C4) 1.97 165.9° OH(water) 1.87 171.1°
R5' N3 (A ll) 1.93 174.5° OH(water) 1.92 165.6°
a Data adopted from Barkley et al., 1991. ^ O and N refer to oxygen and nitrogen atoms 
in DNA bases C and A, respectively.
Table 2.5 Parameters for Dipole-Dipole Interaction 
between N10-H and C l 1-OMe in TMEa
diastereomer distance torsional angle
11R 2.8 A i 00 o 0
1 IS 2.4 A 34°
a Data for (115,1 la£)-TM E were obtained from the energy minimization 
starting from the crystal structure of (1 1/?,1 laS)-TM E using SYBYL.
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Chapter 3. Time-Resolved Fluorescence Studies of Tomaymycin 
Bonding to DNA
3.1 Introduction
Tomaymycin reacts covalently with DNA through an aminal bond from C l 1 of 
tomaymycin to N2 of guanine in the minor groove of B-form DNA (Petrusek et al., 
1981; Barkley et al., 1986). The covalent linkage was definitively established by *H 
NMR in tomaymycin-d(CICGAATTCICG )2  adduct (Boyd et al., 1990). Despite 
specific reaction with guanine base, tomaymycin does not alkylate all guanine residues 
in a DNA sequence with the same frequency. The relative reactivity of a particular 
guanine depends upon the antibiotic and upon the proximal bases on the modified 
strand. There are 16 flanking base sequences with G in the middle. The preferred 
bonding sequence was originally reported to be 5'PuGPu (Hertzberg et al., 1986; Hurley 
et al., 1988). Recent results indicate that tomaymycin favors the 5'AGA sequence by a 
factor o f three compared to the second preferred sequences 5G GC, 5'TGC, 5'AGC, and 
5G G A  (Pierce et al., 1993).
There are four possible binding modes of tomaymycin for each bonding 
sequence on DNA: R or S  configuration at C l 1 with the aromatic ring of the drug 
pointing toward the 3' or 5' end of the modified DNA strand. The binding modes of 
tomaymycin at 5'TGC, 5'CGA, 5'AGC three-base sites have been determined by 
fluorescence, two-dimensional 1H NMR, and molecular modeling studies of 
oligodeoxynucleotide adducts containing unique binding sites (Cheatham et al., 1988; 
Boyd et al., 1990; Remers et al., 1992; Wang et al., 1992; Barkley et al., 1994;
Appendix B .l). The combination of these techniques is particularly powerful for
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determining the structure of drug-DNA complexes in the case of multiple binding 
modes (Remers et al., 1992). The fluorescence lifetimes of tomaymycin adducts with 
unique bonding sites appear to be more sensitive to binding mode than to flanking base 
sequence (Barkley et al., 1994). The lifetimes group into two classes. The major 
lifetime component usually has a longer lifetime of 5-8 ns, and the minor component a 
shorter lifetime of 1.5-5 ns. The longer lifetime has been assigned to the 1 IS 
diastereomer and the shorter lifetime to the 11/? diastereomer. The lifetime difference 
among binding modes has been attributed to excited-state proton transfer (see Chapter
2.4 for details).
In this chapter, the bonding of tomaymycin to calf thymus DNA, which has all 
16 bonding sites, will be examined. We use time-resolved fluorescence spectroscopy to 
identify the number and type o f tomaymycin-DNA adducts present on natural sequence 
DNA based on the results from tomaymycin-oligodeoxynucleotide adducts. Analysis of 
the data by least squares and maximum entropy methods in conjunction with simulation 
resolves the question of whether the fluorescence decay represents a few discrete 
lifetimes or a distribution of lifetimes in the range of 1.5-8 ns. The effects o f solution 
variables on the bonding reaction are determined. Finally, the observed lifetimes are 
assigned to specific binding modes and DNA bonding sites.
3.2 Materials and Methods
Tomaymycin-DNA Adduct. To prepare adduct solution, an aliquot of 
tomaymycin methyl ether stock solution in methanol (see Chapter 2.2 for detail) was 
placed in a vial and the methanol was evaporated under vacuum. Certain amount of 
DNA solution (1.0 x 10' 3 M nucleotide unless indicated otherwise) was added to give 
desired P/D ratio. P/D ratio refers to the relative amounts of DNA and tomaymycin
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used in the reaction. The reaction was equilibrated for 2 weeks at 4 °C. DNA adducts 
appeared to be stable for up to one year when stored at 4 °C. Unbound tomaymycin 
was removed by three or four extractions with equal volumes of ethyl acetate. Traces of 
ethyl acetate were removed under vacuum. The amount of tomaymycin actually bound 
to DNA was determined by a difference method, in which the amount of unbound 
tomaymycin was measured by fluorescence after iso-butanol extraction. At P/D -  1 all 
sites on DNA are saturated at 17-18 nucleotides per tomaymycin (Hurley, 1977;
Barkley et al., 1994). For the sample prepared at P/D = 100, 0.50 mL of adduct solution 
was extracted four times at 5 °C with equal volumes of iso-butanol saturated with 10 
mM phosphate buffer, pH 7.5. The iso-butanol layers were combined and adjusted to a 
total volume of 5.00 mL at 25 °C. The fluorescence intensity was recorded at 319 nm 
excitation wavelength and 400 nm emission wavelength. Tomaymycin concentration 
was determined by comparison to a standard curve obtained under the same 
experimental conditions. At P/D = 100 the bonding density is 140 nucleotides per drug.
Photobleaching under laser light was completely eliminated by scrupulous 
removal of oxygen. Adduct solution was placed in a 4 x 10 mm2 cell (Helma) sealed 
with the lubricated rubber stopper from a Vacutainer sterile tube (Becton Dickinson, 
#6381). The stopper was punctured by a needle above the solution. Oxygen gas was 
removed from the cell by alternative cycles of vacuum and argon for 0.5 hr. High 
purity argon gas was introduced through a copper line containing an Oxisorb gas 
purifier (Messer Griesheim). The stoppered cell was filled with argon after 
deoxygenation. Solutions remain oxygen free for at least 3 days when properly 
stoppered. Both extraction and deoxygenation were performed in an ice bath. Sample 
absorbance at the lowest energy absorption maximum was <0.15 with 10-mm path 
length.
Time-Resolved Fluorescence Measurements. Fluorescence lifetimes were 
measured on a Photochemical Research Associates time-correlated single photon 
counting instrument equipped with a Coherent 701-3 cavity-dumped DCM dye laser 
synchronously pumped by a mode-locked, frequency-doubled Quantronix 416 Nd-YAG 
laser. The output beam from the dye laser was frequency doubled by a BBO crystal and 
vertically polarized by a half-wave retarder. Excitation wavelength was selected with a 
three-plate birefringent filter. Emission was detected by a cooled Hamamatsu R955 
photomultiplier, which was wired for an instrumental response of 360 ps FWHM 
(McMahon et al., 1992). The emission polarizer was set at 54.7° in order to eliminate 
anisotropic effects. Emission wavelength was selected by an Instruments SA H-10 
monochromator (8 -nm bandpass). Data acquisition was controlled by a Macintosh Ilex 
computer using a program based on the Lab VIEW software package (Stryjewski, 1991). 
Sample temperature was controlled by a circulating bath at 5 °C unless indicated 
otherwise.
Fluorescence decays from the sample and reference fluorophore were acquired 
contemporaneously to 2.5-5 x 104  counts in the peak channel (5-10 x 106 total counts). 
The counting rate was usually about 6  kHz; the excitation rate was 760 kHz. Decay 
curves were stored in 512 or 1024 channels of 0.06 or 0.03 ns per channel, respectively. 
Solutions of quenched POPOP (Fluka) in 75% ethanol and 0.8 M KI (containing a trace 
of sodium thiosulfate to retard 13’ formation) or BBO in ethanol were used as reference 
fluorophore. About 0.21-ns lifetime of quenched POPOP and about 1.24-ns lifetime of 
BBO were determined in separate experiments using anthracene in ethanol as 
monoexponential standard. Data sets at high P/D ratio as well as different pH, DNA 
concentration, wavelength, chain length, and temperature were collected to about 
9 x 103 counts in the peak channel (about 6  x 105 total counts) using a nitrogen flash
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lamp as described elsewhere (Barkley et al., 1994). All low count measurements were 
made by Dr. Karol Maskos.
Data Analysis. Fluorescence decay curves were analyzed by reference 
deconvolution (Kolber & Barkley, 1986) assuming discrete and distributed decay 
models. The discrete lifetime model is described by
where I(keK, Xcm; t) is the fluorescence intensity, and the fluorescence lifetimes x; and 
relative amplitudes oc<(A.ex> ^em) are the fitting parameters. Single curve and multiple 
curve analyses were performed using a global non-linear least squares fitting program 
(Beechem, 1989). The lifetimes are usually linked in multiple curve analyses. The 
reference lifetime is fixed at a known value determined separately. The success of the 
fit is judged by statistical parameters: reduced chi-square X?, weighted residuals, and 
autocorrelation function of the weighted residuals.
The fluorescence decay curves measured at different temperatures were 
analyzed according to eq 1 with the lifetimes X; replaced by an Arrhenius expression:
where the amplitudes oq, the temperature-independent rate constants k0i, the frequency 
factors Ai, and activation energies £) are the fitting parameters. The values of k0i, A ;, 
and Ei at different temperatures are linked in the global analysis.
The distribution model is described by
n
^ e m i  t )  — ^ c m )  e x p ( - t  /  X /) (3.1)
X,-1 = k0i + A-, exp (-Ei / RT) (3.2)
(3.3)
o
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where a(x) is the spectrum of lifetimes x. Two types of distribution analysis were done:
(1) a(x) is assumed to have a Gaussian distribution, and (2) ot(x) is allowed to take the 
form most compatible with the experimental data by maximizing the Skilling-Jaynes 
entropy function (Jaynes, 1983; Livesey & Skilling, 1985).
In the Gaussian distribution model, the function a(x) is given by
a(x) = X  [a/ /  (a /V 2 tt )] exp[-(x-xOJ- )2  /(2a;2)] (3.4)
;=i
where n = 1 and n > 1 means unimodal and multimodal Gaussian distribution,
respectively. The mean lifetimes x0(- , standard deviations a,-, and peak areas a ; are the
fitting parameters. In order for a(x) to be a valid probability density function, otj must
n
be normalized so that the total area under the function a(x) is unity, £  a,- = 1. This
( = 1
distribution analysis is also globalized in the same way as the discrete analysis. The 
integration in eq 3.3 is carried out numerically. The user has a choice of a few different 
numerical integration methods and a flexible step size (Beechem, 1989). Although in 
principle multiple components are allowed, in practice it is almost impossible to resolve 
more than two. Attempts to use three or more components result in high sensitivity to 
initial guess, which follows from the large number of fitting parameters and the 
presence of local minima. This is a disadvantage of the model-fitting approach, in 
addition to the potentially more serious one of prescribing the type of distribution. The 
Beechem global program features three types of distributions: Gaussian, Lorentzian, 
and Uniform. However, expanding the repertoire of probability density functions does 
not give full flexibility to the shape of the function a(x). These weaknesses are 
overcome by using an entirely different approach to data analysis, the so-called 
maximum entropy method (Gull & Skilling, 1984; Skilling & Bryan, 1984).
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The important advantage of MEM is that the shape of the function a(x) is not 
predetermined. The analysis automatically results in inclusion of as many peaks (called 
"modes" in Gaussian analysis jargon) as necessary for the best fit to the data. The basic 
model for the decay function is still the same as in eq 3.3, but the shape of a(x) is 
determined from the experimental data. The best fit is approached by maximizing the 
Skilling-Jaynes entropy function:
where m(x) is the initial guess, usually set to a flat distribution in the absence of a priori 
knowledge about the distribution. The FAME5 program replaces the integrations in eqs 
3 and 5 by summations of up to 250 lifetime values equally spaced in logarithmic or 
linear scale. The entropy S is maximized together with minimization of X? (the 
normalized overall fitting error) for the fit to eq 3. Thus, the conventional distribution 
and MEM analyses are similar in that both use the same fitting function and minimize 
X r as in any non-linear least squares fitting technique. They differ in that MEM 
determines the density function a(x) by maximizing the entropy function 5(a), whereas 
conventional distribution analysis specifies the form of the distribution. The one 
limitation of the current version of FAME5 is that it is not globalized. However, a 
global version may be available in the near future (J.-C. Brochon, personal 
communication). The broadness of a peak in FAME5 is described by the dispersion D
oo
5 (a) = J (a(x) - m(x) - a(x) log[a(x)/m(x)]} dx (3.5)
0
k k
D = { [ £  a (i){ x (0 - l } 2] / X  a « } 1/2 (3.6a)
' = J
where the average lifetime x is
k k
(3.6b)
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and j  and k  define the range o f the peak. The dispersion D  is the equivalent of the 
estimated standard deviation a  in the case of a Gaussian distribution. The relative 
amplitude a t of a peak is determined from its relative area.
Fluorescence decay data containing Gaussian noise were simulated by 
convolution of the desired decay model with an experimental lamp profile in the 
Beechem global program. One, two, and three exponential decays were generated using 
eq 3.1. Unimodal and bimodal Gaussian distributions were generated using eqs 3.3 and
Bonding Kinetics. The whole measurement and part of the data analysis were 
done by Dr. Karol Maskos. The formation of DNA adduct was monitored by 
fluorescence lifetime measurements with flash lamp excitation as described elsewhere 
(Barkley et al., 1994). Decay curves were acquired at different times after mixing TME 
and DNA and were deconvolved by global analysis assuming three exponentials. Rate 
constants were determined from changes in relative amplitudes of the lifetime 
components as a function of time. The reaction
was carried out at P/D = 100 or 25-fold excess of potential DNA bonding sites. The 
hydrolysis of tomaymycin methyl ether to form tomaymycin is fast compared to the 
reaction with DNA. Therefore, at early times in the reaction where there is negligible 
dissociation of adduct, pseudo-first-order kinetics can be assumed. The apparent 
pseudo-first-order rate constants were k\ = k\ [DNA ]0  for the shorter lifetime species, 
k i  = k2 [DNA ]0  for the longer lifetime species, and k{ = &f[DNA]0  for free
3.4.
(TOM-DNA),
TOM + DNA
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tomaymycin, where k f = k\ + k i  and [DNA ] 0  = 1 x 10-3 M nucleotide. The pseudo- 
first-order rate constant kf was determined from the slope of the linear portion of a plot 
of -In (X f vs t, where o t f  is the relative amplitude of the free drug decay. The pseudo- 
first-order rate constant ki' for species i was obtained by a least-squares fit of the 
amplitude oq to eq 3.7.
oq = (fcj'/ kf)[l - exp(-&f't)] (3.7)
The value of kf was fixed in the analysis of aj. Arrhenius parameters were calculated 
from the temperature dependence of the apparent bimolecular rate constant k\.
ki = A exp(-£a/RT) (3.8a)
A = (KBT/h)*exp( 1 + AS*/R) (3.8b)
where Ea is the activation energy, AS+ is the activation entropy, KB is the Boltzmann 
constant, and h is the Planck constant.
3.3 Results
Model Discrimination. There are 16 DNA bonding sites on natural DNA 
sequences and four binding modes at each site, for a total of 64 possible tomaymycin- 
DNA adducts with lifetimes in the range of 1.5-8 ns. In order to determine the number 
and type of adducts present on DNA, we need to establish criteria for distinguishing 
decay models. It is well known that frequently more than one model will fit the
experimental data equally well. It can be a difficult, sometimes impossible, task to
isolate the true decay model under such circumstances. Simulation studies are a very 
useful tool to validate or refute particular lifetime models. Therefore, we performed 
extensive simulation studies to gain insight into the analysis of discrete and distributed
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decay models with lifetimes in the range of interest for tomaymycin-DNA adducts. A 
summary of the major conclusions follows:
(1) Simulated discrete models. Increasing the model order in a discrete analysis 
improves X? until redundancy of the model becomes obvious. A Gaussian distribution 
analysis always gives a good fit with the same mean lifetimes T0; as the discrete 
lifetimes x,- and poorly determined standard deviations a,-. For example, a simulated 
3.5-ns single exponential gives an excellent fit to a unimodal Gaussian with xG = 3.5 ns 
and a  = 0.15-0.20. It is practically impossible to distinguish between a triple 
exponential and a wide unimodal Gaussian without the help of a model-free approach, 
such as MEM. Simulated data for discrete models also fit quite well to continuous 
distributions by MEM. However, in such cases typically the dispersions of the modes 
are rather small, and the number of peaks in the recovered a(x) distribution matches the 
actual number of components in the discrete model.
(2) Simulated unimodal Gaussian models. A discrete analysis gives a good X? 
value if the standard deviation of the distribution is small: a  = 0.01-0.15 ns. As a  gets 
larger, higher order discrete models give better fits. However, the recovered lifetimes 
may be quite different between double and triple exponential models. A wide unimodal 
Gaussian gives acceptable fits to both uni- and bimodal Gaussian models, particularly 
for noisy data, because the standard deviation is so poorly determined in the analysis.
(3) Simulated bimodal Gaussian models. A double exponential analysis gives 
acceptable X^  values of about 1.3-1.5. As <7 gets larger, a triple exponential may give an 
acceptable fit and a new set of recovered parameters.
It is preferable to recover the lifetime distribution without having to assume a 
specific form in the analysis program. James and Ware (1986) proposed a common- 
sense method, which fixes a large number of lifetime values and determines the
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corresponding preexponential factors in a least squares analysis. Negative amplitudes 
occur frequently during this type of fitting process. The approach of clipping the 
negative values to zero and then searching for the best fit lacks theoretical rigor. Our 
trials with this method were unsatisfactory. We therefore turned to the maximum 
entropy method for fluorescence data analysis (Livesey & Brochon, 1987). Presently 
we are using the MEM program in conjunction with other deconvolution programs to 
help distinguish various models that fit our data equally well. In this paper Gaussian 
distribution and MEM analyses are used in a cooperative, not competitive fashion; both 
methods are also aided by extensive simulation studies to explore the probable behavior 
o f specific models. Below we outline our strategy for model discrimination gleaned 
from simulation studies.
(1) We routinely analyze all data with both discrete and distribution models. If 
the data fit substantially better to one model, as judged by a lower j}x value or more 
random autocorrelation function or both, then the other is discarded.
(2) If the distribution model fits equally well or better than the discrete model, 
we try to confirm the distribution model by discrete analyses with increasing numbers 
of components. Simulation studies have shown that the X? value for distributed lifetime 
data analyzed by discrete models keeps improving with increasing numbers of 
components in the analysis. Therefore, if the fit to higher order discrete models fails to 
show progressive improvement, then the distribution model may be discarded.
(3) If the data fit well to a bimodal Gaussian model but MEM shows only one 
peak, we incline toward a unimodal distribution of non-Gaussian shape. If the data fit 
equally well to the double exponential and bimodal Gaussian models, and the presence 
of two peaks is verified by the MEM analysis, then we carry out simulation studies in 
an attempt to reach a conclusion. Typically, we would simulate a biexponential decay
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with the same amplitudes and lifetimes as the values recovered from discrete analysis of 
the experimental data, and analyze the simulated data with various distribution models. 
We would then compare the standard deviation or dispersion obtained from these 
distribution analyses to the experimental values. If they are similar, then the 
distribution model is discarded altogether. Obviously, a known discrete data set 
producing the same results for a distribution analysis as our experimental data renders 
the distribution results meaningless.
(4) On the other hand, if the standard deviation or dispersion for a distribution 
analysis of the experimental data were substantially larger than the value obtained from 
the discrete simulated data, then we would choose the distribution model over the 
discrete model. As to the actual shape of the density function a(x), the MEM result is 
more trustworthy. In our experience a data set that truly represents a Gaussian 
distribution o f lifetimes yields the same values of the decay parameters for the Gaussian 
and MEM analyses, whereas the fit to a discrete model gives a larger X? value.
Lifetime Model fo r  Tomaymycin-DNA Adduct. Two extreme examples of 
tomaymycin-DNA adducts were studied. At P/D = 100 there is a large excess of DNA 
bonding sites and the drug will react preferentially at preferred bonding sequences. At 
P/D = 1 the DNA is completely saturated with tomaymycin and less preferred bonding 
sequences will also be occupied. Fluorescence decays were measured at various 
excitation and emission wavelengths at 5 °C. Unreacted tomaymycin was removed 
immediately prior to the experiments by extraction of adduct solutions. Decay curves 
were deconvolved in single and multiple curve analyses.
For tomaymycin-DNA adduct prepared at P/D = 100, 30 decay curves were 
acquired at 318, 320, 323, and 333 nm excitation and 400, 410, 415, and 420 nm 
emission wavelengths. Global analysis linking the lifetimes gave X? values of 1.3-1.5
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and randomly oscillating autocorrelation functions for fits to a double exponential and 
to unimodal and bimodal Gaussian distributions (Figure 3.1; Table 3.1). Increasing the 
number o f components in the discrete analysis did not improve the fit. Except for five 
samples containing small amounts of free drug, the lifetimes obtained from single curve 
analyses were within 0.3 ns of the global results. The fluorescence lifetimes were 
independent of both excitation and emission wavelengths. The relative amplitudes were 
also independent of emission wavelength, but slightly dependent on excitation 
wavelength. Figure 3.1 shows the double exponential and unimodal and bimodal 
Gaussian fits. The discrete analysis gave lifetimes Ti = 4.3 and %2 = 7.1 ns, compared to 
mean lifetimes of 2.7 and 6.3 ns for the two narrow peaks o f the bimodal Gaussian 
distribution. A much broader unimodal Gaussian distribution gave a slightly lower X? 
value than the bimodal distribution, possible because the two discrete lifetimes are very 
close. From these results alone it is difficult to choose between the double exponential 
and unimodal Gaussian models.
For 25 o f the 30 decay curves, two overlapping peaks at about 4 and 7 ns were 
resolved by MEM in single curve analyses (Figure 3.2). These lifetimes are very close 
to the values obtained for the double exponential model. The dispersions are 0.4-0.8 ns. 
However, synthetic data generated for a discrete model having these decay parameters 
gave the same two peaks with comparable dispersions as the experimental data (Figure 
3.3). Other simulated double exponential decays were also analyzed to see how well 
MEM recovers parameters from data with 3.5 x 104  counts in the peak. Two distinct 
peaks were observed for the 4 and 7 ns double exponential, where X2/X1 = 1.75. The 
two peaks merge into a broader peak as X2/X1 decreases, and finally become one peak at 
X2 /X1 = 1.2 (Figure 3.3). Therefore, the MEM analysis argues strongly for the double 
exponential model for tomaymycin-DNA adduct. The unimodal Gaussian distribution 
model was discarded because two peaks were usually obtained by MEM.
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Figure 3.1. Global analysis of fluorescence decay of tomaymycin-DNA adduct at pH
7.5, P/D = 100, 5 °C. Xex = 333 nm, Xem = 410 nm, 0.037 ns per channel. Left curve is 
reference decay; points are sample decay; smooth curve through points is best fit to the
following: (upper) double exponential model, a i  = 0.41, x\ = 4.3 ns, ct2 = 0.59, %2 = 7.1
ns, local X? = 1.4; (middle) unimodal Gaussian distribution, t q  = 5.8 ns, a  = 1.4 ns, local
%r = 1-5; (lower) bimodal Gaussian distribution, oq = 0.25, Xj = 2.7 ns, ctj = 0 .13  ns, ct2
= 0.75, X2 = 6.3 ns, <32 = 0.23 ns, local X? = 1.5. Weighted residuals and autocorrelation 
function o f the residuals (inset) are also shown.
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Table 3.1 Analysis of Time-resolved Fluorescence Data for Tomaymycin-DNA Adductfl
analysis method ai(333  nm ) 6
t l  (ns) 
x (ns)c a  (ns)^ a 2(333 nm ) 6
x2 (ns) 
x (ns)c a  (ns)^
x3 (ns)
X?
P/D = 100 
least squares6 
single 
double 
unimodal 
bimodal
0.41 ±0 .02  
0.25
6 . 0
4.3 ± 0 .3
5.8
2.7
1.4
0.13
7.1 ± 0 .2  
6.3 0.23
11.5
1.5 
1.3
1.5
M EM / 0.40 ± 0.05 4.2 ±  0.4 0.55 7.0 ± 0 .4 0.75 1.4
P/D = 1 
least squares# 
single 
double 
triple 
unimodal 
bimodal
0.29 ± 0.02 
0.18 ± 0 . 0 2
0.54 ±  0.03
5.8 
2 . 2  ± 0 .1  
1 .6  ±  0 .1
5.3
3.3
1.9
2 . 2
0.28 ± 0 .0 1
6.4 ±0.1
4.4 ± 0.6
6 . 6 0 .0 1
6.7 ±  0.3
20.9
1.7
1.5 
3.4
1 .6
MEM/! 0.25 ± 0.03 1 .8  ± 0 .1 0.43 6 . 0  ± 0 .1 0.97 1.5
apH 7.5, 5 °C. ^ Amplitude for discrete models; area under the peak for Gaussian distributions and MEM. cLifetimes for discrete 
models are obtained from global analysis. These lifetimes are identical to the average values from single curve analyses. Errors are 
standard deviations from the single curve analyses. Mean lifetimes for Gaussian distributions are obtained from global analysis. 
Average lifetimes and standard deviations for MEM are obtained from single curve analyses. ^Standard deviation in Gaussian 
distribution analysis; dispersion in MEM analysis. ^Global analysis of 30 decay curves. /Single curve analyses of 25 decay curves. 
^Global analysis of 10 decay curves. ^Single curve analyses of 10 decay curves.
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Figure 3.2. Lifetime distributions of tomaymycin-DNA adduct at P/D = 100 from 
MEM. Analysis carried out in logarithmic space; results displayed on linear scale.
Normalized areas of relative amplitude under peak and average lifetimes are: (-----) A,ex
= 318 nm, Xem = 410 nm, a j  = 0.44, x\ = 4.3 ns, D\ = 0.54 ns, a 2  = 0.56, x2  = 6.9 ns,
D 2 = 0.73 ns, X? = 1.33; (---- ) Xex = 323 nm, Xem = 410 nm, a j  = 0.11, Xi = 0.8 ns, D\
= 0.07, a 2  = 0.89, x2 = 5.8 ns, D2 = 1.50, X2r = 1 .2 0 .
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Figure 3.3. Lifetime distributions of simulated double exponential decays analyzed by 
MEM. Amplitude ratio OC2/OC1 = 3:2, Xj = 4 ns. Lifetime ratios X2 /X1 used in simulation
and recovered dispersions are: (-----) X2/X1 = 1.75, D\ = 0.49 ns, D2 = 0.85 ns; (— )
X2 /X1 = 1.5, D  = 1.02 ns; (.....) X2/X1 = 1.2, D  = 0.46 ns.
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For five of the 30 decay curves, only one peak around 6  ns plus a small peak 
around 1 ns was obtained (Figure 3.2). The major peak had a shoulder on the short­
lifetime side and a dispersion o f 1.3-1.6 ns. The presence o f a small amount of 
unreacted drug, which has a 1 -ns lifetime, appears to mask the two closely spaced 
lifetimes. Treating the 1-ns component as a single discrete fixed lifetime component in 
the MEM analysis did not improve the resolution. Accordingly, data were simulated 
using the decay parameters recovered from the double exponential analysis (4.3 and 7.1 
ns) plus a 1.04-ns component for free drug. Two peaks corresponding to the longer 
lifetimes could still be resolved as long as the relative amplitude of the free drug 
component was < 5 % (Figure 3.4). Above this value, the two longer lifetime peaks 
gradually merged into a single peak with a shoulder on the short-lifetime side and the 
dispersions increased from 0.7 to 1.4 ns with increasing amounts of the free drug 
component. The shoulder finally disappeared in the presence of a large amount of 
unreacted drug. This indicates that the resolution of two lifetime components depends 
not only on their relative separation but also on the presence of a third component. It 
also explains why a few experimental data files gave a single broad peak for 
tomaymycin-DNA adduct: either extraction of free drug was incomplete or some drug 
dissociated after the extraction. On the other hand, the MEM results convinced us that 
the extraction procedure was adequate in most circumstances.
For tomaymycin-DNA adduct prepared at P/D = 1, 10 decay curves were 
acquired at 330, 333, and 337 nm excitation and 400, 405, and 410 nm emission 
wavelengths and were analyzed by the strategy outlined above. Unlike the case for P/D 
= 1 0 0 , increasing the number of components in the discrete model improved the fit up 
to a triple exponential (Table 3.1). Fits to four and five components depended on initial 
guess with no improvement in global values. This suggested the presence of a 
distribution of lifetimes. The fit to a unimodal Gaussian distribution was unacceptable.
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Figure 3.4. Lifetime distributions of simulated triple exponential decays with two DNA
adduct components (xi = 4.3 and X2 = 7.1 ns) and one free drug component (Xf = 1.04
ns) analyzed by MEM. Amplitude ratio <X2/(X[ = 3:2. Amount of free drug component 
used in simulation and recovered amplitude and dispersion of the major peak are:
(------- ) otf = 0 %, a i  = 0 %, D j  = 0.43 ns, Eh, = 0.78 ns; (— ) ctf = 5 %, a i  = 6 % ,D \ =
0.08 ns, D 2 = 0.48 ns, Lh, = 0.84 ns; (-----) (Xf = 7 %, a i  = 8  %, D \ = 0.15 ns, £>2 = 1.36
ns; and (.....) (Xf = 22 %, a i  = 22 %, D\ = 0.27 ns, D i = 1-38 ns.
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The bimodal Gaussian distribution gave a much better X? value, pointing to the 
presence of at least two groups of lifetimes. The trimodal Gaussian distribution gave 
physically unreasonable results and no improvement in Xp MEM recovered two peaks 
at about 1.8 and 6.0 ns with dispersion values of 0.43 and 0.97 ns, respectively (Figure 
3.5a). MEM analysis of a double exponential simulated with these decay parameters 
returned two narrow peaks with the same lifetimes and amplitudes but dispersion values 
of only 0.11 and 0.17 ns (Figure 3.5b). In addition, a triple exponential decay was 
simulated using the parameters obtained in the three component fit of the experimental 
data (Table 3.1) and was analyzed using MEM. The MEM analysis gave one narrow 
peak at 1.6 ns with dispersion of 0.26 ns and a broad peak at 6.7 ns with dispersion of 
1.17 ns. The broad peak contained a distinct shoulder at about 4 ns, clearly indicating 
the presence of the third lifetime. Such a shoulder was never seen in MEM analyses of 
the experimental data. Therefore, we conclude that the two peaks from MEM analysis 
of the experimental data represent two groups of distributed lifetimes rather than two or 
three discrete lifetimes. The average lifetimes were independent of both excitation and 
emission wavelengths. However, the relative amplitudes of the two peaks varied with 
excitation wavelength. For example, a i  decreased from 28 % at 330 nm to 22 % at 337 
nm. This is much greater than the 2 % change observed between 313 and 337 nm for 
the adduct prepared at P/D = 100 (Table 3.2), presumably reflecting more 
heterogeneous bonding species.
The Gaussian and MEM analyses both indicate bimodal lifetime distributions 
for the experimental data at P/D = 1. The two methods gave somewhat different decay 
parameters with similar X? values. The bimodal Gaussian distribution looks like one 
broad peak at 3.3 ns with a standard deviation of 2.2 ns and a discrete lifetime of 6 . 6  ns, 
whereas the MEM profile has two broad peaks at 1.8 and 6.0 ns (Table 3.1). Synthetic
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Figure 3.5. (a) Lifetime distributions of tomaymycin-DNA adduct at P/D = 1 from 
MEM. Analysis carried out in logarithmic space; results displayed on linear scale. Xex 
= 333 nm, Xem = 400 nm. Normalized areas o f relative amplitude under peak and 
average lifetimes are: a i  = 0.25, t i  = 1.8 ns, D\ = 0.43 ns , ct2  = 0.75, %2 = 6.0 ns, D 2 =
1.01 ns, X? = 1.41. (b) Lifetime distribution of simulated double exponential with decay 
parameters in (a) analyzed by MEM. Recovered a i  = 0.25, t i  = 1.8 ns, D\ = 0.11 ns,
012 = 0.75, %2 -  6-0 ns, D 2 = 0.17 ns.
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Table 3.2 Effect of Conditions on Tomaymycin-DNA Adduct0
P/D pH [DNA] (mM) Size^ Xex (nm) a \ c
1 0 0 6.4 2.5 high MW 313 0.35
500 0.36
1 , 0 0 0 0.34
1 0 0 6.4 2.5 high MW 337 0.38^
7.5 0.31d
8.9 0.34d
1 0 0 7.5 0.25 high MW 337 0.33
0.63 0.34
1.3 0.34
2.5 0.34
1 0 0 7.5 2.5 high MW 313 0.34
337 0.32
350 0.29
1 0 0 7.5 65-110 bp 350 0.41
25-36 bp 0.44
< 18 bp 0.41
5-140 bp 0.44
"Global analysis assuming a double exponential model of data acquired at 5 °C: 
X \  = 3 .7  ns, X2  = 6.7 ns. pH dependence data were acquired at 25 °C and analyzed
separately: xi = 3.1 ns, %2 = 5.6 ns. ^High MW is highly polymerized calf thymus 
DNA. Short DNA fragments prepared by sonication of salmon sperm DNA and 
fractionation by gel chromatography. "Estimated standard deviation < 0.02. 
^Experiments at 25 °C.
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data were generated for a bimodal Gaussian distribution model with the decay 
parameters obtained from the MEM analysis. Bimodal Gaussian distribution and MEM 
analyses recovered the input decay parameters. Synthetic data were also generated for a 
bimodal Gaussian distribution with a single broad peak at 3.3 ns and a discrete lifetime 
of 6 . 6  ns. The bimodal Gaussian distribution analysis recovered either the input 
parameters or two broad peaks, depending on initial guess. MEM analysis returned two 
broad peaks with shorter lifetimes than the input parameters, similar to the results from 
the experimental data. Combining the Gaussian and MEM results, the major group of 
lifetimes appears centered at 6 -6 . 6  ns and the minor at around 2-3 ns. However, the 
profile of the distribution is uncertain.
Experimental Conditions. Tomaymycin appears to form only two species of 
adduct on natural sequence DNA at P/D = 100, pH 7.5, and 5 °C. We surveyed a 
variety of experimental conditions and found no evidence for additional species, A 
large data set containing almost 2 0 0  decay curves was measured at different excitation 
and emission wavelengths, P/D ratio, pH, DNA concentration, and DNA chain length.
A X? value of 1.1 was obtained for the global fit to a triple exponential model with the 
lifetimes linked: two components for tomaymycin-DNA adduct and one component for 
free drug. The two lifetimes for DNA adduct were T) = 3.7 ns and %2 = 6.7 ns. Note 
that these lifetimes are shorter than the values reported in Table 3.1. The reason 
appears to be numerical. These decay curves were fitted to three exponentials because a
1-ns free drug component was always present, whereas the lifetime values in Table 3.1 
were recovered from double exponential fits of data from extracted samples. It can be 
easily verified that the mean lifetimes remain the same in all cases. Theoretical 
considerations and simulation studies also suggest that if the free drug component has a 
very small pre-exponential factor, the double exponential analysis will yield slightly 
greater lifetime values than the triple exponential analysis. The insensitivity of the
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fluorescence lifetimes to experimental variables suggests that the same two species of 
DNA adduct are present under all conditions. However, there were small changes in the 
relative amplitudes of the two components under some conditions (Table 3.2). In the 
case of ground-state heterogeneity, the amplitudes of a fluorescence decay are 
proportional to molar extinction spectrum, fluorescence emission spectrum, radiative 
lifetime, and concentration of the different species. As above, the amplitudes were 
independent of emission wavelength, indicating that the emission spectra of the two 
lifetime components are the same. On the other hand, the amplitudes of the minor 
lifetime component decreased slightly relative to the major lifetime component with 
increasing excitation wavelength, signifying that the absorption spectrum of the minor 
component is blue-shifted relative to the spectrum of the major component. This is 
consistent with previous results showing that different species of tomaymycin-DNA 
adduct have the same emission spectra, but slightly shifted absorption spectra (Barkley 
e ta l., 1986).
The relative amplitudes of the two components are constant at P/D ratios > 100. 
Such ratios are well above the saturation level of 17 nucleotides per drug in calf thymus 
DNA (Barkley et ai., 1994). At P/D = 100 the relative concentrations o f the two 
species o f DNA adduct are not affected by DNA concentration over a 10-fold range and 
by pH in the range of 6-9. The relative concentration of the minor species of DNA 
adduct is 12-14 % higher in short fragments of sonicated salmon sperm DNA (42 %
GC) than in highly polymerized calf thymus DNA (43 % GC). Apparently, short DNA 
sequences favor formation of the minor species of DNA adduct.
Temperature Dependence. The fluorescence lifetimes of tomaymycin-DNA 
adducts are weakly temperature dependent. Fluorescence decay curves were acquired at 
5° intervals from 5-25 °C at 313, 337, and 355 nm excitation and 420 nm emission 
wavelengths. The temperature data set was deconvolved globally according to eq 3.2
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with the temperature-independent rates kai, frequency factors A-h and activation energies 
Ei linked in the analysis. The double exponential fit gave a global i}x o f 1.2. The 
temperature-independent rates and activation energies were the same for both 
components. Linking these parameters in the global analysis gave k0l = 1.1 x 108 s_1 
and Ei = 21 kJ/mol. While the frequency factors were different, A \ = 1.1 x 1012 s_1 for 
the shorter lifetime component and A i  = 3.5 x 1011 s_1 for the longer lifetime 
component. Intersystem crossing and excited-state proton transfer are the major 
nonradiative processes for tomaymycin (Barkley et al., 1994; Chen & Barkley, 1994).
The temperature-independent processes are the same for both components, while the 
temperature-dependent proton transfer rates are different due to different binding modes 
in the two components. The temperature-independent rate kol is usually the sum of the 
radiative kT and intersystem crossing kjsc rates. Taking kT = (5-8) x 107  s ' 1 from average 
lifetime and quantum yield date (Barkley et al., 1986), the recovered k0i = 1.1 x 108 s_1 
gives k\sc = (3-6) x 107  s '1. This intersystem crossing rate is a little lower than the 8  x 
107 s- ' value estimated from low temperature luminescence yields in ethanol (Barkley 
et al., 1994). The activation energies determined from lifetime data agree well with the 
23 kJ/mol value derived from quantum yield data (Barkley et al., 1991).
Bonding Kinetics. The rate o f formation of tomaymycin-DNA adduct was 
measured at 5° intervals from 5-25 °C. At each temperature fluorescence lifetime data 
were acquired at 313 nm excitation and 420 nm emission wavelengths as a function of 
time after mixing tomaymycin and DNA. The set of decay curves from the kinetics 
experiment and a free drug decay curve were fitted to a triple exponential by global 
analysis. Figure 3.6 shows the time course of the relative amplitudes o f the free drug 
component and the two DNA adduct components at 10 °C. The amplitude of each 
species is proportional to its concentration. The rate constants for formation of DNA 
adducts were calculated assuming pseudo-first-order kinetics. Table 3.3 gives the
0 2 4 6  8  10
Time (hr)
Figure 3.6. Kinetics of formation of tomaymycin-calf thymus DNA adduct. Xcx = 313
nm, A-em = 420 nm, pH 7.5, 10 °C, [DNA] = 1 x 10' 3 M, P/D = 100. Results from
global fit to three exponentials, X? = 1.1. (■ )  free drug, (A ) 3.74-ns component, ( • )  
6.57-ns component. Smooth curves are the best fit using equation 3.7.
77
Table 3.3 Kinetics Data for Formation of Tomaymycin-DNA Adduct0
species ki (M -h - ')b Ea (kJ/mol) A x  10-6 (M -V 1) A StCJK-tmol'1)
free drug 0.219 39 3.48 -127
short lifetime 0.078 40 1.90 -124
long lifetime 0.141 39 2.05 -131
°pH 7.5, [DNA] = 1 x 10-3 m , P/D = 100. b 10 °C.
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apparent bimolecular rate constants measured at 10 °C along with the Arrhenius 
par ameters for the bonding reaction. The rate of formation of the longer lifetime 
species is faster than the shorter lifetime species. Drug binding usually involves 
positive entropy changes, presumably due to release of ordered water from the DNA to 
bulk solvent (Breslauer et al., 1987; Barkley et al., 1991). The negative AS* values 
suggest that the water molecules remain in the transition state for formation of 
tomaymycin-DNA adduct.
3.4 Discussion
For tomaymycin-DNA adduct at low bonding density the preferred lifetime 
model is a double exponential. The reasons are: (1) the experimental data were fitted 
equally well by distribution and double exponential models; (2 ) the fit was not 
improved when more components were considered in the discrete analysis; (3) the 
standard deviations in the bimodal Gaussian distribution (0.13-0.23 ns) and the 
dispersions in the MEM amplitude profile (0.55-0.75 ns) were small; (4) probably most 
important, the MEM analysis of a biexponential decay simulated with the same 
parameters as the biexponential analysis of the experimental data gave the same two 
peaks as the experimental data; and (5) the dispersions of the peaks obtained from these 
analyses of simulated and experimental data were similar. When the DNA is saturated 
with tomaymycin, the fluorescence decay data no longer fit a double exponential model 
and the lifetime model becomes a bimodal distribution. The reasons are: (1) the fit was 
improved by increasing the number of discrete components up to three; (2 ) only two 
peaks were recovered from Gaussian and MEM analyses; (3) simulation studies of 
discrete and Gaussian distribution models supported a bimodal distribution. In practice, 
it is impossible to distinguish lifetime distributions from closely-spaced multiple
discrete lifetimes (Siemiarczuk et al., 1990). Given the possibility of 64 bonding 
species, a distribution is plausible in tomaymycin-DNA adduct at high bonding density.
Because MEM analysis of time-resolved' fluorescence data is still relatively new 
(Siemiarczuk & Ware, 1989; Gentin et al., 1990; Royer et al, 1990; Fetler et al., 1992), 
we comment briefly on its performance in our hands. Apparently, MEM could separate 
two discrete lifetimes as close together as 2.5 ns with the ratio %2l%\ > 1 .5  (Figure 3.4). 
Tomaymycin-DNA adduct has two lifetimes separated by 2.8 ns with X2^ i  = 1-65 
(Table 3.1). However, these lifetime differences and ratios are higher than the reported 
2 ns with %2^ l  = 1-4 (Livesey & Brochon, 1987). Our failure to match the published 
resolution is due to lower counts in our data. The data collected by Brochon and 
coworkers using a synchrotron light source has 5-8 times better counting statistics than 
our data. Simulation results showed that about 1.5 x 105 counts in the peak channel are 
required to achieve the reported resolution. Unfortunately, it is impractical to acquire 
data of such high precision with a picosecond dye laser excitation source. On the other 
hand, dispersion values are relatively insensitive to the number of counts. For two 
discrete lifetimes of 4.3 and 7.1 ns, the dispersions decreased from 0.55 and 0.75 ns to 
0.35 and 0.48 ns, with a 20-fold increase in counts in the peak channel from 3.6 x 104 to
7.2 x 105. Thus, it appears impossible to distinguish a lifetime distribution with 0.5 ns 
dispersion from a discrete model for these two peaks.
Natural sequence DNAs contain all 16 possible DNA bonding sites. At the low 
bonding density (140 nucleotides per drug) used in our experiments, one drug is bonded 
per 70 base pairs or one per 23 bonding sites assuming a three base pair site. Under 
these conditions tomaymycin will bond preferentially at the 5'AGA sequence. Thus, 
there is probably only one or at least a predominate species owing to the sequence 
preference of adduct formation. 5'AGA has two lifetimes of 4.8 and 7.2 ns with relative 
amplitudes of 0.37 and 0.63 (see Appendix B .l). Similarly, calf thymus DNA has two
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lifetimes of 4.3 and 7.1 ns with relative amplitudes of 0.41 and 0.59. The fluorescence 
lifetime depends more strongly on binding mode than on flanking base sequence 
(Barkley et al., 1994). Most likely the major species with the longer lifetime is the S3' 
adduct, and the minor species with the shorter lifetime is the R5' adduct (Cheatham et 
al., 1988; Boyd et al., 1990; Wang et al., 1992; Barkley et al., 1994). We propose that 
the two species of DNA adduct represent mostly R5' and S3' binding modes at 5'AGA 
site. Purine-pyrimidine tracts, up to 100 bp in length, are frequently found in the 5’- 
flanking regions of eukaryotic genes, representing up to 1 % of the genome (Hoffman- 
Liebermann et al., 1986). The SI-nuclease hypersensitivity of these tracts suggests that 
they adopt unusual conformations to regulate gene transcription (Wells, 1988). The 
strong preference of pyrrolo[l,4]benzodiazepines for homopurine sites points to 
regulatory regions of the DNA as a likely biological target.
Tomaymycin saturates calf thymus DNA when there is one drug bonded per 8-9 
base pairs or one per 2-3 potential bonding sites (Barkley et al., 1994). Assuming 
random DNA sequences, one third to one half of the 16 bonding sites would be 
occupied. The lifetimes of DNA adducts at unique bonding sites cluster in two groups: 
minor component of 1.5-5 ns and major component of 5-8 ns (Barkley et al., 1994).
The amplitude profile from MEM analysis suggests that all these species may be 
present on the natural DNA sequence. On the other hand, the bimodal Gaussian results 
suggest that the longer discrete lifetime may represent S3' adducts at 5'PuGPu and 
5'PyGPy sequences with the shorter broad lifetime distribution corresponding to the rest 
of the bonding species. However, the lifetimes of adducts at specific bonding sites may 
change at high bonding density due to distortion of the DNA. Finally, the bimodal 
distributions at high bonding density are probably not contaminated by free drug 
because all samples were extracted four times, kept at or below 5 °C, and discarded <12 
hr after extraction, during which time dissociation of the adduct is negligible.
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Tomaymycin is buried in the minor groove of the DNA helix with the 8 - 
hydroxyl group pointing away from the DNA core. The fluorescence intensity of the 
DNA adduct prepared at P/D = 100 is invariant from pH 6.5 to 10.5 (Barkley et al.,
1991). Thus, we expect and observe the fluorescence decay parameters to be 
independent of pH over the same range. Low molecular weight DNA fragments appear 
to have a larger fraction of minor species. This may be related to the DNA 
conformational change presumed to limit the bonding reaction in high molecular weight 
DNAs (Kizu et al., 1993; Barkley et al., 1994). Relaxation of distortion through the 
ends of the molecule may allow formation of a larger percentage o f the less favored 
species.
Excited-state proton transfer appears to be the major environmentally sensitive 
nonradiative process in tomaymycin (see Chapter 2 for details). Presumably, it 
accounts for the temperature dependence of the fluorescence lifetimes of DNA adducts. 
The frequency factors of 1.1 x 1012 and 3.5 x 101 1 s' 1 and activation energy of 21 
kJ/mol are comparable to values reported for intermolecular excited-state proton 
transfer reactions: 7.2 x 1010 s_1 and 15 kJ/mol in 3-methylindole (Yu et al., 1992); 8.1 
x 1012 s ' 1 and 17 kJ/mol in naphthyl-ammonium ion-18-crown-6 complexes (Shizuka et 
al., 1985), and for the intramolecular excited-state proton transfer in tryptamine: 3.8 x 
101 1 s-1 and 17 kJ/mol and (Shizuka et al., 1988). The proton transfer rate depends on 
the proximity of proton donors or acceptors to tomaymycin in the DNA adduct. As 
suggested by molecular modeling studies of tomaymycin-d(ATGCAT ) 2  adduct, 
different binding modes have different H-bonding patterns between tomaymycin and 
DNA bases and water molecules in the minor groove (Barkley et al., 1991). The 
hydrogen bonding pattern may be responsible for the different frequency factors in the 
S3' and R5' adducts.
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Chapter 4. Flexibility of the DNA Helix Determined from Time- 
Resolved Fluorescence Emission Anisotropy
4.1 Introduction
The internal motions o f the DNA helix are in the time scale of subnanoseconds 
to at least several hundred nanoseconds. They are characterized by torsional rigidity 
and bending rigidity. Time-resolved fluorescence emission anisotropy of a fluorescent 
probe tightly attached to the DNA helix has been proved to be a powerful tool to 
investigate these motions, particularly for torsional motions (Barkley & Zimm, 1979, 
Fujimoto & Schurr, 1990). However, the studies on bending motions have been limited 
by the lack of a suitable fluorescent probe. The relative contributions of torsional and 
bending motions to the fluorescence emission anisotropy decay depend on the relative 
orientation between the transition dipole and the DNA helix as well as the time scale. 
Bending motions are more heavily weighted at smaller angles. The commonly used 
probe is ethidium bromide which intercalates into the DNA helix. It has a fluorescence 
lifetime of about 23 ns and an angle of about 71°. The emission transition dipole of 
tomaymycin presumably lies inside the aromatic plane (Figure 4.1). The angle is 30- 
45° depending on binding mode as shown in Figure 4.2 (W. A. Remers, personal 
communication). The smaller angle may help resolve the ambiguities in DNA 
dynamics, particularly the bending rigidity. Tomaymycin can also be used for 
dynamics studies of unusual DNA structures such as triplex DNA and Z DNA. 
Tomaymycin remains bound when B DNA is converted into Z DNA (unpublished 
results, see Appendix B.2).
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Figure 4.1. The orientation of the absorption and emission transition dipoles of 
tomaymycin.
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Figure 4.2. Space-filling models of tomaymycin-d(ATGCAT) 2  adducts: (upper left) S3', 
(upper right) S5 \ (lower left) R 3 \  and (lower right) R5\
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In addition, a well-characterized DNA sample is very important to the 
meaningful interpretation of the internal motions of the DNA helix (Hagerman, 1988). 
The general rule is that DNA helix must be long enough in order to separate the internal 
motions from the tumbling and diffusive motions of the whole molecule. Besides, the 
molecular weight distribution of DNA, if it is not uniform, must be very narrow to rule 
out potential length-dependence.
In this chapter, the bending theory of the DNA helix and the corresponding 
computational analysis program will be addressed. The flexibility of poly(dA- 
dG)*poly(dC-dT) and calf thymus DNA, which have the same binding species 5'AGA, 
will be measured using time-resolved fluorescence emission anisotropy in different time 
spans. The effect of different bonding density will also be examined.
4.2 Bending Theory and Fluorescence Anisotropy Decay Function
The torsional and bending rigidities of the DNA helix are determined by fitting 
the fluorescence anisotropy decay of TOM-DNA adduct to the theoretical decay model. 
Two fluorescence decay curves /y y  and /y n  are acquired. The first letter in the 
subscript denotes the polarization of excitation light and the second the polarization of 
emitted light. These two observed decay curves will obey the following equations:
/y y  (t) = lamp (t) ® { Flu (t) * (1 + 2 * r ( t ) ) / 3 ) (4.1a)
I\H  (t) = lamp (t) ® { Flu (t) * ( 1  - r ( t ) ) / 3 } (4.1b)
where the predicted total intensity of fluorescence from all three polarization directions 
Flu(t) = X oq exp(-t !%\) is independent of polarization, lamp (t) is the instrumental
response function, and r (t) the predicted fluorescence anisotropy decay. The symbol ® 
denotes convolution.
For a fluorescent probe that is tightly attached to a very long DNA helix and has 
parallel absorption and emission transition dipoles, the fluorescence emission 
anisotropy decay r(t) depends on the initial anisotropy rQ, the internal correlation 
function In(t), the torsional correlation function Fn(t), and the bending correlation 
function G n(t) (Barkley & Zimm, 1979; Schurr, 1984):
r(0 = roX  I„(t) F„(t) Gn(t)
i= l ( 4 . 2 )
The internal correlation function is given by:
= (3cqs2e - 1)2_ = 3sm?2e j = 3smie ( 4  3a. c)
u 4  ' 4  z 4  v
where e is the relative orientation between the transition dipole of the fluorescent probe 
and the axis of the DNA helix.
The torsional correlation function Fn(t) is determined by:
Fn(t) = exp [-u2KtqT  (7tC p ) ' , /2  t 1/2] (4.4)
where A'g is the Boltzmann constant, T the absolute temperature, C the torsional 
rigidity, and p the friction coefficient per unit length for rotation about the helix axis. C 
governs the equilibrium root-mean-square fluctuation in twist: Yrms = (3.4 x 10~8 
tfBT /C )1/2. p is equal to 47trib2, where b is the radius of the DNA helix.
The bending correlation function Gn(t) is determined by: 
Gn(0 = exP [ - ( 6  - n2 )B(t) t 1/4 / 4] (4.5)
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where B(t) is a complicated function depending on T, b, time, the bending rigidity El, 
and solvent viscosity T|. E l is related to the persistence length, P, as E l = PXb T. The 
explicit expression of B(t) is given in the next section.
4.3 Computational Analysis Program: BZFIT
Based on the anisotropy decay theory described in the above section, a global 
non-linear least squares fitting program, BZFIT, was written in FORTRAN 77 language 
on the VAX 3100 workstation (see Appendix C .l for codes). The fitting parameters 
include: i) anisotropy decay parameters: r0, b, P, e, and C; and ii) lifetime parameters:
Ti ,  and otj. The lifetime Xj can be specifically associated with an anisotropy decay 
model. The fluorescence decay curves acquired at magic angle (54.7°) can also be 
included in the global data analysis with Xj  linked with the polarized decay curves, 
which restrains the lifetime parameters and thus helps recover the anisotropy 
parameters. In addition, a very important advantage of BZFIT is that all these 
parameters can be set free, linked, associated, and/or fixed during the global fitting of 
multiple decay curves, which has not been done in other labs (Wu et al., 1987; Wu et 
al., 1988; Brown et al., 1991; Guest et al., 1991).
In BZFIT, the analytical derivatives of Xj and oq were computed directly from 
the equations. However, the numerical convolution and the numerical derivative of 
anisotropy decay were used due to the non-exponential expressions of Fn(t), Gn(t), the 
modified Bessel function, and the transcendental equations involved in the decay 
model, which is the reason for the enormous computing time required for the data 
analysis. The general formula for numerical convolution is:
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N
c(n) = X a(k)*b(n-k+l)
k= 0  (4.6)
where N is the maximum length of vectors a and b, and integers k < n.
B(t) is given as
3.466ATb T z(t)
B®  = (4 ?)
where z(t) is given by the transcendental equations 4.8a & b. 
z(t) = [K0 (zmax) + ^ M .K ,(z max) ] 1/4 (4.8a) 
(4.8b)w ( t )  z ( t) | (E I)t |
and Ko and Kj are the solutions of the modified Bessel function which is solved using 
the polynomial approximation (Abramowitz & Stegun, 1965; Weast, 1989):
i) when 2  < x <
jt1/2 e*K 0 (x) = 1.25331414 - 0.07832358(2/x) + 0.02189568(2/x)2 -
0.01062446(2/x)3 + 0.00587872(2/x)4 - 0.00251540(2/x)5 + 
0.00053208(2/x)6 + e; le! < 1.9x1 O' 7
(4.10a)
x m  ex Ki(x) = 1.25331414 + 0.23498619(2/x) - 0.03655620(2/x)2 +
0.01504268(2/x)3 - 0.00780353(2/x)4 + 0.00325614(2/x)5 - 
0.00068245(2/x)6 + e; lei < 2.2x 10' 7
(4.10b)
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ii) when 0  < x < 2 :
K0 (jc) = -ln(jc/2)I0 (jc) - 0.57721566 + 0.42278420(x/2)2 + 0.23069756(;t/2)4 
+ 0.03488590(jc/2)6 + 0.00262698(v/2)8 + 0.00010750(x/2)'0 + 
0.00000740(^/2)12 + e; lei < lx lO ' 8
(4.10c)
x K \(x) = xln(x/2)Ii(;c) + 1 + 0.15443144(jt/2)2 - 0.67278579(x/2)4 - 
0.18156897(x/2)6 - 0.01919402(x/2)8 - 0.001 10404(jc/2)10 - 
0.00004686(^/2)12 + e; lei < 8 x l0  9
(4.10d)
Io(y) = 1 + x l —  + , x~ + - - ■y 6  + -  (4.10e)
22 (1 ! ) 2 24(2 ! )2 26 (3 ! )2
Il&-) = f - + ^ - + - / -  + ^ Z- + -  (4 I Of)
2  23 1!2! 25 2!3! 273!4! v ;
The reduced %2 value, weighted residuals, and the autocorrelation function of 
the weighted residuals are used to judge the goodness of fit, combined with the 
knowledge from simulation and lifetime analysis at magic angle.
Some examples of auxiliary programs are BZPAR for generating various 
parameter matrices as input for BZFIT, SUMWT for calculating the total fluorescence 
intensities and the corresponding weighting factors, and GCORR for polarization error 
corrections of total intensities using the steady-state anisotropy and of the perpendicular 
data file using the measured G-factor. The G-factor is equal to / hv^HH- BZSIMU, 
which was written using the MATLAB software package, is used to simulate the 
anisotropy decay curve using numerical convolution from either the experimental or
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theoretical instrumental response function. A theoretical instrumental function can be 
given as:
Lamp (t) = exp(-t/A) - exp(-t/B) (4.11)
where A and B can be any positive value with A>B. The codes for these programs can 
be found in Appendix C.
4.4 Methods and Materials
Poly(dA-dG)*poly(dC-dT) was purchased from Pharmacia Co. and dissolved 
into 0.01 M phosphate buffer containing 0.1 M NaCl and 0.1 mM EDTA, pH 7.5. Its 
molecular weight as well as distribution was determined using 1 .0 % agarose gel 
electrophoresis compared with two molecular weight markers, 1 kb DNA Ladder and 
123 bp DNA Ladder purchased from GIBCO BRL. As a wide distribution was found 
from the commercial samples (Figure 4.3), fractionation was performed on a 
Nucleogen-DEAE 4000-7 HPLC anion-exchange preparative column purchased from 
Macherey-Nagel, Diiren, F.R.G. (Colpan & Riesner, 1984; Coppella et al., 1987). This 
is a silica gel-based weak anion exchange column with a hydrophilic surface. HPLC 
was performed on a Rainin Rabbit-HP liquid chromatography system equipped with a
2-ml sample loop and a variable-wavelength ISCO V4 absorbance detector. The buffer 
A contained 50 mM KH2PO4  and 4 M urea (note: 6  M was found to give better 
separation later) with pH 7.5. The buffer B was buffer A plus 1.5 M KC1. The running 
gradient was 0-40 % of buffer B in 30 minutes and 40-80 % of B in 60 minutes at flow 
rate of 1.0 ml/min and pressure of 500 psi. The fractions were detected at 260 nm and 
collected every minute. After fractionation, salt and urea were removed by dialysis into 
the desired buffer at 4 °C for at least three days. Molecular weights and distribution of 
each fraction were determined using gel electrophoresis. Among them, about 4-6
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Figure 4.3. Molecular weight o f poly(dA-dG)*poly(dC-dT) determined from gel 
electrophoresis: (left column) before HPLC fractionation, (middle column) after HPLC 
fractionation, and (right column) molecular marker 1 kb. The arrow indicates the 1 kb 
band.
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fractions that gave strongest signal at 260 nm turned out to have the same molecular 
weight and were combined. The molecular weight of the combined fractions was 
determined as 1,000 ± 50 bp or (6.1 ± 0.3) x 105 daltons (Figure 4.3). The final 
concentration used in the fluorescence emission anisotropy decay was about 1.5 x 10-4  
M nucleotide or 50 pg-DNA/ml, which gave about 0.9 absorbance at 260 nm. Other 
fractions were discarded due to very low concentrations and widely spread molecular 
weight in different fractions. The adduct solution was prepared as described in Chapter
3.2 at P/D = 100 and 50. Unreacted drug was removed by extraction with ethyl acetate 
prior to use. Photobleaching under intense laser light was minimized by deoxygenation.
In the fluorescence emission anisotropy decay measurement, the excitation light 
from the dye laser (see Chapter 3.2 for details) is vertically polarized. The four-position 
thermostatted sample holder was used in L-format detection. A dilute solution of 
glycogen (Sigma) in water or water itself was used as a scatter to measure the 
instrumental response profile. Two blackened quartz microcuvettes (3x3x5 mm 3 inside, 
Helma) containing the adduct solution were placed in the sample holder. One position 
had a vertical polarizer on the emission side (i.e., VV or parallel) and the other a 
horizontal polarizer (i.e., VH or perpendicular). A DPU-2.5 optical depolarizer (Optical 
For Research, Co.) was placed before the emission monochromator to eliminate 
polarization dependence in the detection train. Measurements were carried out at 
different time scales of 5-41 ps/channel for 1024 channels and at 5 °C. Excitation 
wavelength was 333 nm. Emission wavelength was 400-420 nm at 5-nm intervals. 
About 3.5 x 104 counts in the peak channel were collected for parallel data file, and 2 x 
104  for the perpendicular. The G-factor was measured from the two samples with 
horizontally-polarized excitation light. It is defined as the fluorescence intensity ratio 
of /hv //hh - The G-factor was measured before and after each measurement for a 
period of 15 minutes, and the average value was used. For those decays that have less
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than 0.5 % counts in the tail compared to the counts in the peak channel, the G-factor 
correction was done using the steady state anisotropy value from the same solution as 
determined separately on an SLM 8000 fluorometer at the same wavelengths and 
temperature.
4.5 Experimental Results and Discussions
Fluorescence Lifetime. The fluorescence decay curves for tomaymycin-DNA 
and tomaymycin-poly(dA-dG)»poly(dC-dT) adducts fit well to a biexponential lifetime 
model (Table 4.1). The similar lifetimes suggest that both adducts have the same 
binding species (see Chapter 3.4 for more details). The longer lifetime species 
presumably represents the S3' species, and the shorter lifetime the R5' species. In 
addition, two extra lifetime species are present due to the free drug (1.04 ns) and stray 
light under intense laser light (-3 0  ps). They are fixed and dissociated from r(t) in 
global anisotropy decay analysis.
Anisotropy Decay. Global anisotropy decay analysis were performed on 16 
pairs of polarized decay curves acquired at different wavelengths, time scales, and P/D 
ratios. The initial anisotropy (r0) is determined as -0 .36 for both tomaymycin-calf 
thymus DNA and -poly(dA-dG)*poly(dC-dT) adducts. It is close to the limiting 
anisotropy of -0 .34  obtained from free drug in ethanol glass at 77 K. The radius of the 
DNA helix used in the data analysis was 12.5 A. Figure 4.4 shows an example of the 
polarized decay curve and the best fit to it.
The relative contributions of twisting and bending motions to the anisotropy 
decay depend on the angle (e) between the transition dipole and the helix axis. The 
recovered value of e from the experimental data is -35°, which agrees with the value 
estimated from the molecular modeling studies. This angle is rather small compared to
Table 4.1 Lifetime Data of Tomaymycin-Poly(dA-dG)*poly(dC-dT) and Tomaymycin- 
Calf Thymus DNA Adducts0
adduct XI « 2 X2 X2
poly(dA-dG)*poly(dC-dT) 0.63 7.2 0.37 4.8 1 . 6
calf thymus DNA 0.60 7.1 0.40 4.3 1.7
a pH 7.5, P/D = 100, 5 °C, Xcx = 333 nm, A,em = 400-420 nm at 5-nm intervals.
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Figure 4.4. Polarized fluorescence decay curve of tomaymycin-calf thymus DNA
adduct at parallel orientation at pH 7.5, P/D = 100, 5 °C. A,ex = 333 nm, Aem = 400 nm, 
33 ps per channel. Left curve is instrumental response function; points are sample
decay; smooth curve through points is best fit to the following: oci = 0.6, Ti =7.1 ns, %2
= 4.3 ns, r0  = 0.36, b = 12.5 A, C = 2.4 x 1 0 - 19 erg.cm, e = 35°, P = 470 A, local y }  = 
1.7. Weighted residuals and autocorrelation function of the residuals (inset) are also 
shown.
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ethidium-DNA complex whose angle is 71°. Therefore, the bending motions dominate 
the anisotropy decay o f tomaymycin-DNA adduct. In contrast, twisting motions 
dominate the decay in the case of ethidium-DNA complexes. This is shown in the 
simulation of r(t) using equations 1-7 (Figure 4.5). The relative contribution from 
bending motions is greater at early times.
Flexibility o f  the DNA Helix. The observed flexibility o f calf thymus DNA is 
close to consensus values (Hagerman, 1988; Fujimoto & Schurr, 1990). However, 
poly(dA-dG)*poly(dC-dT) has similar torsional rigidity but smaller bending rigidity 
than calf thymus DNA. Similar flexibility is observed at P/D ratio of 100 and 50 for 
poly(dA-dG)*poly(dC-dT), indicating drug binding does not significantly distort the 
DNA helix at this bonding density. When the persistence length in the data analysis is 
linked between the curves acquired at different time ranges, the recovered P is 130-140
o o o
A. When P is not linked, however, it varies from 120 A in the range of 41 ns to 180 A 
in the range of 5 ns (Table 4.2).
It is known that purine-pyrimidine tracts may adopt some unusual 
conformations and base pair stacking (Wells, 1988). The sequence-dependence of
o
bending rigidity has been reported. A P value of as low as 180 A was observed for 
poly(dA)»poly(dT) using a triplet quenching technique (Hogan & Austin, 1987). But 
the small P for poly(dA-dG)»poly(dC-dT) must be confirmed by further experiments.
0.4
0.2
403010 200
Time (ns)
Figure 4.5. Simulated r(t) curves. 1024 channels, 41 ps/channel, 278 K, r\ = 0.01549 poise, ro = 0.4, b = 12.5 A. curve a)
£ = 71°, C = °o ,P  = 500 A; b) 8  = 35°, C = 1.3 x 10~1 9 erg.cm,P = °°; c) 8  = 35°, C = ° ° ,P  = 500 A; d) e = 7 1 ° ,C = 1 .3 x  
-1 910 erg*cm, P = °°.
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Table 4.2 Torsional (C) and Bending (El) Rigidity of the DNA Helix
Adduct P/D time
(ns)
C
(x 10*9 
erg-cm)
Yrms
p  a
o
(A)
El 
(x 1019 
erg*cm)
calf thymus DNA 1 0 0 33 2.4 4.2° 470 1 . 8
1 0 0 41 2 . 2 4.4° 140 (130) 0.54
poly(dA-dG) 50 41 2 . 2 4.4° 140 (120) 0.54
•poly(dC-dT) 1 0 2 . 2 4.4° 140 (150) 0.54
5 2 . 2 4.4° 140 (180) 0.54
a Shown in parenthesis are the recovered persistence length values when P was not 
linked between the polarized decay curves acquired at different time ranges.
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Chapter 5. Conclusions and Future Research
There are two major nonradiative processes occurring at the singlet excited-state 
o f tomaymycin. They are intersystem crossing (k\sc) and excited-state proton transfer 
(kp{). The latter is responsible for the different fluorescence properties in different 
solvents and DNA adducts due to its environmental sensitivity. In aqueous solution, kpt 
is much faster than /qsc and the radiative rate (kr), which yields observable solvent 
isotope effect as well as a short lifetime. In contrast, kpi in alcoholic solvent and DNA 
adduct would be very slow compared to kr and k\sc so that the solvent isotope effect is 
negligible. The excited-state proton transfer can result in photochemical H-D exchange 
on the aromatic carbons C6  and C9 of tomaymycin with similar reaction rate. 8 - 
phenolic group is not responsible for the solvent isotope effect. Moreover, hydroxy and 
methoxy groups on the aromatic ring alone cannot lead to the photochemical H-D 
exchange. It is most likely that the excited-state proton transfer occurs between N10-H 
of tomaymycin and solvent or DNA base, which quenches fluorescence and renders the 
aromatic ring susceptible to protonation. Based on the proposed mechanism, the H- 
bonding between N 10-H and solvent or DNA base plays an important role in the 
excited-state proton transfer which affects the fluorescence lifetime.
Phosphorescence becomes more efficient than fluorescence at 77 K. The 
emission transition dipole of T]->S0 is most likely perpendicular to the absorption 
transition dipole of Si<-SG, resulting in a negative limiting anisotropy. In contrast, the 
emission transition dipole of S]-> SG is parallel to the absorption dipole of S]<-S0.
Two binding species exist in tomaymycin-natural DNA adduct at bonding 
density lower than one drug molecule per 70 nucleotides. Both occupy the preferred
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binding site 5’AGA. The major species has longer lifetime than the minor species.
They are presumably assigned to the S3' and R5' adducts, respectively. A different 
fluorescence lifetime is due to a different H-bonding pattern between N10-H of 
tomaymycin and the proton acceptor on the flanking DNA base. The lifetimes are not 
sensitive to pH, DNA size, DNA concentration, and P/D ratio (when < 100). At high 
bonding density, less preferred binding sites are also occupied, which yields distributed 
lifetimes ranging from 1.5 to 8  ns due to the presence of various binding species.
Tomaymycin appears to be a promising probe to report the internal motions of 
the DNA helix, particularly for bending motions. It does not seem to stiffen the DNA 
helix at low bonding density. The transition dipole of tomaymycin in the DNA adduct 
is oriented at -35° to the helix axis. Therefore, bending motions dominate the 
fluorescence emission anisotropy decay of tomaymycin-DNA adduct in the time range 
up to 50 ns. Poly(dA-dG)«poly(dC-dT) possesses the same two binding species as calf 
thymus DNA. Both DNA helices have similar torsional rigidity. But poly(dA- 
dG)-poly(dC-dT) is more flexible in terms of bending rigidity.
Tomaymycin can remain bound in the DNA helix when B DNA is converted 
into Z DNA. It may also remain bound or even be able to bind to other unusual DNA 
helices such as triplex. Therefore, it provides a good opportunity to further study the 
dynamics of unusual DNAs as well as B DNA. A lot of circumstantial evidence 
suggests that unusual DNA structures are involved in gene expression processes. The 
dynamics of the DNA helix governs its deformation and conformational change.
Besides these unusual DNA helices, the B-Z junction may be investigated because it is 
possible that the tomaymycin-bound areas remain in B DNA. Tomaymycin has shown 
the ability to stabilize B DNA and inhibit B-Z transition.
Appendix A. Abbreviations and Symbols
a  pre-exponential amplitude
b radius of the DNA helix
BBO 2,5-bis-(4-biphenylyl)-oxazole
C torsional rigidity
CD circular dichroism
D/ the broadness of the ith peak from MEM analysis
DEAE diethylamine
Ea activation energy
F.DTA ethylenediaminetetraacetic acid
El bending rigidity
0  quantum yield
FWHM full width at half maximum
h Planck constant
r) viscosity
HPLC high performance liquid chromatography
K b  Boltzmann constant
/qsc intersystem crossing rate
km  nonradiative rate
&PX proton transfer rate
kr radiative rate
Xcm emission wavelength
Aex excitation wavelength
MEM maximum entropy method
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MTOM
NMR
P
P/D
POPOP
Pu
Py
ro
T
x
TME
TOM
UV-Vis
<8>
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8 -methyl tomaymycin 
nuclear magnetic resonance 
persistence length 
nucleotide to drug ratio
l,4-bis-(5-phenyl-2-oxazoyl)-benzol or l,4-bis-(5-phenyloxazol-
2 -yl)-benzene
purine
pyrimidine
limiting anisotropy or initial anisotropy
absolute temperature
lifetime
tomaymycin 1 1 -methyl ether 
tomaymycin 
ultraviolet-visible 
convolution
Appendix B. Some Additional Experimental Results
B .l T he Fluorescence Lifetim es of Some Tom aymycin-DNA A dducts C ontaining 
U nique B inding Sites.
Tomaymycin-d(CICGATCICG)2, -d(CIAGCICTCG)2, and -d(CITCICGACG ) 2 
adducts were generously provided by Dr. Hurley as lyophilized samples with two 
tomaymycin molecules bonded per duplex. They were dissolved into 10 mM phosphate 
buffer, pH 7.0, containing 0.1 M NaCl and 0.1 mM EDTA, to give final concentration 
of about 1 x 10' 5 M duplex. Poly(dA-dG)«poly(dC-dT) was purchased from Pharmacia, 
Co. and dissolved into pH 7.5 phosphate buffer. The concentration was determined 
from the absorbance at 260 nm using extinction coefficient of 5700 M _1c n r 1. The 
tomaymycin adduct was prepared as described in Chapter 3 with P/D = 1 0 0  and 50.
The fluorescence lifetimes of the above samples were measured using time-correlated 
single photon counting technique at 5 °C as described in Chapter 3. All adduct 
solutions were subject to the same extraction and deoxygenation procedures prior to 
use. The analysis results are shown in Table B .l.
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Table B .l The Fluorescence Lifetime Data of Some Tomaymycin-DNA Adducts 
Containing Unique Binding Sites.
sequence A-ex (nm) a i X\ (ns) %2 (ns) X2
d(CICGATCICG)2a 318 1 . 0 0 5.6 1.3
323
328
333
d(CIAGCICTCG)2" 318 0.89 + 0.01 5.4 2 . 6 1.35
323 0.95 + 0.01
328 0.96 + 0.01
333 0.99 ±0.01
d(CITCICGACG)2" 318 0.640 + 0.003 5.6 1.4 1.3
323 0.726 ±  0.002
328 0.796 ± 0.003
333 0.825 + 0.005
poly(dA-dG)»poly(dC-dT)fc 333 0.63 + 0.05 7.2 4.8 1.7
"Global analysis o f the intensity decay curves at ACm = 395-415 nm (5-nm intervals). 
The counts in the peak channel were 2.5 x 104. POPOP in 0.8 M KI ethanol/water (3:1) 
solution was used as the reference fluorophore (see Chapter 2 for detail). ^Global 
analysis of 8  intensity decay curves at Xem = 400-420 (5-nm intervals). The counts in 
the peak channel were 2.5 x 104. Glycogen in aqueous solution was used as the scatter 
(see Chapter 4 for detail). A short lifetime of -30  ps was present due to stray light and 
subtracted.
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B.2 The Effect of Tomaymycin Bonding on the B-Z Transition of Poly(dG- 
dC)-poIy(dG-dC)
Poly(dG-dC)*poly(dG-dC) was purchased from Pharmacia, Co. and dissolved in 
0.01 M phosphate buffer, pH 7.5, containing 0.1 M NaCl and 0.1 mM EDTA. The 
solution concentration was determined from the absorbance at 254 nm using extinction 
coefficient of 8400 M '1c n r 1. The tomaymycin adduct solution was prepared as 
described in Chapter 3. The amount o f unreacted drug was determined from the 
isobutanol extraction method as described in Chapter 3. The B-Z transition was 
induced by 5 M NaCl (F. M. Pohl & T. M. Jovin, J. M o l Biol. 1972, 67, 375-396). The 
transition was monitored from circular dichroism (CD) spectra on an AVIV 14DS CD 
spectrometer. All measurements were carried out at 5 °C.
The B-Z transition of poly(dG-dC)*poly(dG-dC) can be completed in less than 3 
hr. In contrast, the formation and dissociation of adduct are very slow. Therefore, the 
effect of bound tomaymycin on the B-Z transition can be observed by adding NaCl to 
solution after isobutanol extraction. The effect of unreacted tomaymycin can be 
observed right after adding drag to DNA solution. The bonding densities of 
tomaymycin in B and Z DNAs were very similar for up to 2 weeks within the 
experimental error, indicating that tomaymycin adduct remains in Z DNA. The B-Z 
transition of adducts prepared at P/D = 10 and 20 was partially inhibited, while the 
inhibition at P/D = 60 was negligible (Table B.2 and Figure B .l). The percentage of Z 
DNA without isobutanol extraction is very close to that with the extraction. No 
inhibition was observed when the B-Z transition was induced right after adding drug to 
DNA solution. These results indicated that only the bound drug was able to inhibit the 
B-Z transition.
Table B.2 The Effect of Tomaymycin Bonding on B-Z Transition
Z % h
P/D bonding without with
density0 extraction extraction
10 26 ± 2 29 ± 5 37 + 5
20 61 + 5 72 ±  5 80 ±  5
60 386 ±  50 100 ± 5  100 + 5
°The bonding density refers to the ratio of nucleotide to reacted drug. 
bZ  % was calculated based on the average changes of ellipticity at 251 
and 292 nm.
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Figure B .l. The CD spectra of poly(dG-dC)»poly(dG-dC) and its 
tomaymycin adducts in 5 M NaCl solution, 5 °C. B DNA is in 0.1 M NaCl.
Appendix C. Computational Program Codes
C.l. BZFIT.for
* BBBB ZZZZZ FFFFF in TTTTT
* B B Z F I T
* BBBB Z FFFF I T
* B B Z F I T
* BBBB ZZZZZ F in T
*****'* ****************************************************************************** 
* *
* 
*
* 
*  
*
*  *
* DATA ANALYSIS PROGRAM OF DNA INTERNAL MOTIONS MONITORED *
*  B Y  *
* TIME-RESOLVED FLUORESCENCE EMISSION ANISOTROPY *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
*
* BASED ON BARKLEY_ZIMM'S DNA BENDING MOTION THEORY (J. CHEM. PHYS., 1979)
* USING THE NON-LINEAR LEAST SQUARE FITTING METHOD AND
* THE SIMILAR FLOWCHAT IN 'TFIT' FOR FLUORESCENCE LIFETIME DECAY WRITTEN
* BY MARK PRITT AND JOE BEECHEM.
*
* WRITTEN IN DR. BARKLEY'S LAB ON DECEMBER 4, 1992
* MAGIC ANGLE CURVES LINKING OPTION ADDED IN JULY, 1993
* NON-1 G-FACTOR OPTION ADDED ON DECEMBER 6, 1993
*
* AVAILABLE OPTIONS:
*
* 1. LAMP METHOD ONLY
* 2. LIFETIME-ANISOTROPY ASSOCIATIVE OR NON-ASSOCIATIVE
* 3. Q-SHIFT
* 4. CHANNEL LIMITS SPECIFIED OR UNSPECIFIED
* 5 STANDARD OR CUSTOMER WEIGHTING
* 6. SAME OR DIFFERENT LAMPS FOR PARALLEL AND PERPENDICULAR CURVES 
7. FILENAME CAN BE IN ANY FORMAT
6. MAGIC ANGLE CURVES LINKABLE
7. NON-1 G-FACTOR
8. ALL MOLECULAR PARAMETERS ARE FITTING PARAMETERS
INPUTS:
1. BZFIT.DAT CONTAINING DATA FILENAMES, INSTRUMENTAL AND EXPERIMENTAL 
CONDITIONS, AND FITTING PARAMETERS
* 2. DECAY CURVES
*
EXAMPLE OF BZFIT.DAT 
1024 (CHANNEL NUMBER)
FT AGO 1 .DAT (LAMP FOR PARALLEL CURVE FOLLOWED BY ) 
FTAG01.DAT (LAMP FOR FOR PERPENDICULAR CURVE) 
FTAG02.DAT
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* FTAG02.DAT
* FTAG03.DAT (LAMP FOR MAGIC ANGLE CURVE, OPTIONAL)
* .END
* VTAG01.DAT (PARALLEL CURVE)
* YATG01 .DAT (PERPENDICULAR CURVE)
* VTAG02.DAT
* YTAG02.DAT
* ,NRT (END OF ANISOTROPY DECAY CURVES)
* VTAG03.DAT (MAGIC ANGLE CURVE, OPTIONAL)
* .END
* ATAG01.DAT (FITTED CURVES, OPTIONAL)
*
* .END
* STANDARD (OR FILENAME CONTAINING THE WEIGHTING FACTORS)
* 0 0 0  (Q-SHIFT, ONE PER LAMP)
* 0.03 0.03 (NS PER CHANNEL, ONE PER EXPERIMENT)
* 0 0 0 0 0 0  (CHANNEL LIMITS FOR SAMPLE DECAYS, ONE PAIR PER CURVE) 
* 1 2 3 4 0 0 0 0 0 0  (LOGICAL NUMBER FOR LIFETIME IN EXPERIMENT 1) 
* 5 6 7 8 9 0 0 0 0 0  (LOGICAL NUMBER FOR RO, C, B, EPSILON, PL IN EXPERIMENT 1)
*
* 0.5 7 0.3 3 0.4 1.2 11 33 500 (INITIAL GUESSES)
*
* 1 1 1 1 1  (ASSOCIATIVE MATRIX FOR EXPERIMENT 1)
*
* 0.9 0.9 (G-FACTOR, ONE PER ANISOTROPY EXPERIMENT)
* 278 278 (TEMPERATURE, ONE PER ANISOTROPY EXPERIMENT)
* 0.01 0.01 (VISCOSITY, ONE PER ANISOTROPY EXPERIMENT)
* L (LAMP METHOD)
*
*
* IMPORTANT NOTES:
*
* 1. LOGICAL NUMBERS DO NOT HAVE TO BE IN ORDER, BUT MUST BE CONSECUTIVE
* FROM 1 OVERALL.
* 2. IN PRACTICE, FIX ANISOTROPY PARAMETERS FIRST FOR THE BEST FIT OF
* LIFETIME PARAMETERS TO AVOID FALLING INTO ARITHEMATIC TRAP, THEN
* CONTINUE FROM THE BEST FIT WITH OR WITHOUT FIXING LIFETIMES.
PROGRAM BZFIT
* * * DECLARATION SECTION * * *
PARAMETER (NEXP=30, NCOMP=10, NCHANM=1024, NPAR=300,
$ FLINC1 = 10.0, FLINC2=10.0, PRE=l.0/3.0, LU=5, FCNGE=l.E-6,
$ DELTA_DDER=0.001)
DIMENSION ALFA(NPAR,NPAR), ALFA_LOCAL(2*NCOMP,2*NCOMP),
$ AMP(NCOMP), ARR(NPAR,NPAR), ASSOC(NCOMP/2,NEXP),
$ BETA(NPAR), BETA_LOCAL(2*NCOMP),
$ CDERIV(NCHANM), CFIT(NCHANM), CFITX(NCHANM), CHISQR(2*NEXP),
$ DELTA(NPAR), DERIV(NCHANM,2*NCOMP), DERIVX(NCHANM),
$ DKDATA(NCHANM,2*NEXP), ELAMP(NCHANM,2*NEXP), ELAMPI(NCHANM),
$ FIT(NCHANM), FITDATA(NCHANM,2*NEXP), FITX(NCHANM), FLU(NCHANM),
$ GFACM(NEXP), LIMIT(2), LIMS(2,2*NEXP), LIMS_LAMP(2,2*NEXP),
$ NCHAN_BAD(2*NEXP), NCHAN_BAD_NEW(2*NEXP), MPOINT(NCOMP,NEXP,2), 
$ PAR(5), PMAIN(NPAR), PMAIN_NEW(NPAR), RT(NCHANM),
$ RTFLU(NCHANM), RTX(NCHANM), RTY(NCHANM), QS(2*NEXP),
$ S(NPAR,NPAR), SCALED_BETA(NPAR), SCRATCH(NCHANM),
$ SIGMA(NCHANM,2*NEXP), T(NPAR), TAU(NCOMP),
$ TAUP(NEXP), TCALS(NEXP), TEMPM(NEXP), VISCM(NEXP) 
CHARACTER*40 NAMR, PARAM_FILE, ANSWER_FILE, CURVMAT_FILE, 
$ FITNAME(2*NEXP)
CHARACTER*] EXP_TYP
LOGICAL EX, SWITCH, FLAMDEJBAD, PROBE
INTEGER ASSOC, PAR_ORDERING_DONE, BEGINNING, MARQUARDT,
$ EXIT_AND_SAVE_RESULTS, MATRIX_ERROR, EXIT_CHI_LOOP,
$ SUM_CHANNELS
DOUBLE PRECISION SUMM, SUM, Z, SCALED_BETA, ARR, S, T 
DATA FLAMDE / .Oi l ,  FLAMDE_BAD /.FALSE./, PROBE /.FALSE./
ASSIGN 100 TO PAR_ORDERING_DONE 
ASSIGN 200 TO BEGINNING 
ASSIGN 300 TO MARQUARDT 
ASSIGN 400 TO EXIT_AND_SAVE_RESULTS 
ASSIGN 500 TO EXIT_CHI_LOOP 
ASSIGN 990 TO MATRIX_ER.ROR
* * * INPUT SECTION * * *
* OPEN PARAMETER FILE
PARAM_FILE = 'BZFIT.DAT'
OPEN(51, ERR=900, FILE=PARAM_FILE, STATUS='OLD', IOSTAT=IOS)
* GET THE NUMBER OF CFIANNNELS
READ (51, '(14)’) NCHAN
* GET LAMP/PROBE CURVES
NLAMPCURVES = 0
READ (51, '(A)', ERR=910) NAMR
DO WHILE (INDEX (NAMR, '.END') .EQ. 0)
NLAMPCURVES = NLAMPCURVES + 1
WRITE (LU, '(2X, "READING LAMP FILE ", A)’) NAMR
OPEN (61, ERR=900, FILE=NAMR, STATUS=’OLD', IOSTAT=IOS)
READ (61, FMT-(A)', ERR=910) FJUNK 
DO I = 1, NCHAN 
READ (61, *, ERR=910) FJUNK, ELAMP(I, NLAMPCURVES)
ENDDO 
CLOSE (61)
READ (51, '(A)’, ERR=910) NAMR 
ENDDO
WRITE (LU, '(2X, 13, " LAMP CURVES")') NLAMPCURVES
* GET ANISOTROPY DECAY DATA CURVES
NRTCURVES = 0
READ (51, '(A)', ERR=910) NAMR
DO WHILE (INDEX (NAMR, '.NRT') .EQ. 0)
NRTCURVES = NRTCURVES + 1
WRITE (LU, '(2X, "READING DATA FILE " ,A)') NAMR
OPEN (61, ERR=900, FILE=NAMR, STATUS='OLD’, IOSTAT=IOS)
READ (61, FMT='(A)', ERR=910) FJUNK 
DO I = 1, NCHAN 
READ (61, *, ERR=910) FJUNK, DKDATA(I, NRTCURVES)
ENDDO 
CLOSE (61)
READ (51, ’(A)’, ERR=910) NAMR 
ENDDO
* GET LIFETIME DECAY DATA CURVES
NLTCURVES = 0
READ (51, ’(A)1, ERR=910) NAMR
DO WHILE (INDEX (NAMR, '.END') .EQ. 0)
NLTCURVES = NLTCURVES + 1
WRITE (LU, '(2X, "READING DATA FILE ", A)’) NAMR
OPEN(6I, ERR=900, FILE=NAMR, STATUS='OLD', IOSTAT=IOS)
READ (61, FMT='(A)', ERR=910) FJUNK 
DO I = 1, NCHAN
READ (61, *, ERR=910) FJUNK, DKDATA(I, NRTCURVES+NLTCURVES) 
ENDDO 
CLOSE (61)
READ (51, ’(A)', ERR=910) NAMR 
ENDDO
NDATACURVES = NRTCURVES + NLTCURVES 
IF (NDATACURVES .NE. NLAMPCURVES) THEN 
WRITE (LU, '(4X, "WARNING: THE NUMBER OF LAMPS IS NOT EQUAL", 
$ " TO THE NUMBER OF DATA CURVES")')
STOP
ENDIF
FIGURE OUT NUMBER OF EXPERIMENTS 
NRTEXPTS = NRTCURVES/2 
NLTEXPTS = NLTCURVES 
NEXPERIMENTS = NRTEXPTS + NLTEXPTS 
GET FIT FILENAMES 
INDEX_SCRATCH = 0 
READ (51, '(A)', ERR=910) NAMR 
DO WHILE (INDEX (NAMR, '.END') .EQ. 0)
INDEX_SCRATCH = INDEX_SCRATCH + 1 
FITNAME(INDEX_SCRATCH) = NAMR 
READ (51, '(A)VERR=910) NAMR 
ENDDO 
GET WEIGHTING 
READ (51, '(A)', ERR=910) NAMR 
IF (INDEX (NAMR, ’STANDARD') .NE. 0) THEN 
WRITE (LU, '(2X, "USING STANDARD WEIGHTING...")')
DO J = 1, NDATACURVES 
DO I = 1,NCHAN 
DATA_PT = DKDATA(I, J)
IF (DATA_PT .EQ. 0.) THEN 
SIGMA(I, J) = 1.
ELSE
SIGMA(I, J) = l./DATA_PT 
ENDIF 
ENDDO 
ENDDO 
ELSE
WRITE (LU, '(2X,"FILE CONTAINING WEIGHTING IS ", A)') NAMR 
OPEN (61, ERR=900, FILE=NAMR, STATUS='OLD', IOSTAT=IOS)
READ (61, *, ERR=910) ((SIGMA(I, J), 1=1, NCHAN), J=l,
$ NDATACURVES)
CLOSE (61)
ENDIF
GET QSHIFTS, TCALS, AND CHANNEL LIMITS 
READ (51, *, ERR=910) (QS(I), 1=1,  NLAMPCURVES),
$ (TCALS(I), 1=1,  NEXPERIMENTS),
$ ((LIMS(I,J), I = 1, 2), J = 1, NDATACURVES)
GET ALPHA/TAU LOGIC - ANISOTROPIC DATA FIRST 
READ (51, *, ERR=910) (((MPOINT(I, J, K), I = 1, NCOMP),
$ K = 1, 2), J = 1, NRTEXPTS)
IF (NLTEXPTS .NE. 0) THEN 
READ (51, *, ERR=910) ((MPOINT(I, J, 1), I = 1, NCOMP),
$ J = NRTEXPTS + 1, NEXPERIMENTS)
ENDIF
FIGURE OUT HOW MANY INITIAL GUESSES THERE ARE TO GET 
NIN = 0
DO 1=1,  NCOMP 
DO J = 1, NEXPERIMENTS 
IF (J .LE. NRTEXPTS) THIRDDIM = 2 
IF (J .GT. NRTEXPTS) THIRDDIM = 1 
DO K = I, THIRDDIM 
L = IABS (MPOINT(I, J, K))
IF (L .GT. NIN) NIN = L 
ENDDO 
ENDDO 
ENDDO
WRITE(*, *) NIN 
NIN = 0
DO 1=1,  NCOMP 
DO J = 1, NEXPERIMENTS 
IF (J .LE. NRTEXPTS) THIRDDIM = 2 
IF (J .GT. NRTEXPTS) THIRDDIM = I 
DO K = 1, THIRDDIM 
L = IABS (MPOINT (I,J,K))
IF (L .GT. NIN) NIN = L 
ENDDO 
ENDDO 
ENDDO
WRITE (LU,'(2X,"TOTAL NUMBER OF INDEPENDENT PARAMETERS = ”,14)') 
$ NIN
GET INITIAL GUESSES 
READ (51, *, ERR=910) (PMAIN(I), 1=1,  NIN)
GET ASSOCIATION MATRIX ASSOC, ASSOC(I.K) = 1 IF TAU#I IS ASSOC’D 
WITH R(T) IN EXPT#K=0 OTHERWISE ASSOC(I.K) = 0 
READ (51, *, ERR=910) ((ASSOC(I, K), I = 1, NCOMP/2),
$ K = 1, NRTEXPTS)
GET G-FACTORS, TEMPERATURES, AND VISCOSITIES 
READ (51, *, ERR=910) (GFACM(I), 1=1,  NRTEXPTS),
$ (TEMPM(I), 1=1 ,  NRTEXPTS),
$ (VISCM(I), 1=1,  NRTEXPTS)
GET INFORMATION ON WHAT TYPE OF EXPERIMENTS (L FOR LAMP OR 
P FOR PROBE). IF PROBE, GET TAUPROBE FOR EACH 'LAMP.'
READ (51,FMT='(A1)') EXP_TYP 
PROBE = .TRUE.
IF (EXP_TYP .EQ. 'L') PROBE = .FALSE.
IF (PROBE) READ (51, *) (TAUP(J), J = 1, NLAMPCURVES)
CLOSE (51)
* * DATA PREPARATION SECTION * * *
GET NAMRS FOR ANSWER OUTPUT FILES 
DO WHILE (PARAM_FILE( 1:1) .EQ. ") ! LEFT-JUSTIFY FILENAMR 
PARAM_FILE = PARAM_FILE(2:40)
ENDDO
ANSWERJFILE = 'ABZFIT.DAT'
CURVMAT_FILE = CBZFIT.DAT’
INQUIRE (FILE=ANSWER_FILE, ERR=930, IOSTAT=IOS, EXIST=EX)
OPEN (51, ERR=902, FILE=ANSWER_FILE, IOSTAT=IOS, STATUS='NEW') 
CLOSE (51)
INQUIRE (FILE=CURVMAT_FILE, ERR=930, IOSTAT=IOS, EXIST=EX)
OPEN (51 ,ERR=904, FILE=CURVMAT_FILE, IOSTAT=IOS, STATUS='NEW') 
CLOSE (51)
SHIFT LAMPS
WRITE (LU, '(2X, "SHIFTING LAMPS WHEN NEEDED")')
DO J = 1, NLAMPCURVES 
Q = QS(J)
IF (Q .NE. 0.) THEN 
WRITE (LU, '(2X, "SHIFTING LAMPS # ",I4)') J 
IQ = ABS(Q)
RQ = ABS(Q) - FLOAT(IQ)
IF (Q .GE. 0.) THEN ! POSITIVE SHIFT
JUMP = -1 
IUPLIM = NCHAN 
ILOLIM = IQ + 2 
IQ = -IQ
DO I = 1, ILOLIM - 2 
SCRATCH® = 0.
ENDDO
SCRATCH(ILOLIM-l) = (1. - RQ)*ELAMP(1, J)
ELSE 
JUMP = 1
IUPLIM = NCHAN - IQ - 1 
ILOLIM = 1
DO I = IUPLIM + 2, NCHAN 
SCRATCH® = 0.
ENDDO
SCRATCH(IUPLIM+1) = (1. - RQ)*ELAMP(NCHAN, J)
ENDIF
DO I = ILOLIM, IUPLIM 
SCRATCH® = ELAMP(I+IQ, J) + RQ*(ELAMP(I+IQ+JUMP, J)
$ - ELAMP(I+IQ, J))
ENDDO
DO I = 1, NCHAN 
ELAMP(I, J) = SCRATCH®
ENDDO
ENDIF
ENDDO
* CALCULATE ANY UNSPECIFIED CHANNEL LIMITS 
DO J = 1, NDATACURVES 
IF (LIMS(1,J) -EQ. 0) THEN 
THRESHU = 15.
I = 1
DO WHILE (I .LT. NCHAN .AND. DKDATA® J) .LT. THRESHU) 
1 =  1 + 1  
ENDDO 
LIMS(1, J) = I 
ENDIF
IF (LIMS(2, J) .EQ. 0) THEN 
PEAK = 0.
DO I = 1, NCHAN 
IF (PEAK .LT. DKDATA® J)) THEN 
PEAK = DKDATA® J)
IPEAK = I 
ENDIF 
ENDDO
THRESHL = ,005+PEAK 
I = IPEAK
DO WHILE (I .LT. NCHAN .AND. DKDATA® J) .GT. THRESHL) 
1 =  1 + 1  
ENDDO 
LIMS(2, J) = I
ENDIF
WRITE (LU, '(2X, "CHANNEL LIMITS FOR DECAY #", 13, " =",
$ 15,18)')J, LIMS(1, J), LIMS(2, J)
I = 1
DO WHILE (I .LT. NCHAN .AND. ELAMP(I,J) .LT. THRESHU)
1 =  1 + 1  
ENDDO
LIMS_LAMP(1, J) = I 
PEAK = 0.
DO I = 1, NCHAN 
IF (PEAK .LT. ELAMP(I, J)) THEN 
PEAK = DKDATA(I, J)
IPEAK = I 
ENDIF 
ENDDO
THRESHL = ,005*PEAK 
I = IPEAK
DO WHILE (I .LT. NCHAN .AND. ELAMP(I, J) .GT. THRESHL)
1 =  1 + 1  
ENDDO
LIMS_LAMP(2, J) = I
WRITE (LU,'(2X,"CHANNEL LIMITS FOR LAMP #",13," =",I5,I8)’)
$ J,LIMS_LAMP( 1 ,J),LIMS_LAMP(2, J)
ENDDO
RE-ORDER THE PARAMETERS IN MPOINT SO WE CAN IGNORE THE 
FIXED PARAMETERS: FOR EXAMPLE, IF 
MPOINT( , ,1) = 1 -2 -3 4 0 0 0 0 0 0  
5 -2 6 4  0 0 0 0 0 0  
MPOINT( , ,2) = -7 8 9 1 0 - 1 1 - 1 2 0 0 0 0  
13 8 -14 10-15 -12 0 0 0 0  
THEN IT WILL BE CHANGED TO 
MPOINT(, , 1) = 1-9-13 2 0 0 0 0 0 0  
3- 9 4 2  0 0 0 0 0 0  
MPOINT(, ,2) = -10 5 6 7-11 - 1 2 0 0 0 0  
8 5 -14 7 -15 - 1 2 0 0 0 0
NUM = 0
DO WHILE (NUM.LE.NIN)
NUM = NUM + 1 
NEXPT= 1 
IPOS = I 
IVH = 1
DO WHILE (MPOINT(IPOS,NEXPT,IVH) .LT. NUM)
IPOS = IPOS + 1 
IF (IPOS .GT. 10) THEN 
IPOS = 1
NEXPT = NEXPT + 1 
IF (NEXPT .GT. NEXPERIMENTS) THEN 
IF (IVH.EQ.2) GO TO PAR_ORDERING_DONE 
IVH = IVH + 1 
IPOS= 1 
NEXPT = 1 
ENDIF
IF ((NEXPT .GT. NRTEXPTS) .AND. (IVH.EQ.2)) GO TO 
$ PAR_ORDERING_DONE 
ENDIF 
ENDDO
NUM_SWITCH=MPOINT(IPOS,NEXPT,IVH)
IF (NUM .NE. NUM_SWITCH) THEN
SWITCH = .FALSE.
DO NEXPT = 1, NEXPERIMENTS 
DO IPOS = 1, 10
IF (NEXPT.LE.NRTEXPTS) THIRDDIM = 2 
IF (NEXPT .GT. NRTEXPTS) THIRDDIM = 1 
DO IVH = 1, THIRDDIM 
IF (MPOINT(IPOS,NEXPT,IVH).EQ.NUM_SWITCH) THEN 
MPOINT(IPOS,NEXPT,IVH) = NUM 
SWITCH = .TRUE.
ELSE
IF (MPOINT(IPOS,NEXPT,IVH).EQ.-NUM) THEN 
MPOINT(IPOS, NEXPT, IVH) = -NUM_SWITCH 
SWITCH = .TRUE.
ELSE
IF (MPOINT(IPOS,NEXPT,IVH).EQ.NUM) THEN 
MPOINT(IPOS,NEXPT,IVH) = NUM_SWITCH 
SWITCH= .TRUE.
ENDIF
ENDIF
ENDIF
ENDDO
ENDDO
ENDDO
IF (SWITCH) THEN 
P = PMAIN(NUM)
PMAIN(NUM) = PMAIN(NUM_SWITCH)
PMAIN(NUM_SWITCH) = P 
ENDIF 
ENDIF 
ENDDO 
100 NIN_FREE = NUM - 1 
IF (NIN .NE. NIN_FREE) THEN 
WRITE (LU, '(2X, "NO. OF FIXED PARAMETERS = ", 14)')
$ NIN-NIN_FREE 
WRITE (LU, '(2X, "NO. OF FITTING PARAMETERS = ", 14)')
$ NIN_FREE 
ENDIF
* * * MAIN ANALYSIS SECTION * * *
* GLOBALIZED CURVE FIT
WRITE (LU, '(2X, "STARTING THE ANALYSIS ...")')
ITERATION = 0 
200 ITERATION = ITERATION + 1
* ZERO OUT GLOBAL BETA, ALFA, SUM_CHANNELS, CHISQR_SUM
DO I = 1, NIN 
BETA(I) = 0.
DO K = 1, NIN 
ALFA(I, K) = 0.
ENDDO
ENDDO
SUM_CHANNELS = 0 
CHISQR_SUM = 0.
NEXPT = 1
DO WHILE (NEXPT .LE. NEXPERIMENTS)
IF (NEXPT .LE. NRTEXPTS) THEN 
DO IVH = 1, 2 ! IVH = 1 FOR PARALLEL, 2 FOR PERPENDICULAR
IF (IVH .EQ. 1) NCUR = 2*NEXPT - 1 
IF (IVH .EQ. 2) NCUR = 2*NEXPT
ICHAN_FIRST = LIMS(1, NCUR)
ICHAN_LAST = LIMS(2, NCUR)
GET LOCAL ALPHAS, TAUS, & BZPARS (AMP, TAU,C, PL, B, RO, AND 
EPSILON) FROM THE GLOBAL ONES (IN PMAIN)
IF (IVH .EQ. 1) THEN 
NTERMS_SUM = 0 
DO I = 1, NCOMP 
IF (MPOINT(I,NEXPT, 1) .NE. 0)
$ NTERMS_SUM = NTERMS_SUM + 1
ENDDO
NTAU = NTERMS_SUM / 2 
DO I = 1, NTAU
AMP(I) = PMAIN(IABS(MPOINT(2*I - 1, NEXPT, 1)))
TAU(I) = PMAIN(IABS(MPOINT(2*I, NEXPT, 1)))
ENDDO
PAR(l) = PMAIN (I AB S(MPOINT (1, NEXPT, 2)))
PAR(2) = PMAIN(IABS(MPOINT(2, NEXPT, 2)))
PAR(3) = PMAIN(IABS(MPOINT(3, NEXPT, 2)))
PAR(4) = PMAIN(IABS(MPOINT(4, NEXPT, 2)))
PAR(5) = PMAIN(IABS(MPOINT(5, NEXPT, 2)))
ENDIF
ZERO CHISQR AND LOCAL ALFA, BETA, DERIV, FIT, RTFLU 
CHISQR(NCUR) = 0.
DO I = 1, 2*NTAU + 5 
BETA_LOCAL(I) = 0.
DO J = 1 ,1 
ALFA_LOCAL(I, J) = 0.
ENDDO
DO ICHAN = 1, NCHAN 
DERIV(ICHAN, I) = 0.
ENDDO
ENDDO
DO ICHAN = 1, NCHAN 
FIT(ICHAN) = 0.
RTFLU(ICHAN) = 0.
ELAMPI(ICHAN) = ELAMP(ICHAN, NCUR)
ENDDO
CALCULATE LIFETIME DECAY, ANISOTROPY DECAY, AND CONVOLUTION 
IF (IVH .EQ. 1) SCALE = 2.
IF (IVH .EQ. 2) SCALE = -1.
IF (IVH .EQ. 1) THEN 
TCAL = TCALS(NEXPT)
TEMP = TEMPM(NEXPT)
VISC = VISCM(NEXPT)
GFAC = GFACM(NEXPT)
ENDIF
CALL BZFUN (PAR, TEMP, VISC, ICHAN_LAST, TCAL,
$ RT, ICHAN_BAD)
NCHAN_BAD(NCUR) = 0 
IF (ICHAN_BAD .GT. 0) THEN
NCHANJBAD(NCUR) = ICHAN_BAD + LIMS_LAMP(2, NCUR) - 
$ LIMS_LAMP(1, NCUR)
ENDIF
DO I = 1 ,NTAU 
CALL FLUFUN(ICHAN_LAST, 1, AMP(I), TCAL, TAU(I), FLU)
DO ICHAN = 1, ICHAN_LAST 
RTFLU(ICHAN) = ASSOC(I, NEXPT)*FLU(ICHAN) +
$ RTFLU(ICHAN)
FIT(ICHAN) = PRE*FLU(ICHAN)*( 1 +ASSOC(I, NEXPT)*
$ SCALE*RT(ICHAN)) + FIT(ICHAN)
ENDDO
ENDDO
CALL NUMCONV (FIT, ICHAN_LAST, ELAMPI, ICHAN_LAST, CFIT) 
DO I = 1, ICHAN_LAST 
FITDATA(I, NCUR) = CFIT(I)
ENDDO
IF (IVH .EQ. 2) THEN 
DO I = 1, ICHAN_LAST
FITDATA(I, NCUR) = FITDATA(I, NCUR) / GFAC 
ENDDO 
ENDIF
GET DERIVATIVE FOR TAUS AND AMPS 
DO ITAU = 1, NTAU 
DO ICHAN = 1, ICHAN_LAST 
TAU_AMP = EXP(-TCAL*ICHAN/TAU(ITAU))
FITX(ICHAN) = PRE*(1 + ASSOC(ITAU, NEXPT)*SCALE*
$ RT(ICHAN))*TAU_AMP
FIT(ICHAN) = PRE*( 1 + ASSOC(ITAU, NEXPT)*SCALE*
$ RT(ICHAN))*TAU_AMP*AMP(ITAU)*TCAL*ICHAN/(TAU(ITAU)**2) 
ENDDO
CALL NUMCONV (FITX, ICHAN_LAST, ELAMPI,
$ ICHANJLAST, CFITX)
CALL NUMCONV (FIT, ICHAN_LAST, ELAMPI, ICHAN_LAST, CFIT) 
DO ICHAN = I, ICHANJLAST 
DERIV(ICHAN, 2*ITAU-1) = CFITX(ICHAN)
DERIV(ICHAN, 2*ITAU) = CFIT(ICHAN)
ENDDO 
ENDDO 
GET DERIVATIVE FOR RTS 
DO IPAR = 1, 5
DDER = DELTA_DDER*PAR(IPAR)
PARI = PAR(IPAR)
PAR(IPAR) = PARI + DDER
CALL BZFUN (PAR, TEMP, VISC, ICHAN_LAST, TCAL, RTY,
$ ICHAN_BAD)
PAR(IPAR) = PARI - DDER
CALL BZFUN (PAR, TEMP, VISC, ICHANLAST, TCAL, RTX,
$ ICHAN_BAD)
PAR(IPAR) = PARI 
DO ICHAN = 1, ICHAN_LAST
FIT(ICHAN) = PRE*RTFLU(ICH AN)*( 1 + SCALE*RTY(ICHAN)) 
FITX(ICHAN) = PRE*RTFLU(ICHAN)*(1 + SCALE*RTX(ICHAN)) 
ENDDO
DO ICHAN = 1, ICHAN_LAST
DERIVX(ICHAN) = (FIT(ICHAN) - FITX(ICHAN))/(2.*DDER)
ENDDO
CALL NUMCONV (DERIVX, ICHANJLAST, ELAMPI, ICHANJLAST,
$ CDERIV)
DO ICHAN = 1, ICHAN_LAST 
DERIV(ICHAN, 2*NTAU+IPAR) = CDERIV(ICHAN)
ENDDO
ENDDO
IF (IVH .EQ. 2) THEN 
DO ICHAN = 1, ICHAN_LAST 
DO J = 1, 2*NTAU + 5
DERIV(ICHAN,J) = DERIV(ICHAN,J) / GFAC
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ENDDO
ENDDO
ENDIF
* THE CHANNEL LIMITS APPLY ONLY WHEN CALCULATING RESID, CHISQR, BETA, &
* ALFA
DO I = ICHAN_FIRST, ICHANJLAST 
RESID = DKDATA(I, NCUR) - FITDATA(I, NCUR)
CHISQR(NCUR) = CHISQR(NCUR) + SIGMAII, NCUR)*RESID**2 
DO J = 1, 2*NTAU + 5 
BETAJLOCAL(J) = BETA_LOCAL(J)
$ + SIGMA(I, NCUR)*RESID*DERIV(I, J)
DO K = 1, J
ALFA_LOCAL(J, K) = ALFA_LOCAL(J, K)
$ + SIGMA(I, NCUR)*DERIV(I, J)*DERIV(I, K)
ENDDO
ENDDO
ENDDO
* GLOBAL MAPPING: LOCAL ALPHAS, BETAS ~> GLOBAL ALPHAS, BETAS
DO I = I, 2*NTAU + 5 
IF (I .LE. 2*NTAU) THEN 
KMPOINT = 1 IMPOINT K POINTER
IMPOINT = I 
ELSE 
KMPOINT = 2 
IMPOINT = I - 2*NTAU 
ENDIF
IP = IABS (MPOINT(IMPOINT, NEXPT, KMPOINT))
BETA(IP) = BETA(IP) + BETA_LOCAL(I)
DO J = I, 1,-1 
IF (J .LE. 2*NTAU) THEN 
JMPOINT = J 
KMPOINT = 1 
ELSE
JMPOINT = J - 2*NTAU 
KMPOINT = 2 
ENDIF
JP = IABS (MPOINT(JMPOINT, NEXPT, KMPOINT))
IF (JP .GT. IP) THEN
ALFA(JP, IP) = ALFA(JP, IP) + ALFA_LOCAL(I, J)
ELSE
ALFA(IP, JP) = ALFA(IP, JP) + ALFA_LOCAL(I, J)
ENDIF
ENDDO
ENDDO
SUM_CHANNELS = SUM_CHANNELS + (ICHAN_LAST - 
$ ICHAN_FIRST + 1)
CHISQR_SUM = CHISQR_SUM + CHISQR(NCUR)
LIMIT(IVH) = ICHAN_LAST - ICHAN_FIRST + 1 
ENDDO ! DO IVH = 1 , 2
WRITE (LU, *)' EXPT #',NEXPT 
WRITE (LU, *) (AMP(I), TAU(I), 1=1,  NTAU),
$ CHISQR(2*NEXPT-1 )/LIMIT( 1), CHISQR(2*NEXPT)/LIMIT(2)
WRITE (LU, *) (PAR(I), 1=1 , 5 )
WRITE (LU, *) NCHANJBAD(2*NEXPT-1), NCHAN_BAD(2*NEXPT)
ELSE 
IVH = 1
NCUR = 2*NRTEXPTS + (NEXPT-NRTEXPTS)
ICHAN_FIRST = LIMS(1, NCUR)
ICHAN_LAST = LIMS(2, NCUR)
GET LOCAL ALPHAS, TAUS,& BZPARS (AMP,TAU,C,PL,B,RO,AND 
EPSILON) FROM THE GLOBAL ONES (PMAIN)
NTERMS_SUM = 0 
DO 1=1, NCOMP 
IF (MPOINT(I, NEXPT, 1) .NE. 0)
$ NTERMS_SUM = NTERMS_SUM + 1 
ENDDO
NTAU = NTERMS_SUM/2 
DO I = 1,NTAU
AMP(I) = PMAIN(IABS(MPOINT(2*I - 1, NEXPT, 1)))
TAU(I) = PMAIN(IABS(MPOINT(2*I, NEXPT, 1)))
ENDDO
ZERO CHISQR AND LOCAL ALFA, BETA, DERIV, FIT, RTFLU 
CHISQR(NCUR) = 0.
DO I = 1, 2*NTAU 
BETA_LOCAL(I) = 0.
DO J = 1 ,1 
ALFA_LOCAL(I, J) = 0.
ENDDO
DO ICHAN = 1, NCHAN 
DERIV(ICHAN, I) = 0.
ENDDO
ENDDO
DO ICHAN = 1, NCHAN 
FIT(ICHAN) = 0.
ELAMPI(ICHAN) = ELAMP(ICHAN, NCUR)
ENDDO
CALCULATE LIFETIME DECAY,ANISOTROPY DECAY, AND CONVOLUTION 
TCAL = TCALS(NEXPT)
DO I = 1,NTAU 
CALL FLUFUN (ICHAN JA S T , 1, AMP(I), TCAL, TAU(I), FLU)
DO ICHAN = 1, ICHAN_LAST 
FIT(ICHAN) = PRE*FLU(ICHAN) + FIT(ICHAN)
ENDDO
ENDDO
CALL NUMCONV (FIT, ICHAN_LAST, ELAMPI, ICHAN_LAST, CFIT)
DO I = 1, ICHAN_LAST 
FITDATA(I, NCUR) = CFIT(I)
ENDDO
GET DERIVITIVE FOR TAUS AND AMPS 
DO ITAU = 1, NTAU 
DO ICHAN = 1, ICHAN_LAST 
TAU_AMP = EXP(-TCAL*ICHAN/TAU(ITAU))
FITX(ICHAN) = PRE*(TAU_AMP)
FIT(ICHAN) = PRE*TAU_AMP*AMP(ITAU)*TCAL*
$ ICHAN/(TAU(ITAU)**2)
ENDDO
CALL NUMCONV (FITX, ICHAN_LAST, ELAMPI, ICHANJLAST, CFITX) 
CALL NUMCONV (FIT, ICHANJLAST, ELAMPI, ICHANJAST, CFIT)
DO ICHAN = 1, ICHAN J A S T  
DERIV(ICHAN, 2JTAU-1) = CFITX(ICHAN)
DERIV(ICHAN, 2*ITAU) = CFIT(ICHAN)
ENDDO
ENDDO
THE CHANNEL LIMITS APPLY ONLY WHEN CALCULATING RESID,
CHISQR, BETA, & ALPHA
DO I = ICHAN JIRST, ICHAN J A S T
RESID = DKDATA(I, NCUR) - FITDATA(I, NCUR) 
CHISQR(NCUR) = CHISQR(NCUR) + SIGMA(I, NCUR)*RESID**2 
DO J = 1, 2*NTAU
BETA_LOCAL(J) = BETA_LOCAL(J) +
$ SIGMA(I, NCUR)*RESID*DERIV(I, J)
DO K = 1, J
ALFA_LOCAL(J, K) = ALFA_LOCAL(J, K)
$ + SIGMA(I, NCUR)*DERIV(I, J)*
$ DERIV(I, K)
ENDDO
ENDDO
ENDDO
GLOBAL MAPPING: LOCAL ALPHAS, BETAS ~> GLOBAL ALPHAS, BETAS 
DO I = 1, 2*NTAU 
KMPOINT = 1 IMPOINT K POINTER
IMPOINT = I
IP = IABS (MPOINT(IMPOINT, NEXPT, KMPOINT))
BETA(IP) = BETA(IP) + BETA_LOCAL(I)
DO J = I, 1, -1 
JMPOINT = J 
KMPOINT = 1
JP = IABS (MPOINT(JMPOINT, NEXPT, KMPOINT))
IF (JP .GT. IP) THEN 
ALFA(JP, IP) = ALFA(JP, IP) + ALFA_LOCAL(I, J)
ELSE
ALFA(IP, JP) = ALFA(IP, JP) + ALFA_LOCAL(I, J)
ENDIF
ENDDO
ENDDO
SUM_CHANNELS = SUM_CHANNELS + (ICHAN_LAST - ICHAN_FIRST + 1) 
CHISQR_SUM = CHISQR_SUM + CHISQR(NCUR)
LIMIT(IVH) = ICHAN_LAST - ICHAN_FIRST + 1
WRITE (LU, *) ’ EXPT #', NEXPT
WRITE (LU, *) (AMP(I), TAU(I), 1=1,  NTAU),
$ CHISQR(NCUR)/LIMIT( 1)
ENDIF !IF NEXPT .LE. NRTEXPT
NEXPT = NEXPT + 1 
ENDDO !DO WHILE NEXPT .LE. NEXPERIMENTS
CALCULATE REDUCED CHI-SQUARE, RCHISQR 
RCHISQR = CHISQR_SUM / (SUM_CHANNELS - NIN_FREE)
WRITE (LU, *) 'ITERATION ', ITERATION,' CHISQUARE = ', RCHISQR 
COMPUTE ARR (THE SCALED ALFA MATRIX) AND SCALED BETA 
DO I = 1, NIN_FREE 
ARR(I, I) = 1.0 + FLAMDE 
DO J = 1, I
ARR(I, J) = ALFA(I, J) / SQRT(ALFA(I, I)*ALFA(J, J))
ARR(J, I) = ARR(I, J)
ENDDO
ENDDO
DO I = 1, NINJFREE
SCALED_BETA(I) = BETA(I) / SQRT(ALFA(I, I))
ENDDO
SOLVE SYSTEM TO GET DELTA (ROUTINE: SYMSV)
INPUT: ARR = SCALED ALPHA ARRAY
SCALED_BETA = SCALED BETA ARRAY
NIN_FREE = # FREE PARS. (DIMENSION OF ALPHA & BETA ARRAYS) 
SCRATCH ARRAYS USED: S, T
OUTPUT: DELTA = VECTOR (TO MOVE PMAIN IN DIRECTION OF)
300 IF (ARR( 1, 1) .EQ. 0.) GO TO MATRIX_ERROR 
WRITE (LU, *) ' FLAMDE = FLAMDE 
IF (NIN_FREE .EQ. 1) THEN 
DELTA(l) = SCALED_BETA(1) / ARR( 1, 1)
ELSE
S(l, 1) = DSQRT(DABS(ARR(1, 1)))
DO I = 2, NIN_FREE 
S( I, I) = ARR( 1 ,1) / S( 1, 1)
ENDDO
DO I = 2, NIN_FREE 
DO J = I, NINJFREE 
SUMM = 0.
DO K = 1 ,1 - 1 
SUMM = SUMM + S(K, I)*S(K, J)
ENDDO
SUM = ARR(I, J) - SUMM 
IF (I .EQ. J) THEN 
IF (SUM .EQ. 0.) GO TO MATRIX_ERROR 
SUM = DABS (SUM)
S(I, I) = DSQRT (SUM)
ELSE 
S(I, J) = SUM / S(I, I)
ENDIF
ENDDO
ENDDO
T( 1) = SCALED_BETA( 1) / S( 1, 1)
DO I = 2, NIN_FREE 
Z = 0.
D O K = l , I - l  
Z = Z + S(K, I)*T(K)
ENDDO
T(I) = (SCALED_BETA(I) - Z) / S(I, I)
ENDDO 
L = NINJFREE 
DELTA(L) = T(L) / S(L, L)
DO WHILE (L .GE. 2)
L = L - 1 
SUMM = 0.
DO I = L + 1, NINJFREE 
SUMM = SUMM + S(L, I)*DELTA(I)
ENDDO 
SUM = SUMM
DELTA(L) = (T(L) - SUM) / S(L, L)
ENDDO 
ENDIF 
SCALE DELTA 
DO I = 1, NIN_FREE
DELTA(I) = DELTA(I) / SQRT (ALFA(I, I))
ENDDO
DO I = NIN_FREE + 1,NIN 
DELTA(I) = 0.
ENDDO
PUT NEW SET OF ANSWERS IN PMAIN_NEW 
DO I = 1, NIN
PM AIN_NE W (I) = PMAIN(I) + DELTA(I)
IF (PMAINJSIEW(I) .LE. 1.E-35) PMAIN_NEW(I) = PMAIN® 
ENDDO
GET REDUCED CHI-SQUARE (RCHISQR_NEW) FOR PMAIN_NEW
SUM_CHANNELS = 0 
CHISQR_SUM_NEW = 0.
NEXPT = 1
DO WHILE (NEXPT .LE. NEXPERIMENTS)
IF (NEXPT .LE. NRTEXPTS) THEN 
DO IVH = 1,2 ! FIRST PARALLEL, THEN PERPENDICULAR
IF (IVH .EQ. 1) NCUR = 2*NEXPT - 1 
IF (IVH .EQ. 2) NCUR = 2*NEXPT 
ICHAN_FIRST = LIMS(1, NCUR)
ICHAN_LAST = LIMS(2, NCUR)
* GET LOCAL ALPHAS, TAUS, BZPARS (AMP, TAU, C, B, PL, EPSILON AND 
C R0) FROM THE GLOBAL ONES (IN PMAIN_NEW).
IF (IVH .EQ. 1) THEN 
NTERMS_SUM = 0 
DO 1=1 ,  10 
IF (MPOINT(I, NEXPT, 1 ) .NE. 0)
$ NTERMS_SUM = NTERMS_SUM + 1
ENDDO
NTAU = NTERMS_SUM / 2 
DO I = 1, NTAU
AMP(I) = PMAIN_NEW (IABS (MPOINT(2*I - 1, NEXPT, 1)))
TAU(I) = PMAIN_NEW (IABS (MPOINT(2*I, NEXPT, 1)))
ENDDO
PAR(l) = PMAIN_NEW (IABS (MPOINT(l, NEXPT, 2)))
PAR(2) = PMAIN_NEW (IABS (MPOINT(2, NEXPT, 2)))
PAR(3) = PMAINJ'JEW (IABS (MPOINT(3, NEXPT, 2)))
PAR(4) = PMAIN_NEW (IABS (MPOINT(4, NEXPT, 2)))
PAR(5) = PMAIN_NEW (IABS (MPOINT(5, NEXPT, 2)))
TCAL = TCALS(NEXPT)
TEMP = TEMPM(NEXPT)
VISC = VISCM(NEXPT)
GFAC = GFACM(NEXPT)
ENDIF
* CALCULATE DECAYS AND CONVOLUTION
IF (IVH .EQ. 1) SCALE = 2.
IF (IVH .EQ. 2) SCALE = -1.
CALL BZFUN (PAR, TEMP, VISC, ICHANJLAST, TCAL,
$ RT, ICHAN_BAD)
NCHAN_BAD_NEW(NCUR) = 0 
IF (ICHANJBAD .GT. 0) THEN
NCHAN_BAD_NEW(NCUR) = ICHAN_BAD + LIMS_LAMP(2, NCUR) - 
$ LIMS_LAMP(1, NCUR)
ENDIF
DO ICHAN = 1, NCHAN 
FIT(ICHAN) = 0.
ELAMPI(ICHAN) = ELAMP(ICHAN, NCUR)
ENDDO 
DO I = 1,NTAU 
CALL FLUFUN (ICHAN_LAST, 1, AMP(I), TCAL, TAU(I), FLU)
DO ICHAN = 1, ICHANJLAST 
FIT(ICHAN) = PRE*FLU(ICHAN)*(1 + ASSOC(I, NEXPT)*SCALE 
$ *RT(ICHAN)) + FIT(ICHAN)
ENDDO
ENDDO
CALL NUMCONV (FIT, ICHAN JA S T , ELAMPI, ICHAN_LAST, CFIT) 
IF (IVH .EQ. 2) THEN 
DO ICHAN = 1, ICHAN_LAST 
CFIT(ICHAN) = CFIT(ICHAN) / GFAC
ENDDO
ENDIF
DO I = ICHANJFIRST, ICHAN_LAST 
RESID = DKDATA(I, NCUR) - CFIT(I)
CHISQR_SUM_NEW = CHISQR_SUM_NEW+SIGMA(I, NCUR)*RESID**2 
ENDDO
SUM_CHANNELS = SUM_CHANNELS + (ICHAN_LAST - 
$ ICHAN_FIRST + 1)
IF ((CHISQR_SUM_NEW-CHISQR_SUM)/CHISQR_SUM .GT. FCNGE)
$ GO TO EXIT_CHI_LOOP 
ENDDO !D0 IVH= 1,2 ABOVE 
ELSE 
IVH = 1
NCUR = 2*NRTEXPTS + (NEXPT-NRTEXPTS)
ICHAN_FIRST = LIMS(1, NCUR)
ICHAN_LAST = LIMS(2, NCUR)
GET LOCAL ALPHAS, TAUS FROM THE GLOBAL ONES( IN PMAIN_NEW). 
NTERMS_SUM = 0 
DO 1=1 ,  10
IF (MPOINT(I, NEXPT, 1) .NE. 0) NTERMS_SUM = NTERMS_SUM + 1 
ENDDO
NTAU = NTERMS_SUM/2 
DO I = 1, NTAU
AMP(I) = PMAIN_NEW (IABS (MPOINT(2*I-l, NEXPT, 1)))
TAU(I) = PMAIN_NEW (IABS (MPOINT(2*I, NEXPT, 1)))
ENDDO
TCAL = TCALS(NEXPT)
DO ICHAN = 1, NCHAN 
FIT(ICHAN) = 0.
ELAMPI(ICHAN) = ELAMP(ICHAN, NCUR)
ENDDO 
DO I = 1 ,NTAU 
CALL FLUFUN (ICHANjLAST, 1, AMP(I), TCAL, TAU(I), FLU)
DO ICHAN = 1, IOHAN_LAST 
FIT(ICHAN) = PRE*FLU(ICHAN) + FIT(ICHAN)
ENDDO
ENDDO
CALL NUMCONV (FIT, ICHAN_LAST, ELAMPI, ICHAN_LAST, CFIT)
DO I = ICHAN_FIRST, ICHAN_LAST 
RESID = DKDATA(I, NCUR) - CFIT(I)
CHISQR_SUM_NEW = CHISQR_SUM_NEW + SIGMA(I, NCUR)*RESID**2 
ENDDO
SUM_CHANNELS = SUM_CHANNELS + (ICHAN_LAST - ICHAN_FIRST + 1) 
IF ((CHISQR_SUM_NEW-CHISQR_SUM)/CHISQR_SUM .GT. FCNGE)
$ GO TO EXIT_CHI_LOOP 
ENDIF !IF (NEXPT .LE. NRTEXPT) FROM ABOVE
NEXPT = NEXPT + 1 
ENDDO !DO WHILE NEXPT .LE. NEXPERIMENTS
500 RCHISQR_NEW = CHISQR_SUM_NEW/(SUM_CHANNELS - NIN_FREE)
SEE IF CHI-SQUARE INCREASED OR DECREASED, AND ACT ACCORDINGLY 
IF (RCHISQR_NEW .GT. RCHISQR) THEN ! CHI-SQUARE INCREASED 
FLAMDE = FLAMDE*FLINC 1
IF (FLAMDE .GE. 1 .E35) THEN ! ABORT IF STUCK 
FLAMDE_BAD = .TRUE.
GO TO EXIT_AND_SAVE_RESULTS 
ENDIF
DO I = 1, NIN 
ARR(I, I) = 1.0 + FLAMDE
ENDDO
DELTA_RCHISQR = ABS(RCHISQR_NEW - RCHISQR) / RCHISQR 
IF (DELTA_RCHISQR .GE. FCNGE) GO TO MARQUARDT 
ELSE ! CHI-SQUARE DECREASED
FLAMDE = FLAMDE / FLINC2
IF (FLAMDE .LE. 1 .E-35) THEN ! ABORT IF STUCK
FLAMDE_BAD = .TRUE.
GO TO e x it_a n d _s a v e _r e su l t s
ENDIF
DO 1=1,  NIN
PMAIN(I) = PMAIN_NEW(I) ! UPDATE ANSWERS
ENDDO
DELTAJRCHISQR = ABS(RCHISQR_NEW - RCHISQR) / RCHISQR 
IF (DELTA_RCHISQR .GE. FCNGE) GO TO BEGINNING 
ENDIF
* * ANSWER SAVING SECTION * * *
SAVE ANSWERS AND CURVATURE MATRIX (ALFA)
400 WRITE (LU, ’(/2X, "ANALYSIS COMPLETED")')
WRITE (LU, '(2X, "ANSWERS STORED IN FILE ",A)') ANSWER_FILE 
IF ('P’ // CURVMAT_FILE(2:40) .NE. PARAM_FILE) THEN 
WRITE (LU, '(2X, "CURVATURE MATRIX IN FILE ",A)')
$ CURVMATJTLE 
ENDIF
WRITE (LU, ’(/2X, "TO GET CONFIDENCE INTERVALS, RUN PROGRAM")') 
WRITE (LU, '(2X, "ACON, WITH PARAMETER FILE ",A)')PARAM_FILE 
SAVE ANSWERS
OPEN (51 ,ERR=900,FILE=ANSWER_FILE,IOSTAT=IOS,STATUS='UNKNOWN') 
L = 40 ! L = CHAR. LENGTH OF PARAMETER FILENAMR
DO WHILE (PARAM_FILE(L:L) .EQ.'')
L = L - 1 
ENDDO
WRITE (51 ,’("* ANSWERS FOR PARAMETER FILE ",A)',ERR=920)
$ PARAM_FILE (1:L)
IF (FLAMDE_BAD) THEN 
WRITE (51 ,’("* ABORTED: FLAMDE OUT OF RANGE")',ERR=920)
ENDIF
WRITE (51 ,’("* GLOBAL REDUCED CHI-SQUARE = ",G14.7)’,ERR=920)
$ RCHISQR
WRITE (51 ,’("* ALPHAS & TAUS, & PAR. & PERP. REDUCED CHISQR",
$ "PER LINE,")’,ERR=920)
WRITE (51,'("* FOLLOWED BY R0, C, B, EPSILON, & PL (EACH ",
$ "LINE = ONE EXPERIMENT):")’,ERR=920)
DO N = 1, NRTEXPTS 
K = 1
DO WHILE (K .LE. NCOMP .AND. MPOINT(2*K-l,N,l) .NE. 0)
K = K + 1 
ENDDO
NUM_COMP_SUM = K - 1
CHISQR_LOC_PAR = CHISQR(2*N - 1) / (LIMS(2,2*N - 1) -
$ LIMS( 1,2*N - 1) - 2*NUM_COMP_SUM - 4)
CHISQR_LOC_PERP = CHISQR(2*N) / (LIMS(2,2*N) - 
$ LIMS( 1,2*N) - 2*NUM_COMP_SUM - 4)
WRITE (51,*,ERR=920) ((PMAIN(IABS(MPOINT(2*I - 1,N,1))), 
$ PMAIN(IABS(MPOINT(2*I,N, 1)))),
$ 1=1,  NUM_COMP_SUM),
$ CHISQR_LOC_PAR, CHISQR_LOC_PERP,
$ NCHAN_BAD(2*N-1 ),NCHAN_BAD(2*N)
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ENDDO
DO N = 1, NLTEXPTS 
NEXPT = NRTEXPTS + N 
NCUR = 2*NRTEXPTS + N 
K = 1
DO WHILE (K .LE. NCOMP .AND. MPOINT(2*K-l,NEXPT, 1) .NE. 0)
K = K + 1 
ENDDO
NUM_COMP_SUM = K - 1
CHISQR_LOC = CHISQR(NCUR) / (LIMS(2, NCUR) - 
$ LIMS( 1, NCUR) - 2*NUM_COMP_SUM + 1)
WRITE (51 ,*,ERR=920) ((PMAIN(IABS(MPOINT(2*I - 1,NEXPT, 1))),
$ PM AIN(IABS(MPOINT(2*I,NEXPT, 1)))),
$ 1=1,  NUM_COMP_SUM),
$ CHISQR_LOC
ENDDO
DON = 1, NRTEXPTS
WRITE (51,*,ERR=920) (PMAIN(IABS(MPOINT(I,N,2))),I = 1,5)
ENDDO 
CLOSE (51)
* SAVE CURVATURE MATRIX
OPEN (51 ,ERR=900,FILE=CURVMAT_FILE,IOSTAT=IOS ,STATUS='UNKNOWN')
WRITE (51,*,ERR=920) NIN_FREE, ((ALFA(I, J),J=1,I),I=1,NIN_FREE)
CLOSE (51)
* SAVE FITS TO DATA
DO I = 1 ,NDATACURVES
OPEN (61 ,ERR=900,FILE=FITNAME(I),STATUS-NEW',IOSTAT=IOS)
WRITE (61JFMT—(" FIT DATA")’)
DO J = 1 ,NCHAN 
WRITE (61, *, ERR=920) J, FITDATA(J, I)
ENDDO 
CLOSE (61)
ENDDO
STOP
* * * ERR MESSAGE AND STOP CONTROL SECTION * * *
900 WRITE (LU, '(2X, "OPEN ERROR",16)') IOS
STOP
902 WRITE (LU, ’(2X, "OPEN ERROR",16,5X,5HFILE ,A)') IOS, ANSWER_FILE 
STOP
904 WRITE (LU, ’(2X, "OPEN ERROR", 16,5X.5HFILE ,A)') IOS, CURVMAT_FILE 
STOP
910 WRITE (LU, '(2X, "READ ERROR",16)') IOS 
STOP
920 WRITE (LU, '(2X, "WRITE ERROR",16)’) IOS 
STOP
930 WRITE (LU, '(2X, "INQUIRE ERROR",16)') IOS 
STOP
990 WRITE (LU, '(2X, "ERROR: CANNOT INVERT MATRIX")')
STOP
END
* * * END OF MAIN PROGRAM * * *
************************************************************************************
* * * SUBROUTINES AND FUNCTIONS SECTION * * *
* NUMERICAL CONVOLUTION ROUTINE TESTED NOV 23,1992
* AM BM - TWO ARRAYS TO BE CONVOLUTED
NA >= NB
SUBROUTINE NUMCONV (AM, NA, BM, NB, CM)
DIMENSION AM(NA), BM(NB), CM(NA)
DO N = 0, NA-1 
CM(N+1) = 0.
DO K = 0, NA-1 
IF (K .GT. N) GO TO 11 
IF ((N-K+l) .GT. NB) GO TO 11 
CM(N+1) = CM(N+1) + AM(K+1 )*BM(N-K+1)
11 ENDDO 
ENDDO 
RETURN 
END
FLUORESCENCE DECAY FUNCTION SUBROUTINE 
SUBROUTINE FLUFUN (ICHAN_LAST, NTAU, AMP, TCAL, TAU, FLU) 
DIMENSION AMP(NTAU), TAU(NTAU), FLU(ICHAN_LAST)
DO ICHAN = 1, ICHAN_LAST 
FLU(ICHAN) = 0.
DO ITAU = 1, NTAU
FLU(ICHAN) = AMP(IT AU)*EXP(-ICH AN*TC AL/TAU (IT AU))
$ + FLU(ICHAN)
ENDDO
ENDDO
RETURN
END
SUBROUTINE PROGRAM FOR R(T) BASED ON BARKLEY_ZIMM BENDING THEORY 
WRITTEN BY QI CHEN ON DECEMBER 4, 1992 IN BARKLEY'S LAB 
SUBROUTINE BZFUN (PAR, TEMP, VISC, ICHAN_LAST, TCAL,
$ RT,ICHAN_BAD)
DIMENSION PAR(5), GI(3), RT(ICHAN_LAST)
REAL GI, K_B, PAR 
PI = 3.141592654 
K_B = 1.380662E-16 
R0 = PAR( 1)
C = PAR(2)*1.E-19 
B = PAR(3)*l.E-8 
EPSILON = PAR(4)
PL = PAR(5)*l.E-8 
El = PL*K_B*TEMP
GI(1) = (3.*COSD(EPSILON)**2 - l.)**2/4.
GI(2) = 3.*(SIND(2*EPSILON))**2/4.
GI(3) = 3.*(SIND(EPSILON))**4/4.
A = K_B*TEMP/SQRT(PI*C*4.*PI*VISC*B**2)
ZMAX_G =4.153382 
ICHAN_BAD = 0 
DO ICHAN = 1, ICHANLAST 
DELTA_Z = 1.
DID_ZERO = B*SQRT(SQRT(5.024*PI*VISC/(EI*TCAL*ICHAN*LE-9)))
IF (DID_ZERO .GT. 1.745274) THEN 
ICHANJ3AD = ICHAN 
Z = 0.4202057 
GO TO 12 
ENDIF
ZMAX FITTING AND BESSEL FUNCTION 
DO WHILE (DELTA_Z .GT. 0.0001)
ZMAX_1 = 2./ZMAX_G
ZMAX_2 = ZMAX_G/2.
IF (ZMAX_G .GT. 2) THEN
BK0_1 = 1.25331414 - 0.07832358*ZMAX_1 + 0.02189568*ZMAX_1**2 
$ - 0.01062446*ZMAX_ 1**3 + 0.00587872*ZMAX_1**4
$ - 0.00251540*ZMAX_ 1**5 + 0.00053208*ZMAX_1**6
BK1_1 = 1.25331414 + 0.23498619*ZMAX_1 - 0.03655620*ZMAX_1**2 
$ + 0.01504268*ZMAX_1**3 - 0.00780353*ZMAX_1**4
$ + 0.00325614*ZMAX_1 **5 - 0.00068245*ZMAX_1 **6
BKO = EXP(LOG(BK0_ 1) - 0.5*LOG(ZMAX_G) - ZMAX_G)
BK1 = EXP(LOG(BK1 _ 1) - 0.5*LOG(ZMAX_G) - ZMAX_G)
ELSE 
BIO = 1.
BI1 = ZMAX_2
* PRECISELY TO 4E-8 FROM 7 ITERATION OF FACTORAL
DO IBI = 1,7
BIO = BIO + ZMAX_2**(2*IBI)/(FACTO (IBI))**2 
BI1 = BI1 + (ZMAX_2)**(2*IBI + 1) /
$ (FACTO(IBI)*FACTO (IBI + 1))
ENDDO
BKO = -LOG(ZMAX_2)*BI0 - 0.57721566 +
$ 0.42278420*ZMAX_2**2 + 0.23069756*ZMAX_2**4 +
$ 0.03488590*ZMAX_2**6 + 0.00262698*ZMAX_2**8 +
$ 0.00010750*ZM AX_2** 10 + 0.00000740*ZMAX_2** 12
BK1 = (ZMAX_G*LOG(ZMAX_2)*BIl + 1. + 0.15443144*ZMAX_2**2 
$ - 0.67278579*ZMAX_2**4 - 0.18156897*ZMAX_2**6
$ - 0.01919402*ZMAX_2**8 - 0.00110404*ZMAX_2**10
$ - 0.00004686*ZMAX_2** 12)/ZMAX_G
ENDIF
Z = SQRT(SQRT(BK0 + (ZMAX_G/2.)*BK1))
Z_MAX = DID_ZERO/Z
DELTA_Z = ABS((Z_MAX - ZMAX_G)/Z_MAX)
ZMAX_G = Z_MAX 
ENDDO
12 BT = 3.466*K_B*TEMP*Z/SQRT(EI*SQRT(PI**5.*EI*VISC)) 
RT(ICHAN) = 0.
DO INDEX = 1,3 
N = INDEX - 1 
RT(ICHAN) = RT(ICHAN)
$ + GI(INDEX)*EXP(-N**2*A*SQRT(TCAL*ICHAN* 1 .E-9)
$ - (6-N**2)*BT*SQRT(SQRT(ICHAN*TCAL* 1 ,E-9))/4.)
ENDDO
RT(ICHAN) = RT(ICHAN)*R0 
ENDDO 
RETURN 
END
* FACTORAL FUNCTION
REAL FUNCTION FACTO(N)
FACTO = 1.
DO I = 1, N 
FACTO = FACTO* I 
ENDDO 
RETURN 
END
* * * END OF COMPLETE PROGRAM * * *
C.2. BZPAR.for
* BZPAR.FOR PROGRAM FOR BZFIT.FOR
* FROM Modified APAR.FOR on November, 1992
* WRITTEN IN BARKLEY_LAB, LSU
DIMENSION LAMPJFILE(200),QSHIFT(200),SAMPLE_AFILE( 100),
$ SAMPLE_FILE( 100), SAMPLE_MHLE( 100), EXPNO(IOO),
$CHAN_LIM(200),STORE JFILE(200),STORE_AFILE(200),
$ STORE_MFILE(200),TCALM( 100),LINK_MAT( 100,10),
$ ALFATAU_MAT(1000),BZ_MAT( 1000),VISC_GFAC_MAT(200),
$ TAUP_MAT( 100),ASSOC(5,200),LINK_MAT_BZTEM( 10),
$ IND_PAR_MAT(2000),TEMPM( 100),VISCM( 100)
CHARACTER WEIGHT*20,QSHIFT_INTEREST,EXP_METHOD,TAUP_NUMBER,
$ TAUP_TYPE,TCAL_NUMBER,LAMP_FILEN*20,LAMP_FILE*20,
$ SAMPLE_AFILE*20,SAMPLE_FILE*20,SAMPLE_MFILE*20,
$ STORE,STORING_STRING*20,STORE_AFILE*20,STORE_MFILE*20,
$ STORE_FILE*20,FIX,TEMP_NUMBER,VISC_NUMBER,GFAC,
$ LINK_TERM_STRING*25,LIM_SET_STRING*25 
CHARACTER*20 WEIGHT_FILE_STRING
REAL TCAL_SINGLE,ALFATAU_MAT,BZ_MAT,TCALM,QSHIFT,IND_PAR_MAT, 
$ TEMP_SINGLE,VISC_SINGLE
INTEGER ANUM,FNUM,AFIT,MFIT,FILENOL,POSITIION,LINK_MAT,
$ LINKEY,EXPNO,ASSOC, LINK_MAT_BZTEM,CHAN_LIM, MNUM
* INSTRUMENTAL SETUP
WRITE(6,fmt='(3x,"The channel number is [512/1024]: "$)')
READ(5,*)nchan
WRITE(6,fmt='(/,3x,"(S)ingle or (M)ultiple Teals? "$)')
READ(5,fmt='(al)')tcal_number 
IF(tcal_number.eq.'s' .or.tcal_number.eq.'S')THEN 
WRITE(6,fmt='(/,3x,"Give the value of Teal: "$)')
READ(5,*)tcal_single 
END IF
* MEASURING CONDITION
WRITE(6,fmt='(/,3x,"(S)ingle or (M)ultiple (Temp)eratures? "$)')
READ(5,fmt='(al)')temp_number
IF(temp_number.eq.'s' .or.temp_number.eq.'S')THEN 
WRITE(6,fmt='(/,3x,"Give the Value of Temp in K: "$)')
READ(5,*)temp_single 
END IF
WRITE(6,fmt='(/,3x,"(S)ingle or (M)ultiple (Visc)osilies? "$)')
READ(5,fmt='(al )')visc_number 
IF(visc_number.eq.'s' .or.visc_number.eq.'S')THEN 
WRITE(6,fmt='(/,3x,"Give the value of viscosity: "$)')
READ(5,*)visc_single 
END IF
* TYPE OF EXPERIMENT
WRITE(6,fmt='(/»3x,"(L)amp or (P)robe Method Experiment: "$)') 
READ(5,fmt='(al)')exp_method 
IF(exp_method.eq.'p'.or.exp_method.eq.'P')THEN 
WRITE(6,fmt='(/,3x,"(S)ingIe or (M)ultiple Tauprobes: "$)')
READ(5,fmt—(al )')taup_number 
IF(taup_number.eq.'S'.or.taup_number.eq.'s')THEN 
WRITE(6,fmt='(/,3x,"Give the Value of Tauprobe: "$)')
READ(5,*)tauprobe
END IF
ELSE
exp_method = 'L'
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WRITE(6,fmt='(/,3x,"Input qshift: "$)') 
READ(5,FMT-(Al)')qshift_interest 
END IF
* WEIGHTING OPTION GET THE WEIGHTING FILE
WRITE(6,FMT='(/,3X,"Enter Weighting Filename or S for Standard 
$ Weighting: "$)')
READ(5,fmt='(a20)')weight 
IF(weight.eq.'S'.or.weight.eq.'s')THEN 
weight_file_string='STANDARD WEIGHTING'
ELSE
weight_file_string=weight 
END IF
WRITE(6,fmt='(/,3x,"Do you wish to store the fitted 
$ data(y/n) ?"$)')
READ(5,fmt=’(a 1 )')store
* READ LAMP FILE NAMES
fnum=l
WRITE(6,fmt='(/,3x,"Lamp filenames: enter lamp files 
$ corresponding to",/,3x," anisotropic files first in 
$ the order of each parallel file",/,3x,"followed by the 
$ corresponding perpendicular file",/,3x,"Then enter lamp 
$ files corresponding",/,3x,"to magic angle files. Type 
$ "end" at the prompt",/,3x,"to terminate requests for 
$ files")')
WRITE(6,fmt='(/,3x,"Lamp/Probe File #",i3,":",$)')fnum 
READ(5,fmt='(a25)')lamp_file(fnum)
DO WHILE(lamp_file(fnum).ne.'end'.and.lamp_file(fnum).ne.'END') 
IF(qshift_interest.eq.'y'.or.qshift_interest.eq.'Y')THEN 
WRITE(6,fmt='(/,3x,"Q_shift",i3," = ",$)')fnum 
READ(5,*)qshift(fnum)
ELSE
qshift(fnum) = 0.
END IF
IF(taup_..number.eq.'m'.or.taup_number.eq.'M')THEN 
WRITE(6,fmt='(/,3x,"Give the Value of Tauprobe for 
$ File #",i3,":",$)')fnum
READ(5,*)taup_mat(fnum)
ELSE
taup_mat(fnum) = tauprobe 
END IF
fnum = fnum + 1
WRITE(6,fmt='(/,3x,"Lamp/Probe File #",I4,":",$)')fnum 
READ(5,fmt='(a25)')lamp_file(fnum)
ENDDO
lamp_lile(fnum) = '.END' 
WRITE(6,fmt='(3x,a)')(lamp_file(i),i=l,fnum) 
filenol = fnum - 1
* READ SAMPLE DATA FILE NAMES 
100 anum = 1
anum = 1
WRITE(6,fmt='(/,3x,"Sample data files: Enter anisotropic 
$ data",/,3x," files first in the order of each parallel 
$ file",/,3x,"followed by the corresponding perpindicular 
$ file.",/,3x," Type "end" at the prompt to terminate 
$ requests for files.")')
WRITE(6,fmt-(/,3x,"Anisotropic Sample Data 
$ File #",i3,":",$)')anum
READ(5,fmt=’(a25)')sample_afile(anum)
DO WHILE(sarnple_afile(anum).ne.'end'
$ .and.sample_afile(anum).ne.'end') 
anum = anum + 1
WRITE(6,fmt='(/,3x,"Anisotropic Sample Data 
$ File #",I3,":",$)')anum 
READ(5,fmt='(a25)')sampIe_afile(anum)
END DO
sample_afile(anum) = '.nrt' 
anum = anum - 1 
read magic angle data files 
WRITE(6,fmt- (/,3x,"Now enter magic angle data files.",
$ /,3x"If there are no magic angle files type "end" at 
$ the",/,3x"prompt. Terminate requests for files by 
$ typing",/,3x,'""end" at the prompt.")') 
mnum = 1
WRITE(6,fmt='(/,3x,"Magic Angle Data File #"
$ ,i3,":",$)')mnum
READ(5,fmt='(a25)')sample_mfile(mnum)
DO WHILE(sample_mfile(mnum).ne.'end'
$.and.sample_mfile(mnum).ne.'END') 
mnum = mnum + 1
WRITE(6,fmt='(/,3x,"Magic Angle Data File 
$ i3,":",$)')mnum
READ(5,fmt='(a25)')sample_mfile(mnum)
END DO
sample_mfile(mnum) = '.end' 
mnum = mnum - 1 
NUMBER OF ANISOTROPIC EXPERIMENTS HAS TO BE EVEN 
IF(mod(anum,2).eq.0)then 
num_aexp = anum/2 
ELSE
WRITE(6,fmt='(/,3x,"# OF DATA FILES LESS THAN EXPECTED.
$ CHECK AND RE-ENTER")')
GO TO 100 
END IF
num_exp = anum/2 + mnum 
CHANNEL LIMITS BEING ESTABLISHED(IN THIS CASE ASSUMED TO BE 0) 
DO LCHN = 1, 2*filenol 
CHANJJM(LCHN) = 0 
END DO 
WRITE STORE FILE NAMES 
IF(store.eq .’y'.or. store.eq.'Y')THEN 
WRITE(6,fmt='(/,3x,"Data will be stored in files with 
$ the same file name",/,3x,"as the sample data file 
$ but with a .fit extension")') 
afit = 0 
lnum = 1 
do i = 1 ,anum
position = index(sample_afile(i),'.') 
storing_string = sample_afile(i) 
storing_string((position+l):(position+3)) = 'fit' 
store_afile(i) = storing_string 
afit = afit + 1 
lnum = lnum + 1 
end do 
mfit = 0 
do k = 1, mnum
position = index(sample_mfile(k),'.')
storing_string = sample_mfile(k) 
storing_string((position+l):(position+3)) = 'fit' 
store_mfile(k) = storing_string 
mfit = mfit + 1 
lnum = lnum + 1 
end do 
END IF
store_file(lnum) = '.END'
* Initialization of linking paramater matrix
DO j = 1, filenol 
DO k = 1,10 
link_mat(j,k) = 0 
END DO 
END DO
* GET THE MAXIMUM NUMBER OF LIFETIME COMPONENTS
WRITE(6,fmt='(/,3x,"Give the Number of Lifetimes: ",$)') 
READ(5,fmt='(i2)')num_at_par
* LINKING OF PARAMETERS
IF(num_exp.eq. 1 )GO TO 5000 
WRITE(6,fmt=’(//,3x,"To link parameters, type in the 
$ names one by one after prompts ",/,3x,"using the 
$ format NAME#")')
WRITE(6,fmt=’(/,3x,"Example: ALFA1, TAU1, C, rO, b, PL,
$ epsilon, and END")')
1000 WRITE(6,fmt='(/,3x,"Link_Term: ",$)') 
READ(5,fmt='(a)')link_term_string 
DO WHILE(link_term_string.ne.'end'.and.link_term_string 
$ .ne.'END')
IF(link_term_string(l:3).eq.'tau'.or.link_term_string(l:3)
$ ,eq.'TAU')THEN 
linkey = ichar(link_term_string(4:4))-ichar('0') 
IF(abs(linkey).gt.5)GO TO 1000 
WRITE(6,fmt='(/,3x,"Linking of TAU #",il,$)')linkey 
DO li = 1 , anum, 2 
lj = 2*linkey 
link_mat(li,lj) = lj 
END DO
DO li = (anum+1), filenol 
lj = 2*linkey 
link_mat(li,lj) = lj 
END DO
ELSEIF(link_term_string(l:4).eq.'alfa'.or.
$ link_term_string( 1:4).eq.'ALFA')THEN 
linkey = ichar(link_term_string(5:5))-ichar('0') 
IF(abs(linkey).gt.5)GO TO 1000 
WRITE(6,fmt-(/,3x,"Linking of ALFA #",il)')linkey 
DO li = 1, anum, 2 
lj = 2*linkcy - 1 
link_mat(li,Ij) = lj 
END DO
DO li = anum+1, filenol 
lj = 2*linkey - 1 
Iink_mat(ii,lj) = lj 
END DO
ELSEIF(link_term_string( 1:2).eq.'r0'.or.link_term_string(l :2)
$ .eq.'R0')THEN 
WRITE(6,fmt='(/,3x,"Linking of r0")')
DO li = 2, anum, 2
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lj = 2*num_at_par + 1 
link_mat(li,l) = lj 
END DO
ELSEIF(link_term_string( 1:1 ).eq.'C'.or.link_term_string( 1:1)
$ .eq.'c')THEN
WRITE(6,fmt='(/,3x,"Linking of C")’)
DO li = 2, anum, 2 
lj = 2*num_at_par + 2 
link_mat(li,2) = lj 
END DO
ELSEIF(link_term_string( 1:1 ).eq.'B'.or.link_term_string( 1:1)
$ .eq.'b')THEN 
WRITE(6,fmt='(/,3x,"Linking of b")’)
DO li = 2, anum, 2 
lj = 2*num_at_par + 3 
Iink_mat(li,3) = lj 
END DO
ELSEIF(link_term_string(l:7).eq.'epsilon'.or.
$ Iink_term_string( 1:7).eq.'EPSILON')THEN 
WRITE(6,fmt='(/,3x,"Linking of epsilon")')
DO li = 2, anum, 2 
lj = 2*num_at_par + 4 
link_mat(li,4) = lj 
END DO
ELSEIF(link_term_string(l:2).eq.'PL'.or.link_term_string(l:2) 
$ .eq.'pl')THEN 
WRITE(6,fmt='(/,3x,"Linking of PL")')
DO li = 2, anum, 2 
lj = 2*num_at_par + 5 
link_mat(li,5) = lj 
END DO 
END IF
WRITE(6,fmt='(/,3x,"Link_Term: ",$)') 
READ(5,fmt='(a)')link_term_string 
END DO
WRITE(6,fmt='( 10i4)')((link_mat(i,j),j= 1,10),i= 1,filenol)
* Initialisation of the visc_gfac_mat 
5000 DO i = 1, anum
visc_gfac_mat(i) = 1 
END DO
WRITE(6,fmt='(/,3x,"Want to input G-factor(y/n)?",$)') 
READ(5,fmt='(a)')gfac
* GET INITIAL GUESSES
WRITE(6,fmt='(///,3x,"Give the Initial Guesses:")')
mat_indexat = 0
mat_indexbz = 0
DO j = 0, (num_exp - 1)
* for lifetimes
WRITE(6,fmt='(/,3x,"For Experiment #",i3)')(j + 1) 
mat_indexat = 2*j*num_at_par 
IF((j+1 ).eq. 1 )THEN 
DO i = I, num_at_par 
WRITE(6,fmt='(//,3x," ALFA #",Il,"=",$)')i 
READ(5,*)alfatau_mat(2*i-1)
WRITE(6,fmt='(//,3x," TAU #",Il,"=",$)')i 
READ(5,*)alfatau_mat(2*i)
END DO 
ELSE
DO i = 1, num_at_par 
IF(link_mat((2*j+1 ),2*i-1 ).eq.O)THEN 
WRITE(6,fmt='(//,3x," ALFA #",Il,"=",$)')i 
READ(5,*)alfatau_mat(mat_indexat+(2*i-1)) 
ELSE
WRITE(6,fmt=,(//,3x," ALFA #",11,"=",O')
$ i,alfatau_mat(2*i-l)
alfatau_mat(mat_indexat+(2*i-l)) = 0 
END IF
IF(Iink_mat((2*j+l),2*i).eq.0)THEN 
WRITE(6,fmt='(//,3x," TAU #",Il,"=",$)')i 
READ(5,*)alfatau_mat(mat_indexat+2*i) 
ELSE
WRITE(6,fmt='(//,3x," TAU #",11,"=",O')
$ i,alfatau_mat(2*i)
alfatau_mat(mat_indexat+2*i) = 0 
END IF 
END DO 
END IF
mat_index_atf = mat_indexat + 2*(i-l)
* for anisotropy decay
IF((J+1 ).LE.NUM_AEXP) THEN 
mat_indexbz = j*5 
IF((j+1 ).eq. 1 )THEN 
WRITE(6,fmt-(/,3x,"rO = "$)') 
READ(5,*)bz_mat(l)
WRITE(6,fmt='(/,3x,"C = "$)') 
READ(5,*)bz_mat(2)
WRITE(6,fmt='(/,3x,"b = "$)’)
RE AD(5, *)bz_mat(3)
WRITE(6,fmt='(/,3x,"epsilon = "$)') 
READ(5,*)bz_mat(4) 
WRITE(6,fmt=,(/,3x,"PL = "$)') 
READ(5,*)bz_mat(5)
ELSE
IF(link_mat(2*(j+l), 1 ).eq .0)THEN 
WRITE(6,fmt='(/,3x," rO = "$)’) 
READ(5,*)bz_mat(mat_indexbz+l)
ELSE
WRITE(6,fmt='(/,3x," rO = ",0')bz_mat(l)
bz_mat(mat_indexbz+l) = 0
ENDIF
IF(link_mat(2*(j+l),2).eq.0)THEN 
WRITE(6,fmt=’(/,3x," C = "$)') 
READ(5,*)bz_mat(mat_indexbz+2)
ELSE
WRITE(6,fmt='(/,3x," C = ”,0')bz_mat(2) 
bz_mat(mat_indexbz+2) = 0 
END IF
IF(link_mat(2*(j+1 ),3).eq.0)THEN 
WRITE(6,fmt='(/,3x," b = "$)') 
READ(5,*)bz_mat(mat_indexbz+3)
ELSE
WRITE(6,I’mt='(/,3x," b = ",0')bz_mat(3) 
bz_mat(mat_indexbz+3) = 0 
END IF
IF(link_mat(2*(j+l),4).eq.0)THEN 
WRITE(6,fmt='(/,3x," epsilon = "$)')
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READ(5,*)bz_mat(mat_indexbz+4)
ELSE
WRITE(6,fmt='(/,3x," epsilon = ",f)')bz_mat(4) 
bz_mat(mat_indexbz+4) = 0 
END IF
IF(link_mat(2*(j+l),5).eq.0)THEN 
WRITE(6,fmt='(/,3x," PL = "$)')
RE AD(5, * )bz_mat(mat_indexbz+5)
ELSE
WRITE(6,fmt='(/,3x,” PL = ”,f),)bz_mat(5) 
bz_mat(mat_indexbz+5) = 0 
END IF 
END IF 
ENDIF
mat_index_bzf = mat_indexbz + 3 
IFCgfac.eq.y.or.gfac.eq.'Y'yTHEN 
WRITE(6,fmt='(/,3x,"Gfactor for Exp #",i3,"= "$)')(j+l) 
READ(5,*)gfact 
visc_gfac_mat(2*(j+l)) = gfact 
ENDIF
IF(tcal_number.eq.'M'.or. tcal_number.eq.'m')THEN 
WRITE(6,fmt='(/,3x,"TCAL for Exp #",i3,"=",$)')(j+l) 
READ(5,*)tcalm(j+I)
ELSE
tcalm(j+l) = tcal_single 
END IF
IF(temp_number.eq.'M'.or. temp_number.eq.'m')THEN 
WRITE(6,fmt=’(/,3x,"TEMP for Exp #",i3,"=",$)')(j+l) 
READ(5,*)tempm(j+1)
ELSE
tempm(j+l) = temp_single 
END IF
IF(visc_number.eq.’M’.or. visc_number.eq.'m’)THEN 
WRITE(6,fmt='(/,3x,"VISC for Exp #",i3,"=",$)')(j+l) 
READ(5,*)viscm(j+l)
ELSE
viscmG+1) = visc_single 
END IF 
END DO 
ind_par_num = 1 
DO i = I, num_exp 
DO j = 1, 2*num_at_par
IF(alfatau_mat(2*(i-1 )*num_at_par+j).ne.O)THEN 
ind_par_mat(ind_par_num) = alfatau_mat(2*(i-l)*num_at_par+j) 
ind_par_num = ind_par_num + 1 
END IF 
END DO 
DO ij = 1, 5
IF(bz_mat((i-1 )*5+ij).ne.0)THEN 
ind_par_mat(ind_par_num) = bz_mat((i-l)*5+ij) 
ind_par_num = ind_par_num + 1 
END IF 
END DO 
END DO 
* Completing the linking matrix 
link_index = 1 
DO i = 1, filenol 
IF(i.eq.2)THEN
IF(num_exp.eq. 1 )THEN 
DOj = 1,5
link_mat(i,j) = linkjndex 
link_index = linkjndex + 1 
END DO 
ELSE 
DOj = I, 5
IF(link_matJ>ztem(j).eq.O)THEN 
link_mat(i,j) = linkjndex 
linkjndex = linkjndex + 1 
ELSE
DO ij = 2, filenol, 2 
link_mat(ij,j) = linkjndex 
END DO
linkjndex = linkjndex + 1 
ENDIF 
END DO 
END IF 
ELSE
IF(mod(i,2).ne.0)THEN 
DOj = 1, 2*num_at_par 
IF(link_mat(i,j).eq.O)THEN 
link_mat(i,j) = linkjndex 
linkjndex = linkjndex + 1 
ELSE
IF(linkJndex.le.link_mat(i,j))linkJndex = linkjndex + 1 
END IF 
END DO 
ELSE 
DOj = 1, 5
IF(link_mat(i,j).eq.O)THEN 
link_mat(i,j) = linkjndex 
linkjndex = linkjndex + 1 
ELSE
IF(linkJndex.le.link_mat(i,j))linkJndex = linkjndex + 1 
ENDIF 
END DO 
END IF 
END IF 
END DO 
FIXING OF PARAMETERS 
WRITE(6,fmt='(/,3x,"Do you wish to fix any parameter 
$ (y/n)?",$)')
READ(5,fmt='(a)')fix 
IF(fix.eq.y.or.fix.eq.'Y')THEN 
WRITE(6,fmt-(/,3x,"Fix TAUS(y/n):",$)’) 
READjS.fmt^jaj'jansfix 
IFCansfix.eq.'y'.or.ansfix.eq.'Y’jTHEN 
1 WRITE(6,fmt='(/,3x,"TAU #",$)')
READ(5,*)taui
WRITE(6,fmt='(/,3x,"EXP #",$)')
READ(5,*)expi
link_mat((2*expi-l),2*taui) = (-l)*link_mat((2*expi-l),2*taui) 
WRITE(6,lmt=’(/,3x,"Fix Another TAU(y/n):",$)') 
READ(5,fmt='(a)')ansfix 
IFjansfix.eq.'y'.or.ansfix.eq.'Y'jGO TO 11 
END IF
WRITE(6,l'mt-(/,3x,"Fix ALPHAS(y/n):",$)')
READ(5,fmt='(a)')ansfix
IF(ansfix.eq.'y'.or.ansfix.eq.'Y')THEN
12 WRITE(6,fmt='(/,3x,"ALFA #",$)’)
READ(5,*)alfai
WRITE(6,fmt='(/,3x,"EXP #",$)')
READ(5,*)expi
link_mat((2*expi-l),(2*alfai-l)) = (-l)*link_mat(
$ (2*expi-1 ),(2*alfai-1))
WRITE(6,fmt='(/,3x,"Fix Another ALFA(y/n):",$)') 
READ(5,fmt='(a)')ansfix
IF(ansfix.eq.'y'.or.ansfix.eq.'Y')GO TO 12 
END IF
WRITE(6,fmt='(/,3x,"Fix rO (y/n):",$)')
READ(5,fmt='(a)')ansfix
IF(ansfix.eq.'y'.or.ansfix.eq.’Y')THEN
13 WRITE(6,fmt='(/,3x,"EXP #",$)')
READ(5,*)expi
link_mat((2*expi),l) = (-l)*link_mat((2*expi),l) 
WRITE(6,fmt='(/,3x,"Fix Another rO(y/n):",$)') 
READ(5,fmt='(a)')ansfix
IF(ansfix.eq.'y'.or.ansfix.eq.'Y')GO TO 13 
END IF
WRITE(6,fmt='(/,3x,"Fix C (y/n):",$)')
READ(5,fmt='(a)')ansfix
IF(ansfix.eq.y.or.ansfix.eq.'Y')THEN
14 WRITE(6,fmt='(/,3x,"EXP #",$)')
READ(5,*)expi
link_mat((2*expi),2) = (-l)*link_mat((2*expi),2) 
WRITE(6,fmt='(/,3x,"Fix Another C(y/n):",$)') 
READ(5,fmt-(a)’)ansfix
IF(ansfix.eq.'y’.or.ansfix.eq.'Y')GO TO 14 
END IF
WRITE(6,fmt='(/,3x,"Fix b (y/n):",$)’)
READ(5,fmt='(a)')ansfix
IF(ansfix.eq.'y'.or.ansfix.eq.'Y')THEN
15 WRITE(6,fmt='(/,3x,"EXP #",$)')
READ(5,*)expi
link_mat((2*expi),3) = (-l)*link_mat((2*expi),3) 
WRITE(6,fmt='(/,3x,"Fix Another b(y/n):”,$)') 
READ(5,fmt='(a)')ansfix
IF(ansfix.eq.'y'.or.ansfix.eq.'Y')GO TO 15 
END IF
WRITE(6,fmt=,(/,3x,"Fix epsilon (y/n):",$)')
READ(5,fmt='(a)')ansfix
IF(ansfix.eq.'y'.or.ansfix.eq.'Y')TFIEN
16 WRITE(6,fmt='(/,3x,"EXP #",$)')
READ(5,*)expi
link_mat((2*expi),4) = (-l)*link_mat((2*expi),4) 
WRITE(6,fmt='(/,3x,"Fix Another epsilon(y/n):",$)') 
READ(5,fmt='(a)')ansfix
IF(ansfix.eq.'y'.or.anslix.eq.'Y')GO TO 16 
END IF
WRITE(6,fmt='(/,3x,"Fix PL (y/n):",$)') 
READ(5,fmt='(a)')ansFix
17 IF(anslix.eq.'y'.or.ansfix.eq.'Y')THEN
WRITE(6,fmt='(/,3x,"EXP #",$)')
READ(5,*)expi
link_mat((2*expi),5) = (-1 )*link_mat((2*expi),5)
WRITE(6,fmt='(/,3x,"Fix Another PL(y/n):",$)’) 
READ(5,fmt='(a)’)ansfix
IF(ansfix.eq.'y'.or.ansfix.eq.'Y')GO TO 17 
END IF 
END IF
* READING THE ASSOCIATION MATRIX
DO 1=1,  num_exp 
DO J = 1, 5 
ASSOC(J,I) = I 
END DO 
END DO
WRITE(6,fmt='(/,3x,"Do you not want to associate any 
$ TAUS & r(t) (y/n)?",$)')
READ(5,fmt='(a)')associate 
IF(associate.eq.'y'.or. associate.eq.'Y')THEN 
51 WRITE(6,fmt='(/,3x,"ASSOCIATE TAU # ",$)')
READ(5,*)NASSO_TAU 
WRITE(6,fmt='(/,3x,"In EXP # ",$)’) 
READ(5,*)NASSO_EXP 
ASSOC(NASSO_TAU,NASSOJEXP) = 0 
WRITE(6,fmt=’(/,3x,"Associate Another TAU & r(t) ?",$)') 
READ(5,fmt='(a)')asso_ans 
IF(asso_ans.eq.'y'.or.asso_ans.eq.'Y')GO TO 51 
END IF
* WRITE SECTION
OPEN(unit=50,file='bzfit.dat',status='new')
WRITE(50,fmt='(i4)')nchan
DO i = 1, (filenol+l)
WRITE(50,fmt='(a20)')lamp_file(i)
END DO
DO i = 1, (anum+1)
WRITE(50,fmt='(a20)')sample_afile(i)
END DO
DO i = l,(mnum+l) 
WRITE(50,fmt='(a20)')sample_mfile(i)
END DO 
DO i = l,afit
WRITE(50,fmt='(a20)')store_afile(i)
END DO 
DO i = 1 ,mfit
WRITE(50,fmt='(a20)')store_mfile(i)
END DO
WRITE(50,fmt='(a20)')store_file(lnum) 
WRITE(50,fmt='(al8)')weight_file_string 
WRITE(50,*)(qshift(i),i=l,filenol) 
WRITE(50,*)(tcalm(i),i=l ,num_exp) 
WRITE(50,frnt='(<2*fnum>i4)')(chan_Iim(i),i= 1,2*fiIenoI) 
WRITE(50,fmt='( 10i4)')((l ink_mat(i,j),j= 1,10),i= 1 ,filenol) 
WRITE(50,*)(ind_par_mat(i),i= 1 ,(ind_par_nuni-1))
DO J = 1, num_exp 
WRITE(50,*)(ASSOC(I,J),I=1,5)
END DO
WRITE(50,*)(visc_gfac_mat(i),i=l,num_exp) 
WRITE(50,*)(tempm(i),i=l,num_exp) 
WRITE(50,*)(viscm(i),i= 1 ,num_exp) 
WRITE(50,fmt='(a)')exp_method 
IF(exp_method.eq.'P'.or.exp_method.eq.'p')THEN 
WRITE(50,*)(taup_mat(i),i=l,filenol)
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END IF
CLOSE(50)
END
C.3. GCORR.for
PROGRAM GCORR
* TO PERFORM G-FACTOR CORRECTION FOR PERPENDICULAR CURVE FROM STEAD Y-
* STATE ANISOTROPY
* MODIFIED BASED ON GFAC.FOR (FAHMIDA CHOWDHARY)
* BY ON 3-17-93
CHARACTER DV*20,DH*20,FV*20,FH*20 
WRITE(6,40)
40 FORMAT(//,3X,'NUMBER OF CHANNELS’,27X,' : $)
READ(5,*)N
WRITE(6,45)
45 FORMAT(//,3X,'STEADY STATE ANISOTROPY VALUE', 16X,1 : $)
READ(5,*)R 
WRITE(6,10)
10 FORMAT(//,3X,'FILENAMES: DECAYS V & H, AND REFERENCES V & H : 7 )
READ(5,FMT='(A)')DV,DH,FV,FH 
OPEN (UNIT= 1 ,HLE=DV,STATUS='OLD’)
OPEN (UNIT=2,FILE=DH,STATUS-OLD1)
OPEN (UNIT=3,FILE=FV,STATUS='OLD')
OPEN (UNIT=4,FILE=FH,STATUS='OLD’)
WRITE(6,*)' OPENING DATA AND REFERENCE FILES'
READ( 1,’(A)’)JUNKLINE 
READ(2,'(A)')JUNKLINE 
READ(3,'(A)’)JUNKLINE 
READ(4,'(A)')JUNKLINE 
SUMDV = 0 
SUMDH = 0 
SUMFV = 0 
SUMFH = 0 
DO 1=1,N 
READ( I,*)X, YDV 
RE AD(2, * )X, YDH 
READ(3,*)X,YFV 
READ(4,*)X,YFH
SUMDV = SUMDV + YDV 
SUMDH = SUMDH + YDH 
SUMFV = SUMFV + YFV 
SUMFH = SUMFH + YFH 
END DO 
CLOSE(l)
CLOSE(2)
CLOSE(3)
CLOSE(4)
DVN = SUMDV/SUMFV 
DHN = SUMDH/SUMFH 
GFAC = DVN*( 1 -R)/(DHN*( 1 +2*R))
WRITE(6,*)' G-FACTOR =',GFAC
WRITE(6,*)’ CORRECTING THE VH DECAY FILE BY G-FACTOR' 
OPEN(UNIT=2,FILE=DH,STATUS='OLD')
OPEN(UNIT=7,FILE=DH,STATUS='NEW')
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READ(2,'(A)')JUNKLINE
WRITE(7,*)’ THIS VH FILE HAS BEEN CORRECTED FOR G = ',GFAC 
DO 1=1, N 
READ(2,*)X,YDH 
YDH = YDH * GFAC 
WRITE(7,*)I, YDH 
END DO 
CLOSE(2)
CLOSE(7)
WRITE(6,*)' ALL DONE...GOOD LUCK WITH ANISOTROPY ANALYSIS!'
STOP
END
C.4. SUMWT.for
* PROGRAM SUMWT
* TO CALCULATE THE TOTAL INTENSITIES AND CORRESPONDING WEIGHTING FACTORS
* FROM PARALLEL AND PERPENDICULAR ANISOTROPY DECAY CURVES USING
* I_TOTAL = I_VV + 2*I_VH
* WEIGHTING_FACTOR = I_VV + 4*I_VH
PROGRAM SUMWT
DIMENSION VVDATA( 1024), VHDATA( 1024),SUMDATA( 1024)
DIMENSION SUMA( 1024),SIGMA( 1024)
CHARACTER*20 VVFILE,VHFILE,TOTAL,WEIGHTINGS 
WRITE(6,FMT=’(2x,"The channel number is "$)’)
READ(5,*) NCHAN
WRITE(6,FMT='(2x,"Parallel file name is "$)')
READ(5,FMT='(A)') VVFILE 
WRITE(6,FMT='(2x,"Perpendicular file name is "$)')
READ(5 ,FMT='(A)') VHFILE
OPEN(61 ,FILE=VVFILE,STATU S='OLD')
READ(61 ,FMT='(A)')FJUNK 
DO I = 1, NCHAN 
READ(61,*)FJUNK,VVDATA(I)
END DO 
CLOSE(61)
OPEN(61 ,FILE=VHFILE,STATUS='OLD')
RE AD(61 ,FMT -  (A)')FJUNK
DO I = 1, NCHAN
READ(61 ,*)FJUNK,VHDATA(I)
END DO 
CLOSE(61)
DO 1=1,  NCHAN
SUMDATA(I) = VVDATA(I) + 2.*VHDATA(I)
END DO
OPEN(61 ,FILE='TOT AL.DAT',STATUS='NEW')
WRITE(61,*)' THE TOTAL INTENSITY'
DO I = 1, NCHAN 
WRITE(61,*)I, SUMDATA(I)
END DO 
CLOSE(61)
DO I = 1 ,NCHAN
SUMA(I) = VVDATA(I) + 4 *VHDATA(I)
IF (SUMA(I).EQ.O) THEN 
SIGMA(I) = 1.
ELSE
SIGMA® = l./(SUMA®)
END IF 
END DO
OPEN(61 ,FILE='WEIGH.DAT',STATUS='NEW') 
DO I = 1, NCHAN 
WRITE(61 ,*)SIGMA(I)
END DO 
CLOSE(61)
END
C.5 BZSIMU.m
clc; clear; echo off; clg;
% Fluorescence Anisotropy Decay Simulation Program 
% supporting function: noiseg.m 
% supporting data file (optional): zmax.dat 
% created October 29,1991 
% modified December, 1992
disp('NOTE: 1. If you will use an experimental lamp file, ');
disp(' please rename the lamp file as "lamp.mat" before you go on.'); 
disp(' 2. C.G.S unit wil be used in this program.');
disp(' 3. Do not type anything unless you see the prom pt»  !');
disp(");
disp(' Hit space_bar to continue » ' ) ;  
pause;
K_B= 1.380662e-16; % erg/K
global noi_length; % Find any files listed under global
a9='y'; alO=’y'; a l5= 'y '; al6= 'y '; a l9= 'y '; 
y= 1; Y= 1 ;n=0;N=0;
while eval(a9) == 1 % to start over
if eval(alO) == 1 % to re-calculate Bessel function
% Molecular Parameters / El to be calculated from PL
b=le-8*input(' Helix Hydrodynamic Radius (b) in Angstrom is »  '); % cm;
PL=le-8*input(' Persistence Length (PL) in Angstrom is »  '); % cm;
% Experimental Conditions
eta=input(' Viscosity in P is »  '); % P = dyn*s*(cm)-2;
Temp=input(' Temperature in Kelvin is »  '); % K;
nchan=input(' Channel number is (512/1024) »  '); 
t_c=le-9*input(' Time Calibreation in ns is »  '); % second;
% Calculation of Parameters & Matrix Assignment (those related to r) 
EI=PL*K_B*Temp; % Bending Ridigity, cm*erg ;
z=zeros(nchan,l); z_0=zeros(nchan,l); time=zeros(nchan,l);
channel=( 1 :nchan); chan(:,l)=channel(:); time=t_c:!:chan;
B=zeros(nchan,l); F=zeros(nchan,3); 10 = zeros(nchan,l);
Il=zeros(nchan,l); KO_l=zeros(nchan,l); K l_l=zeros(nchan,l);
K0=zeros(nchan,l); K l=zeros(nchan,l); GF=zeros(nchan,l);
FF=zeros(nchan,l); delta=zeros(nchan,l); G=zeros(nchan,3); 
zmax=zeros(nchan,l); zmax_l=zeros(nchan,l); zmax_2=zeros(nchan,l); 
disp(");d isp(");d isp(");d isp(");
dispC ****** TO GENERATE r(t) FROM B-Z THEORY ******'); disp("
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% Modified Bessel Function
a30 = input(' Load built-in zmax as initial guess (y/n) »  ','s'); 
y=l;Y =l;n=0;N =0; 
if eval(a30) == 1 
load zmax.dat; 
zmax = zmax(l:nchan); 
else
zmax=exp(z)*input(' Initial zmax is (suggested 1) »  '); 
end % if a30 load zmax 
disp(' Calculating r(t), please wait...'); 
i = sqrt(-l); 
delta=exp(z_0);
zif 1 = 0; zif2 = 0; zif3 = 0; % used to monitor the loops used 
while max(delta) > le-6
zmax_l = 2*zmax.A(-l); zmax_2 = zmax/2;
zindex = length(find(zmax > 2)) + 1; % vary from 0+1 to nchan+1
if zindex == (nchan + 1 )  % for zmax > 2 only
zif 1 = zif 1 + 1;
K0_1=1.25331414 - 0.07832358*zmax_l + 0.02189568*zm ax_l.A2; 
K 0_l=K 0_l-0.01062446*zm ax_l.A3 + 0.00587872*zmax_l A4;
K0_ 1 =K0_ 1 -0.00251540*zmax_ 1. A5 + 0.00053208 *zm ax_l.A6;
K l_ l= l .25331414 + 0.23498619*zmax_l - 0.03655620*zmax_l A2; 
K1_1=K1_1+0.01504268*zmax_ 1.A3 - 0.00780353*zmax_l.A4; 
K l_ l= K l_l+ 0.00325614*zm ax_l.A5 - 0.00068245*zmax_l A6; 
K0=exp(log(K0_l) - 0.5*log(zmax) - zmax);
K l=exp(log(K l_l) - 0.5*log(zmax) - zmax); 
elseif zindex == 1 % for zmax < 2 only
zif2 = zif2 + 1;
10 = iA(-0)*BESSELN(0,i*zmax);
11 = iA(-l)*BESSELN(l,i*zmax); % different from HELP ?
K0 = -log(zmax_2). *real(I0) - 0.57721566 + 0.42278420*zmax_2 A2;
K0 = K0 + 0.23069756*zmax_2.A4 + 0.03488590*zmax_2 A6;
K0 = K0 + 0.00262698*zmax_2.A8 + 0.00010750*zmax_2.A10;
K0 = KO + 0.00000740*zmax_2.A12;
K1 = zmax.*log(zmax_2).*real(Il) + 1 + 0.15443144*zmax_2.A2;
K1 = K 1 -0.67278579*zmax_2. A4-0.18156897*zmax_2. A6- 
0.01919402*zmax_2.A8;
K1 = (K 1-0.00110404*zmax_2.A10-0.00004686*zmax_2.A12).*(zmax.A(-l)); 
else % for both zmax 
% for zmax <=2 
zif3 = zif3 + 1;
IO(zindexrnchan) = iA(-0)*BESSELN(0,i*zmax(zindex:nchan)); 
Il(zindex:nchan) = iA(- l) :|;BESSELN(l,i*zniax(zindex:nchan)); 
K0(zindex:nchan) = -log(zmax_2(zindex:nchan)).*real(I0(zindex:nchan)); 
K0(zindex:nchan) = K0(zindex:nchan) - 0.57721566;
K0(zindex: nchan) = K0(zindex:nchan) + 0.42278420*zmax_2(zindex:nchan).A2; 
K0(zindex:nchan) = K0(zindex:nchan) + 0.23069756*zmax_2(zindex:nchan).A4; 
K0(zindex:nchan) = K0(zindex:nchan) + 0.03488590*zmax_2(zindex:nchan).A6; 
K0(zindex:nchan) = K0(zindex:nchan) + 0.00262698:|:zmax_2(zindex:nchan).A8; 
K0(zindex:nchan) = K0(zindex: nchan) + 0.00010750*zmax_2(zindex:nchan).A 10; 
K0(zindex:nchan) = K0(zindex:nchan) + 0.00000740*zmax_2(zindex:nchan).A12; 
Kl(zindex:nchan) = zmax(zindex:nchan).*log(zmax_2(zindex:nchan));
K1 (zindex: nchan) = Kl(zindex:nchan).*real(Il(zindex:nchan));
Kl(zindex:nchan) = K1 (zindex:nehan)+l+0.15443144*zmax_2(zindex:nchan).A2;
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Kl(zindex:nchan) = K1 (zindex:nchan) - 0.67278579*zmax_2(zindex:nchan).A4; 
Kl(zindex:nchan) = Kl(zindex:nchan) - 0.18156897*zmax_2(zindex:nchan).A6; 
Kl(zindex:nchan) = K1 (zindex:nchan) - 0.01919402*zmax_2(zindex:nchan).A8; 
Kl(zindex:nchan) = Kl(zindex:nchan) - 0.00110404*zmax_2(zindex:nchan).A10; 
Kl(zindex:nchan) = Kl(zindex:nchan) - 0.00004686*zmax_2(zindex:nchan).A12; 
K1 (zindex: nchan) = Kl(zindex:nchan).*(zmax(zindex:nchan).A(-l));
% for zmax > 2
K 0_l(l:zindex-1) = 1.25331414 - 0.07832358*zm ax_l(l:zindex-l); 
K 0_l(l:zindex-1) = K 0_l(l:zindex-1) + 0.02189568*zm ax_l(l:zindex-l).A2; 
K 0_l(l:zindex-1) = K 0_l(l:zindex-1) - 0.01062446*zm ax_l(l:zindex-l).A3; 
K 0_l(l:zindex-1) = K 0_l(l:zindex-1) + 0.00587872*zm ax_l(l:zindex-l).A4; 
K 0_l(l:zindex-1) = K 0_l(l:zindex-1) - 0.00251540*zm ax_l(l:zindex-l).A5; 
K 0_l(l:zindex-1) = K 0_l(l:zindex-1) + 0.00053208*zm ax_l(l:zindex-l).A6; 
K l_ l(l:z index-1) = 1.25331414 + 0.23498619*zm ax_l(l:zindex-l);
K 1_ 1(1:zindex-1) = K l_l(l:zindex-1) - 0.03655620*zm ax_l(l:zindex-l).A2; 
K l_ l(l:z index-1) = K l_l(l:zindex-1) + 0.01504268*zm ax_l(l:zindex-l).A3; 
K l_ l(l:z index-1) = K l_ l(l:z index-1) - 0.00780353*zm ax_l(l:zindex-l).A4; 
K l_ l(l:z index-1) = K l_l(l:zindex-1) + 0.00325614*zm ax_l(l:zindex-l).A5; 
K l_l(l:z index-1) = K l_ l(l:z index-1) - 0.00068245*zm ax_l(l:zindex-l).A6; 
K0(l:zindex-1) = exp(log(KO_l(l:zindex-l)) - 0.5*log(zmax(l:zindex-l))...
- zm ax(l:zindex-l));
K l(l:zindex-1) = exp(log(K l_l(l:z index-l)) - 0.5*log(zmax(l:zindex-l))...
- zmax(l :zindex-1));
end % of if zindex
z = (K0+(zm ax/2).*Kl).A(l/4); 
z_0 = b*(5.024*pi*eta*(EI*time).A(-l)).A(l/4).*z.A(-l); 
delta = abs(z_0-zmax).*abs(z_0).A(-l); 
zmax = z_0;
end % of while max(delta)
B=3.466*KJB*Temp/(piA5*EIA3*eta)A(l/4)*z;
GF=B.*time.A(l/4)/4; % used in loop for k= l:3
end % a 10 if re-calculate Bessel function
5(t ^  ^  ^  ^  ^  •i' *1* 'I ' ^  *i» ^  5|t »{» rjt ^
y= 1; Y= 1 ;n=0;N=0;
if eval(al5) == 1 % new C
C=input(' Torsional Ridigity in erg*cm is »  '); 
end % a l5  if new C
rho=4*pi*eta*bA2;
A=K_B*Temp/(pi*C*rho)A(l/2);
FF=A*time.A(l/2); % used in the loop for k =1:3
y=l ;Y=1 ;n=0;N=0;
if eval(al6) == 1 % if new angle
epsilon=input(' The Angle between the Transition Dipole & the Helix Axis »  ');
epsilon=(epsilon/180)*pi;
I=zeros(3,l);
I( 1 )=(3 *(cos(epsilon))A2 -1) A2/4;
I(2)=3*(sin(2*epsilon))A2/4;
I(3)=3*(sin(epsilon))A4/4;
end % al 6 if new angle
y= 1 ;Y= 1 ;n=0;N=0;
a 17 = eval(a 16) + eval(a 15) + eval(a 10); 
if a l7  >= 1 % new r(t)
r=zeros(nchan,l); G=zeros(nchan,3); F=zeros(nchan,3); 
for k= 1:3
146
n=k-1;
G(:,k)=exp(-(6-nA2)*GF);
F(:,k)=exp(-nA2*FF); 
r=0.4*I(k).*G(:,k).*F(:,k) + r; 
end % of for
end % a 17 if new r(t)
*************************
a7='y'; y=l;Y =l;n=0;N =0;
while eval(a7) == 1 % new lamp and lifetime decay
disp(");disp(");disp(");
dispC ****** TO GENERATE AN IDEAL LIFETIME DECAY CURVE ******'); 
disp(");
y=l;Y =l;n=0;N =0;
if eval(al9) == 1 % new parameters
Flu_the=zeros(nchan,l); Lmax=zeros(nchan,l); L=zeros(nchan,l); 
Flu_obs_max=zeros(nchan, 1); 
n=input(' How Many Components of Lifetime ? »  '); 
for k= l:n
x=[' A lphaJ num 2str(k)' is »  ']; disp(x); alpha(k)=input("); 
x=[' Tau_' num 2str(k)' in ns is »  ']; disp(x); tau(k)=le-9*input(");
F lu jh e  = alpha(k)*exp(-time/tau(k)) + Flu_the; 
end
p=input(' The desired peak counts is »  '); % only filename_max having max p
^  ^  *|» ^  ^  ^  ^  «|f |^/ ^  ^  ft|« ^ J# «J/ ^  kjk k|a kj# kjk k|« kjk
a2=input(' Experimental or theoretical lamp (E or T) »  ','s');
E=l;e=l;T=0;t=0;
if eval(a2)== 1 % a2 for theo / expt lamp
load lamp; Lmax=lamp; 
else
disp(' To generate a lamp file from exp(-t/A) - exp(-t/B )');
D=le-9*input(' A in ns is »  '); E=le-9*input(' B in ns is »  ’);
L=zeros(nchan,l);
L=exp(-time/D)-exp(-time/E); 
plmax = p/max(L);
Lmax = plmax*L; 
disp(");
disp(T. Theoretical lamp with no noise added.1); 
disp('2. Theoretical lamp with Gaussian noise added after convolution.'); 
disp('3. Theoretical lamp with Gaussian noise added before convolution.'); 
a3=input(' Select number 1, 2, or 3 »  '); % a3 for lamp options
if a3==3
noi_length = length(Lmax);
Lmax = Lmax + noiseg.*sqrt(Lmax);
for k = 1 :nchan
if Lmax(k) < 0
Lmax(k) = 0;
end
end
end % of if a3
end % of if a2
I * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * : * * * * * * * * : ( ; * * * * * * * * * * * * * * * * * * * * * * * *
% generate observed decay curves 
Flu_obs = conv(Lmax,Flu_the);
Flu_obs = Flu_obs( 1 :nchan); % take only nchan rows of data
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pmax = p/max(Flu_obs);
Flu_obs_max = pmax*Flu_obs;
end % a l9  if  new parameters
% To generate I_pa & I_pe from r(t), lamp, & Flu_the 
I_pa_the=zeros(nchan,l); I_pe_the=zeros(nchan,l);
I_pa_max=zeros(nchan, 1); I_pe_max=zeros(nchan, 1);
I_pa_the = (1/3)*(1 + 2*r).*Flu_the;
I_pe_the = (1/3)*(1 - r).*Flu_the;
I_pa_obs = conv(Lmax,I_pa_the);
I_pa_obs = I_pa_obs(l: nchan); 
p_I_pa_max = p/max(I_pa_obs);
I_pa_max = p_I_pa_max*I_pa_obs;
I_pe_obs = conv(Lmax,I_pe_the);
I_pe_max = p_I__pa_max*l__pe_obs( 1: nchan); 
if a3==2 % noisey lamp after convolution
noi_length = length(Lmax);
Lmax = Lmax + noiseg.*sqrt(Lmax); 
for k = 1: nchan 
if Lmax(k) < 0 
Lmax(k) = 0; 
end 
end
end
noi_length = length(I_pa_max);
I_pa_max = I_pa_max + noiseg.*sqrt(I_pa_max); 
noi_length = length(I_pe_max);
I_pe_max = I_pe_max + noiseg.*sqrt(I_pe_max); 
for k = 1 :nchan 
if I_pa_max(k) < 0 
I_pa_max(k) = 0; 
end
if I_pe_max(k) < 0 
I_pe_max(k) = 0; 
end 
end
a4=input(' Plot Lamp & Flu_obs (Y/N) ? » ', 's ') ;  y=l;Y =l;n=0;N =0;
axis([l 2 3 4]);axis; 
if eval(a4)==l
plot( le9*time,Lmax,'-', 1 e9*time,Flu_obs_max( 1 :length(time)),7); 
title('Lamp (-) & Flu_obs (.)');
xlabel('TIME (ns) '); disp(' Hit space_bar to continue »  '); pause; 
end % a4 if plot lamp
a5 = input(' Plot I_pa & I_pe (Y/N) ? »  ','s'); y=l;Y =l;n=0;N =0;
axis([l 2 3 4]);axis; 
if e v a l(a 5 )= l 
plot(le9*time,I_pa_max(l:length(time)),':',...
Ie9*time,l_pe_max(l:length(time)),'—'); 
title('I_pa (:) & I_pe (—)'); xlabel('TIME (ns)'); 
disp(' Hit space_bar to continue »  '); pause; 
end % a5 if plot I_pae
disp(");
disp('****** To generate r_obs(t) from I_pa & I_pe ******');disp(");
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I_pa_z = find(I_pa_max > 0); 
if max(I_pa_z) == nchan
x=[' I_pa > 0 at all ',num2str(nchan),' channels'];disp(x); 
else x=[' I_pa = 0 after channel # ',num2str(max(I_pa_z))];disp(x); 
end
I_pe_z = find(I_pe_max > 0); 
if max(I_pe_z) == nchan
x=[' I_pe > 0 at all ',num2str(nchan),' channels'];disp(x); 
else x=[' I_pe = 0 after channel # ',num2str(max(I_pe_z))];disp(x); 
end
j=input(' Start calculation at channel # = »  '); 
k=input(' End calculation at channel # = »  ');
r_obs(j:k)=(I_pa_max(j:k) - I_pe_max(j:k))./(I_pa_max(j:k) + 2*I_pe_max(j:k));
a6 = input(' Plot r_obs(t) (Y/N) ? »  ',’s'); y=l;Y =l;n=0;N =0;
axis([l 2 3 4]);axis; 
while eval(a6)==l
plot(le9*time(j:k),r_obs(j:k));
title('r_obs(t)');
xlabel('TIME (ns)'); disp(' Hit space_bar to continue »  '); pause; 
a6 = input(' Print r_obs(t) (Y/N) ? »  ','s'); y=l;Y =l;n=0;N =0;
if eval(a6)==l 
p rin tjaser;
end % a6 if print r
a6 = input(' W ant to reset the r axis (y/n) »  ','s'); y=l;Y =l;n=0;N =0; 
if eval(a6) == 1
r_min = input(' Lower value of r axis is »  ’); 
r_max = input(' Upper value of r axis is »  '); 
v=[ le9*time(j), le9*time(k),r_rnin,r_max]; 
axis(v);
end % a6 if
end % a6 while plot r
a6 = input(' Plot r(t) directly from theory (Y/N) ? »  ','s'); 
y=l;Y =l;n=0;N =0; axis([l 2 3 4]);axis;
while eval(a6) == 1 
plot( le9*time(j :k),r(j :k)); 
title('r_the(t)');
xlabel('TIME (ns)'); disp(' Hit space_bar to continue »  '); pause; 
a6 = input('Print r_the(t) (Y/N) ? »  ','s'); y=l;Y =l;n=0;N =0;
if eval(a6)==l 
p rin tjaser;
end % a6 if print r
a6 = input('W ant to reset the r axis (y/n) »  ','s'); y=l;Y =l;n=0;N =0;
if eval(a6) == 1
r_min = input(' Lower value of r axis is »  '); 
r_max = input(' Upper value of r axis is »  '); 
v=[le9*tim e(j),le9:i:time(k),r_min,r_max]; 
axis(v);
end % a6 if reset axis
end % a6 while plot r
disp(");
x=['r(l) = ',num 2str(r(l)),' r(end) = ’,num2str(r(nchan))];disp(x); 
x=['r_obs(l) = ’,num 2str(r_obs(l)),’ r_obs(end) = ’,num2str(r_obs(nchan))]; 
disp(x);
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a7=input(' Change Lamp and lifetime parameters now (y/n) »  ','s'); 
a l9 = ’y ’;
end % a7 while new lamp and lifetime decay
a8=input(' Save I_pa_obs & I_pe_obs as VsimOO.VV & VsimOO.VH (y/n) »  ','s'); 
y=l;Y =l;n=0;N =0; 
if eval(a8) == 1 
vsimOOvv = [chan,I_pa_max]; 
vsimOOvh = [chan,I_pe_max]; 
vsimOOdat = [chan,Flu_obs_max]; 
lampdat = [chan,Lmax]; 
save vsimOO.vv vsimOOvv -ascii; 
save vsimOO.vh vsimOOvh -ascii; 
save vsimOO.dat vsimOOdat -ascii; 
save lamp.dat lampdat -ascii;
disp(' I_the and lamp saved as vsimOO.dat and lamp.dat'); 
al8=input(' Generate a probe data file (y/n) »  ','s'); 
y= 1; Y= 1 ;n=0;N=0; 
if eval(al8) == 1 
t_p=le-9*input(' t_p will be '); 
probe=exp(-time/t_p); 
probe=conv(Lmax,probe); 
probe=probe( 1 :nchan); 
probe_max=(p/max(probe))*probe; 
if  a l2  == 1 % 3rd a l 2 if add noise
noi_length = length(probe_max); 
probe_max = probe_max + noiseg.*sqrt(probe_max); 
for k = 1 :nchan 
if probe_max(k) < 0 
probe_max(k) = 0; 
end 
end
end % 3rd a l 2 if add noise
fsimOOdat = [chan,probe_max]; 
save fsimOO.dat fsimOOdat -ascii;
end % a l8  if generate probe
end % a8 if save
a9=input(' Want to start over (y/n) »  ','s'); 
y= 1; Y= 1 ;n=0;N=0;
if eval(a9) == 1 % 2nd a9
alO=input(' Will temperature, viscosity, b, or PL change (y/n) »  ','s'); 
al5=input(' Will torsional rigidity C change (y/n) »  ','s'); 
al6=input(' Will the angle change (y/n) »  ','s'); 
disp(");
disp(' Will Lamp and Lifetime decay param eters'); 
a l9  =input(' (including timing parameters) change (y/n) »  ','s'); 
end % 2nd a9 if
end % 1st a9 while to start over
c^q -}■ -f-'(■ •}■ -j-'j*'}■ '!• -I*'}• ']• 't' '}• end of the pro^fflni
% Function noiseg.m to generate a Gaussian noise array for BZSIMU.M 
% The length is noi_length given by global
function noise=noiseg; 
rand('uniform ');
noise=sqrt(-2*log(rand(noi_length,l))).*cos(2*pi*rand(noi_length,l));
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